Studied for
52 endpoints · 108 findings · 66 papers · 38 null
- Diarrhoea durationlowersEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.
- All-cause mortalitylowersEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- C-reactive protein concentrationlowersEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Body massraisesEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Total cholesterol (TC)lowersEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
Structure
Drawn to one scale across every element, so a circle here is comparable with the same circle on another page. The radii themselves are beside this.
- Atomic radius
- 135 pm
- Ionic radius (Zn²⁺)
- 74 pm
- Electronegativity
- 1.65 Pauling
- Class
- Element, as a monatomic cation
- Formula
- Zn
- Mass
- 65.39 g/mol
- Charge
- +2
- InChIKey
- PTFCDOFLOPIGGS-UHFFFAOYSA-N
- SMILES
- [Zn+2]
- Look it up
- ChEBIBy InChIKey
Identity from ChEBI. Not evidence.
What the evidence says
How to read these marks108 findings · 52 endpoints · 66 papers · 38 null · by evidence strength
- Evidence strength
- Strong
- Moderate
- Limited
- Very limited
- Insufficient
What moved
70 findings
Decreases diarrhoea duration
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.Findingreplicated ×5“On average, zinc supplementation reduced the duration of persistent diarrhoea by around 16 hours (MD −15.84 hours, 95% CI −25.43 to −6.24 hours; 529 children, 5 trials), with no evidence of heterogeneity.”
Quoted verbatim from Oral zinc for treating diarrhoea in children.. - Study
- meta-analysis
- Participants
- 529
- Dose
- oral zinc salt at 5 mg/day or more
- Population
- Children over six months of age with persistent diarrhoea (lasting more than 14 days); oral zinc versus placebo
Effect -15.84 mean difference, 95% CI -25.43 to -6.24
Oral zinc for treating diarrhoea in children.2016PMID:27996088Permalink
Decreases diarrhoea duration
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.Findingreplicated ×5“Twenty-four trials reported on the duration of diarrhoea, and the associated meta-analysis suggested that the duration of diarrhoea decreased significantly in the zinc group as compared to no zinc/placebo group (MD = −13.27 hours; 95% CI = −17.66, −8.89; 24 trials, 6249 participants, moderate certainty of evidence).”
Quoted verbatim from Zinc supplementation for acute and persistent watery diarrhoea in children: A systematic review and meta-analysis.. - Study
- meta-analysis
- Participants
- 6,249
- Population
- Children under 10 years with acute watery diarrhoea; pooled across trials of oral zinc (various salts and doses) versus no zinc or placebo, standard care such as ORS given to both groups
Effect -13.27 mean difference, 95% CI -17.66 to -8.89
Zinc supplementation for acute and persistent watery diarrhoea in children: A systematic review and meta-analysis.2024PMID:39641338An author is affiliated with a producerPermalink
Decreases diarrhoea duration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×5“Acute episodes were 4% (95% CI: 1%–8%) shorter in duration among children treated with zinc compared to those receiving placebo (Table 2).”
Quoted verbatim from Oral zinc supplementation for the treatment of acute diarrhea in children: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Children under five years with acute diarrhoea; pooled non-Chinese randomised placebo-controlled studies only (the Chinese studies were not pooled with these for episode duration)
Oral zinc supplementation for the treatment of acute diarrhea in children: a systematic review and meta-analysis.2013PMID:24284615Permalink
Decreases C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×5“After the treatment period, the Zn-supplemented patients had significantly decreased concentrations of hs-CRP, TNF-α, and IL-1β compared to patients not receiving Zn supplementation.”
Quoted verbatim from Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 11 mg elemental Zn per day (78 mg Zn gluconate), after dinner
- Population
- Long-term hemodialysis patients with low plasma zinc, supplemented for eight weeks versus patients given no supplement
Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.2013PMID:23289009Permalink
Increases blood haemoglobin concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“After eight weeks, HD patients receiving Zn supplementation had markedly higher nPNA, hemoglobin, and albumin concentrations, as well as higher eGFR, than patients who did not receive Zn supplements.”
Quoted verbatim from Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 11 mg elemental Zn per day (78 mg Zn gluconate), after dinner
- Population
- Long-term hemodialysis patients with low plasma zinc, supplemented for eight weeks versus patients given no supplement
Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.2013PMID:23289009Permalink
Increases serum albumin
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“After eight weeks, HD patients receiving Zn supplementation had markedly higher nPNA, hemoglobin, and albumin concentrations, as well as higher eGFR, than patients who did not receive Zn supplements.”
Quoted verbatim from Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 11 mg elemental Zn per day (78 mg Zn gluconate), after dinner
- Population
- Long-term hemodialysis patients with low plasma zinc, supplemented for eight weeks versus patients given no supplement
Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.2013PMID:23289009Permalink
Show the remaining 64
Increases estimated glomerular filtration rate
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“After eight weeks, HD patients receiving Zn supplementation had markedly higher nPNA, hemoglobin, and albumin concentrations, as well as higher eGFR, than patients who did not receive Zn supplements.”
Quoted verbatim from Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 11 mg elemental Zn per day (78 mg Zn gluconate), after dinner
- Population
- Long-term hemodialysis patients with low plasma zinc, supplemented for eight weeks versus patients given no supplement
Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.2013PMID:23289009Permalink
Increases Mini-Mental State Examination total score
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Specifically, the mean MMSE score was significantly higher in the Zn-supplemented group (28.46 (95% CI 27.95–28.97)) in comparison to the placebo group (27.57 (95% CI 26.91–28.94)), indicating improved performance on the test following supplementation.”
Quoted verbatim from Effects of Zinc Supplementation on Inflammatory and Cognitive Parameters in Middle-Aged Women with Overweight or Obesity.. - Study
- RCT
- Duration
- 3 months
- Dose
- 30 mg/day zinc as chelated zinc bisglycinate, one capsule daily after a main meal for 12 weeks
- Population
- Overweight or obese women aged 40 to 60 years, pilot double-blind placebo-controlled trial; post-intervention scores after 12 weeks, adjusted for baseline
Effects of Zinc Supplementation on Inflammatory and Cognitive Parameters in Middle-Aged Women with Overweight or Obesity.2023PMID:37892471Permalink
Decreases HOMA-IR
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Zinc supplementation significantly reduced HOMA‐IR (MD = −1.10; 95% CI −2.05 to −0.15; p = 0.02), with considerable heterogeneity (I 2 = 79%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect -1.1 mean difference, 95% CI -2.05 to -0.15
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Decreases C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×5“Five studies showed a significant reduction in CRP/hs‐CRP following zinc supplementation (SMD = −0.91; 95% CI −1.43 to −0.38; p = 0.0007), with considerable heterogeneity (I 2 = 76%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect -0.91 standardised mean difference, 95% CI -1.43 to -0.38
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Decreases malondialdehyde (circulating)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“Four studies showed significantly lower MDA with zinc supplementation (SMD = −0.76; 95% CI −1.34 to −0.18; p = 0.010), with substantial heterogeneity (I 2 = 77%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect -0.76 standardised mean difference, 95% CI -1.34 to -0.18
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Increases total antioxidant capacity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“Four studies showed significantly higher TAC with zinc supplementation (SMD = 1.79; 95% CI 0.68 to 2.91; p = 0.002), with substantial heterogeneity (I 2 = 92%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect 1.79 standardised mean difference, 95% CI 0.68 to 2.91
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Decreases total cholesterol (TC)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×3“Six studies demonstrated significantly lower total cholesterol with zinc supplementation (MD = −5.70; 95% CI −7.50 to −3.89; p < 0.00001), with negligible heterogeneity (I 2 = 0%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect -5.7 mean difference, 95% CI -7.5 to -3.89
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Increases superoxide dismutase activity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“In the crude analysis, we found that levels of serum zinc, dietary protein intake, and SOD in the zinc supplementation group were higher than levels in control group after treatment.”
Quoted verbatim from Effect of Zinc Supplementation on Maintenance Hemodialysis Patients: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials.. - Study
- meta-analysis
- Dose
- elemental zinc 11 to 100 mg across trials
- Population
- Maintenance hemodialysis patients in 15 pooled randomised trials of oral zinc supplementation against placebo or blank control
Effect of Zinc Supplementation on Maintenance Hemodialysis Patients: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials.2017PMID:29457023Permalink
Decreases C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×5“CRP and MDA levels were lower after zinc supplementation (CRP: WMD = −8.618, 95% CI = −15.579 to −1.656, P = 0.015; MDA: WMD = −1.275, 95% CI = −1.945 to −0.605, P < 0.001).”
Quoted verbatim from Effect of Zinc Supplementation on Maintenance Hemodialysis Patients: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials.. - Study
- meta-analysis
- Dose
- elemental zinc 11 to 100 mg across trials
- Population
- Maintenance hemodialysis patients in 15 pooled randomised trials of oral zinc supplementation against placebo or blank control
Effect -8.618 mean difference, 95% CI -15.579 to -1.656
Effect of Zinc Supplementation on Maintenance Hemodialysis Patients: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials.2017PMID:29457023Permalink
Increases body mass
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“Zinc supplementation after birth significantly increased weight (N = 39, WMD = 0.14 kg, 95%CI: 0.07–0.21, I2 = 84.7).”
Quoted verbatim from Effect of Zinc Supplementation on Growth Outcomes in Children under 5 Years of Age.. - Study
- meta-analysis
- Population
- Infants and children up to 5 years in 39 pooled randomised trials of zinc supplementation lasting 3 months or longer after birth; iron or multi-micronutrient co-interventions given to both groups in 30 of 54 child trials
Effect 0.14 mean difference, 95% CI 0.07 to 0.21
Effect of Zinc Supplementation on Growth Outcomes in Children under 5 Years of Age.2018PMID:29558383An author is affiliated with a producerPermalink
Decreases LDL cholesterol
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“After analyzing the results of 14 studies with 17 effect sizes, a significant reduction in serum concentrations of LDL was observed following zinc supplementation (WMD: −6.18; 95% CI: −9.35, −3.02; P < 0.001).”
Quoted verbatim from The Effect of Zinc Supplementation on Lipid Profiles in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials.. - Study
- meta-analysis
- Population
- Adults with type 2 diabetes mellitus; 14 randomised trials, zinc supplement versus placebo or no zinc, some trials with a co-supplement given identically in both arms
Effect -6.18 mean difference, 95% CI -9.35 to -3.02
The Effect of Zinc Supplementation on Lipid Profiles in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials.2023PMID:37604307Permalink
Decreases tumour necrosis factor alpha concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“After the treatment period, the Zn-supplemented patients had significantly decreased concentrations of hs-CRP, TNF-α, and IL-1β compared to patients not receiving Zn supplementation.”
Quoted verbatim from Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 11 mg elemental Zn per day (78 mg Zn gluconate), after dinner
- Population
- Long-term hemodialysis patients with low plasma zinc, supplemented for eight weeks versus patients given no supplement
Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.2013PMID:23289009Permalink
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×5“Compared to non-users, post-diagnosis zinc supplement use was associated with a suggestively lower risk of lethal prostate cancer (HR [95% CI], 0.82 [0.60–1.13]) and significantly lower all-cause mortality (0.84 [0.74–0.96]).”
Quoted verbatim from Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate Cancer.. - Study
- cohort
- Dose
- any post-diagnostic zinc supplement use (self-reported; dose categories <25 to >=101 mg/day)
- Population
- Men with nonmetastatic prostate cancer in the Health Professionals Follow-up Study (5,788 men; 851 reported post-diagnosis zinc supplement use), compared with non-users; median follow-up 11 years
Effect 0.84 hazard ratio, 95% CI 0.74 to 0.96
Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate Cancer.2023PMID:36453265Permalink
Decreases incidence of stroke
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Serum zinc levels were inversely associated with incidence of ischemic stroke after adjustment for potential confounders (quartile 4 vs. quartile 1: HR=0.78, 95% CI: 0.61-0.98, p=0.03 for trend).”
Quoted verbatim from Serum Zinc Levels and Incidence of Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.. - Study
- cohort
- Population
- Case-cohort within the REGARDS cohort: US adults aged 45 or older, random sub-cohort (n=2,346) plus 660 incident ischemic stroke cases; exposure is baseline endogenous serum zinc by quartile, not a dose
Effect 0.78 hazard ratio, 95% CI 0.61 to 0.98
Serum Zinc Levels and Incidence of Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.2021PMID:34412513Permalink
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×5“At multivariable Cox proportional hazards regression analyses, the 30-day mortality was lower in patients who received zinc sulfate (HR 0.52 CI 0.29, 0.92; p = 0.03).”
Quoted verbatim from Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study.. - Study
- cohort
- Dose
- zinc sulfate 220 mg (50 mg elemental zinc) enteral tablet once daily
- Population
- Critically ill adults with COVID-19 in two Saudi ICUs, propensity-score matched 1:1, zinc sulfate newly started in ICU versus no zinc
Effect 0.52 hazard ratio, 95% CI 0.29 to 0.92
Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study.2021PMID:34663411Permalink
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×5“In the multivariable stratified Cox proportional hazards analysis, zinc supplementation was significantly associated with a reduced risk of mortality (Hazard Ratio [HR]: 0.64; 95% CI: 0.44–0.94; p = 0.023).”
Quoted verbatim from Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver Cirrhosis.. - Study
- cohort
- Dose
- zinc acetate (98.4%) or zinc histidine (1.6%), 50-100 mg/day as formulation weight
- Population
- Adults with liver cirrhosis and baseline serum zinc below 70 µg/dL, zinc-treated vs untreated after propensity score matching (119 per group); retrospective single-centre cohort
Effect 0.64 hazard ratio, 95% CI 0.44 to 0.94
Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver Cirrhosis.2026PMID:42124080Permalink
Decreases triglycerides
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×3“After analyzing the results of 14 studies with 17 effect sizes, a significant reduction in serum concentrations of TG was observed following zinc supplementation (WMD: −13.08; 95% CI: −21.83, −4.34; P = 0.003).”
Quoted verbatim from The Effect of Zinc Supplementation on Lipid Profiles in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials.. - Study
- meta-analysis
- Population
- Adults with type 2 diabetes mellitus; 14 randomised trials, zinc supplement versus placebo or no zinc, some trials with a co-supplement given identically in both arms
Effect -13.08 mean difference, 95% CI -21.83 to -4.34
The Effect of Zinc Supplementation on Lipid Profiles in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials.2023PMID:37604307Permalink
Increases body mass
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Findingreplicated ×1“Two studies showed significantly higher body weight with zinc supplementation (MD = 2.38; 95% CI 1.40 to 3.35; p < 0.00001; I 2 = 0%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect 2.38 mean difference, 95% CI 1.4 to 3.35
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Increases LDL cholesterol
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“Seven studies demonstrated a significant increase in LDL cholesterol with zinc supplementation (MD = 3.46; 95% CI 1.48 to 5.43; p = 0.0006), with very low heterogeneity (I 2 = 3%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect 3.46 mean difference, 95% CI 1.48 to 5.43
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Increases body mass index
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“Four studies reported significantly higher BMI with zinc supplementation (MD = 0.85; 95% CI 0.57 to 1.14; p < 0.00001; I 2 = 0%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect 0.85 mean difference, 95% CI 0.57 to 1.14
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Decreases fasting blood glucose
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Findingreplicated ×3“We observed a significant association of total zinc intake with lower fasting glucose levels (summary P value = 0.0003), with an estimated 0.0012 mmol/L lower fasting glucose concentration per 1 mg greater daily total zinc intake.”
Quoted verbatim from Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis.. - Study
- cohort
- Population
- Adults of European ancestry without diabetes in a 5-cohort cross-sectional meta-analysis; total zinc intake from food plus supplements, per 1 mg/day
Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis.2011PMID:21810599Permalink
Increases all-cause mortality
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“Increased whole blood Zn per 1 mg/L was significantly associated with a 32% higher HR for all-cause mortality, serum Cu per 0.1 mg/L with 18%, and Cu:Zn ratio per 0.1 arbitrary unit with 6%.”
Quoted verbatim from Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients.. - Study
- cohort
- Population
- Newly diagnosed, treatment-naive lung cancer patients; endogenous whole blood zinc concentration (not an administered dose), univariate Cox analysis, median follow-up 43 months
Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients.2020PMID:33375477Permalink
Increases adverse event occurrence (oral or enteral supplement)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Overall adverse events (OR 1.58, 95% CI 1.19 to 2.09) (P = 0.002), bad taste (OR 2.31, 95% CI 1.71 to 3.11) (P < 0.00001) and nausea (OR 2.15, 95% CI 1.44 to 3.23) (P = 0.002) were higher in the zinc group.”
Quoted verbatim from Zinc for the common cold.. - Study
- meta-analysis
- Population
- Participants in randomised double-blind placebo-controlled trials of zinc for treating or preventing the common cold, pooled across zinc formulations
Effect 1.58 odds ratio, 95% CI 1.19 to 2.09
Zinc for the common cold.2013PMID:23775705Permalink
Increases HDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Moreover, zinc supplementation increased HDL-C (WMD = 4.82 mg/dL; 95% CI: 0.88, 8.76; P = 0.016) in patients with T2DM.”
Quoted verbatim from Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.. - Study
- meta-analysis
- Population
- Patients with type 2 diabetes mellitus; 19 RCTs pooled
Effect 4.82 mean difference, 95% CI 0.88 to 8.76
Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.2024PMID:38224402Permalink
Decreases glycated haemoglobin (HbA1c)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Similarly, zinc supplementation significantly decreased fasting blood glucose (SMD - 0.52, 95% CI - 0.96, - 0.07) and HbA1c (SMD - 0.64, 95% CI - 1.27, - 0.02).”
Quoted verbatim from Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Participants in 20 randomized or controlled trials of zinc supplementation (1141 in the intervention groups overall)
Effect -0.64 standardised mean difference, 95% CI -1.27 to -0.02
Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials.2020PMID:31494808Permalink
Decreases colorectal cancer incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Comparing the highest with lowest categories, higher zinc intake was significantly associated with reduced colorectal cancer risk (pooled RR = 0.80, 95% CI: 0.70-0.92; p = 0.002), while zinc intake was not statistically associated with gastric cancer risk (pooled RR = 0.91, 95% CI: 0.64-1.29; p = 0.581) or esophageal cancer risk (pooled RR = 0.72, 95% CI: 0.44-1.17; p = 0.187).”
Quoted verbatim from Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Adults in observational studies; highest versus lowest category of dietary zinc intake
Effect 0.8 risk ratio, 95% CI 0.7 to 0.92
Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis.2014PMID:24148607Permalink
Decreases fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“In the overall analysis, a small but statistically significant reduction in fasting glucose concentrations was observed (-0.19±0.08mmol/L, P=0.013) after zinc supplementation.”
Quoted verbatim from Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans.. - Study
- meta-analysis
- Population
- Participants in fourteen randomised placebo-controlled zinc supplementation trials, pooled overall analysis (healthy and chronic metabolic disease)
Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans.2013PMID:23137858Permalink
Decreases systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Zinc supplementation significantly reduced SBP compared to the control [weighted mean differences (WMD) - 1.49 mmHg; 95% CI - 2.85 to - 0.13; P = 0.03].”
Quoted verbatim from The effect of zinc supplementation on blood pressure: a systematic review and dose-response meta-analysis of randomized-controlled trials.. - Study
- meta-analysis
- Population
- Adults in nine randomized clinical trials of oral zinc supplementation
Effect -1.49 mean difference, 95% CI -2.85 to -0.13
The effect of zinc supplementation on blood pressure: a systematic review and dose-response meta-analysis of randomized-controlled trials.2020PMID:32090294Permalink
Decreases fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Zinc supplementation significantly reduced glycemic indices: including two-hour postprandial glucose (2hpp) (mean difference (MD): -34.34 mg/dl; 95%CI: -51.61∼ -17.07), fast blood sugar (FBS) (MD: -23.32 mg/dl; 95% CI: -33.81∼ -12.83), and hemoglobin A1c (HbA1c) (MD: -0.47; 95% CI: -0.71∼ -0.23).”
Quoted verbatim from Effect of zinc supplementation in the management of type 2 diabetes: A grading of recommendations assessment, development, and evaluation-assessed, dose-response meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults with type 2 diabetes, pooled across randomized trials of oral zinc against placebo; trials with co-supplementation excluded
Effect -23.32 mean difference, 95% CI -33.81 to -12.83
Effect of zinc supplementation in the management of type 2 diabetes: A grading of recommendations assessment, development, and evaluation-assessed, dose-response meta-analysis of randomized controlled trials.2024PMID:37183697Permalink
Decreases depressive symptom severity (across unharmonised instruments)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The meta-analysis of RCTs indicated that zinc supplementation significantly lowered depressive symptom scores of depressed patients [weighted mean difference (WMD = -4.15 point; 95% CI: -6.56, -1.75 point; P < 0.01)], and the improvement in depression status occurred only when zinc supplementation was prescribed as a monotherapy.”
Quoted verbatim from Zinc in depression: From development to treatment: A comparative/ dose response meta-analysis of observational studies and randomized controlled trials.. - Study
- meta-analysis
- Population
- Patients with depression; pooled RCTs, improvement reported only in trials giving zinc as monotherapy
Effect -4.15 mean difference, 95% CI -6.56 to -1.75
Zinc in depression: From development to treatment: A comparative/ dose response meta-analysis of observational studies and randomized controlled trials.2022PMID:32829928Permalink
Decreases total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Zinc supplementation significantly reduced TG (WMD = - 17.41 mg/dL; 95% CI: - 22.60, - 12.22; P < 0.001), TC (WMD: - 19.60 mg/dL; 95% CI: - 28.46, - 10.73, P < 0.001), LDL-C (WMD = - 8.80 mg/dL; 95% CI: - 14.80, - 2.81; P = 0.004), and BMI (WMD = - 0.53 kg/m2; 95% CI: - 1.05, - 0.01; P = 0.046) but not BW (WMD: - 0.51 kg, 95 % CI: - 1.99, 0.97, P = 0.498).”
Quoted verbatim from Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.. - Study
- meta-analysis
- Population
- Patients with type 2 diabetes mellitus; 19 RCTs pooled
Effect -19.6 mean difference, 95% CI -28.46 to -10.73
Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.2024PMID:38224402Permalink
Decreases LDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Zinc supplementation significantly reduced TG (WMD = - 17.41 mg/dL; 95% CI: - 22.60, - 12.22; P < 0.001), TC (WMD: - 19.60 mg/dL; 95% CI: - 28.46, - 10.73, P < 0.001), LDL-C (WMD = - 8.80 mg/dL; 95% CI: - 14.80, - 2.81; P = 0.004), and BMI (WMD = - 0.53 kg/m2; 95% CI: - 1.05, - 0.01; P = 0.046) but not BW (WMD: - 0.51 kg, 95 % CI: - 1.99, 0.97, P = 0.498).”
Quoted verbatim from Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.. - Study
- meta-analysis
- Population
- Patients with type 2 diabetes mellitus; 19 RCTs pooled
Effect -8.8 mean difference, 95% CI -14.8 to -2.81
Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.2024PMID:38224402Permalink
Decreases body mass index
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Zinc supplementation significantly reduced TG (WMD = - 17.41 mg/dL; 95% CI: - 22.60, - 12.22; P < 0.001), TC (WMD: - 19.60 mg/dL; 95% CI: - 28.46, - 10.73, P < 0.001), LDL-C (WMD = - 8.80 mg/dL; 95% CI: - 14.80, - 2.81; P = 0.004), and BMI (WMD = - 0.53 kg/m2; 95% CI: - 1.05, - 0.01; P = 0.046) but not BW (WMD: - 0.51 kg, 95 % CI: - 1.99, 0.97, P = 0.498).”
Quoted verbatim from Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.. - Study
- meta-analysis
- Population
- Patients with type 2 diabetes mellitus; 19 RCTs pooled
Effect -0.53 mean difference, 95% CI -1.05 to -0.01
Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.2024PMID:38224402Permalink
Decreases all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“Combining 30 RRs from 28 RCTs including 237,068 participants revealed that zinc supplementation has significantly reduced the risk of all-causes mortality by 16% in children (SRR: 0.84, 95% CI: 0.74, 0.96).”
Quoted verbatim from Effect of zinc supplementation on mortality in under 5-year children: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- Children under 5 years in randomised trials of zinc supplementation; pooled across all doses and follow-up durations
Effect 0.84 risk ratio, 95% CI 0.74 to 0.96
Effect of zinc supplementation on mortality in under 5-year children: a systematic review and meta-analysis of randomized clinical trials.2022PMID:34120246Permalink
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“There was a significant reduction of circulating CRP (WMD: -32.4; 95% CI: -44.45 to -19.62, p < 0.001), hs-CRP (WMD: -0.95; 95% CI: -1.01 to -0.89, p < 0.001), Neutrophil levels (SMD: -0.46; 95% CI: -0.90 to -0.01, p = 0.043), following zinc supplementation.”
Quoted verbatim from Zinc supplementation and immune factors in adults: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- Adults in randomised trials of zinc supplementation (35 RCTs, 1995 participants across all immune outcomes)
Effect -32.4 mean difference, 95% CI -44.45 to -19.62
Zinc supplementation and immune factors in adults: a systematic review and meta-analysis of randomized clinical trials.2022PMID:33356467Permalink
Decreases diarrhoea duration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“Zinc was beneficial for reducing the duration of diarrhea in hours (mean difference [MD] = -20.12, 95% confidence interval [CI] = -29.15 to -11.09, I² = 91%).”
Quoted verbatim from Zinc supplementation for treating diarrhea in children: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Children up to 5 years old with acute diarrhea in randomized trials; controls received placebo or oral rehydration therapy; duration in hours
Effect -20.12 mean difference, 95% CI -29.15 to -11.09
Zinc supplementation for treating diarrhea in children: a systematic review and meta-analysis.2013PMID:23764669Permalink
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“In comparison with the control groups, serum C-reactive protein (CRP) (ES = -0.92 mg/L, 95% CI = [-1.36, -0.48], P < 0.001, I2 = 90.2%), tumor necrosis factor-alpha (TNF-α) (ES = -0.49 pg/mL, 95% CI = [-084, -0.14], P = 0.006, I2 = 34.6%) and malondialdehyde (MDA) (ES = -0.42, 95% CI = [-083, -0.01], P = 0.04, I2 = 76.1%) were significantly reduced in the groups receiving Zn.”
Quoted verbatim from Zinc supplementation is associated with a reduction in serum markers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults in 21 randomized controlled trials of zinc supplementation
Zinc supplementation is associated with a reduction in serum markers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials.2021PMID:33333394Permalink
Increases total antioxidant capacity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“There were significant increasing effects of Zn supplementation on glutathione (GSH) (SMD = 1.28 μmol/l; 95% CI: 0.42, 2.14; P = 0.003) and total antioxidant capacity (TAC) levels (SMD = 1.39 mmol/l; 95% CI: 0.44, 2.35; P = 0.004).”
Quoted verbatim from Clinical efficacy of zinc supplementation in improving antioxidant defense system: A comprehensive systematic review and time-response meta-analysis of controlled clinical trials.. - Study
- meta-analysis
- Population
- Participants in human controlled clinical trials of zinc supplementation, 4 to 24 weeks
Effect 1.39 standardised mean difference, 95% CI 0.44 to 2.35
Clinical efficacy of zinc supplementation in improving antioxidant defense system: A comprehensive systematic review and time-response meta-analysis of controlled clinical trials.2021PMID:34102185Permalink
Decreases tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“In comparison with the control groups, serum C-reactive protein (CRP) (ES = -0.92 mg/L, 95% CI = [-1.36, -0.48], P < 0.001, I2 = 90.2%), tumor necrosis factor-alpha (TNF-α) (ES = -0.49 pg/mL, 95% CI = [-084, -0.14], P = 0.006, I2 = 34.6%) and malondialdehyde (MDA) (ES = -0.42, 95% CI = [-083, -0.01], P = 0.04, I2 = 76.1%) were significantly reduced in the groups receiving Zn.”
Quoted verbatim from Zinc supplementation is associated with a reduction in serum markers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults in 21 randomized controlled trials of zinc supplementation
Zinc supplementation is associated with a reduction in serum markers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials.2021PMID:33333394Permalink
Decreases malondialdehyde (circulating)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“In comparison with the control groups, serum C-reactive protein (CRP) (ES = -0.92 mg/L, 95% CI = [-1.36, -0.48], P < 0.001, I2 = 90.2%), tumor necrosis factor-alpha (TNF-α) (ES = -0.49 pg/mL, 95% CI = [-084, -0.14], P = 0.006, I2 = 34.6%) and malondialdehyde (MDA) (ES = -0.42, 95% CI = [-083, -0.01], P = 0.04, I2 = 76.1%) were significantly reduced in the groups receiving Zn.”
Quoted verbatim from Zinc supplementation is associated with a reduction in serum markers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults in 21 randomized controlled trials of zinc supplementation
Zinc supplementation is associated with a reduction in serum markers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials.2021PMID:33333394Permalink
Decreases diarrhoea duration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“In children with persistent diarrhoea, zinc supplementation probably shortens the duration of diarrhoea by around 16 hours (MD -15.84 hours, 95% CI -25.43 to -6.24; 529 children, five trials, moderate quality evidence).”
Quoted verbatim from Oral zinc for treating diarrhoea in children.. - Study
- meta-analysis
- Participants
- 529
- Population
- Children aged one month to five years with persistent diarrhoea (subgroup of the review; acute diarrhoea analysed separately), oral zinc versus placebo; duration in hours
Effect -15.84 mean difference, 95% CI -25.43 to -6.24
Oral zinc for treating diarrhoea in children.2013PMID:23440801Permalink
Decreases malondialdehyde (circulating)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“The pooled analysis of data showed that zinc supplementation significantly reduced MDA levels (MD: -0.42 μmol/L; 95 % CI: -0.71 to -0.13), increased serum TAC (MD: 225.96 mmol/L; 95 % CI: 68.42-383.5) and GSH levels (MD: 49.99 μmol/L; 95 % CI: 2.25 t 97.73), compared with the placebo group.”
Quoted verbatim from Clinical effectiveness of zinc supplementation on the biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Participants in ten RCTs of oral zinc supplementation versus placebo
Effect -0.42 mean difference, 95% CI -0.71 to -0.13
Clinical effectiveness of zinc supplementation on the biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.2020PMID:32828910Permalink
Increases total antioxidant capacity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“The pooled analysis of data showed that zinc supplementation significantly reduced MDA levels (MD: -0.42 μmol/L; 95 % CI: -0.71 to -0.13), increased serum TAC (MD: 225.96 mmol/L; 95 % CI: 68.42-383.5) and GSH levels (MD: 49.99 μmol/L; 95 % CI: 2.25 t 97.73), compared with the placebo group.”
Quoted verbatim from Clinical effectiveness of zinc supplementation on the biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Participants in ten RCTs of oral zinc supplementation versus placebo
Effect 225.96 mean difference, 95% CI 68.42 to 383.5
Clinical effectiveness of zinc supplementation on the biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.2020PMID:32828910Permalink
Decreases fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Similarly, zinc supplementation significantly decreased fasting blood glucose (SMD - 0.52, 95% CI - 0.96, - 0.07) and HbA1c (SMD - 0.64, 95% CI - 1.27, - 0.02).”
Quoted verbatim from Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Participants in 20 randomized or controlled trials of zinc supplementation (1141 in the intervention groups overall)
Effect -0.52 standardised mean difference, 95% CI -0.96 to -0.07
Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials.2020PMID:31494808Permalink
Increases reduced glutathione concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The pooled analysis of data showed that zinc supplementation significantly reduced MDA levels (MD: -0.42 μmol/L; 95 % CI: -0.71 to -0.13), increased serum TAC (MD: 225.96 mmol/L; 95 % CI: 68.42-383.5) and GSH levels (MD: 49.99 μmol/L; 95 % CI: 2.25 t 97.73), compared with the placebo group.”
Quoted verbatim from Clinical effectiveness of zinc supplementation on the biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Participants in ten RCTs of oral zinc supplementation versus placebo
Effect 49.99 mean difference, 95% CI 2.25 to 97.73
Clinical effectiveness of zinc supplementation on the biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.2020PMID:32828910Permalink
Decreases waist circumference
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“However, zinc supplementation was associated with a significant increase in body weight (BW) (WMD: 0.68 kg; 95% CI: 0.33 to 1.03; p < 0.001) and a reduction in waist circumference (WC) (WMD: −1.03 cm; 95% CI: −1.92 to − 0.13; p = 0.025).”
Quoted verbatim from Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults in randomised controlled trials of zinc supplementation (pooled, general population)
Effect -1.03 mean difference, 95% CI -1.92 to -0.13
Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:41617950Permalink
Decreases triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Meta-analysis showed that zinc supplementation significantly decreased plasma levels of triglyceride (SMD - 0.66, 95% CI - 1.27, - 0.06), very-low-density lipoprotein (SMD - 1.59, 95% CI - 2.86, - 0.31), and total cholesterol (SMD - 0.65, 95% CI - 1.15, - 0.15).”
Quoted verbatim from Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Participants in 20 randomized or controlled trials of zinc supplementation (1141 in the intervention groups overall)
Effect -0.66 standardised mean difference, 95% CI -1.27 to -0.06
Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials.2020PMID:31494808Permalink
Increases birth weight
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“There was significant positive association between maternal blood zinc concentrations and birth weight.”
Quoted verbatim from Association of selenium, zinc and copper concentrations during pregnancy with birth weight: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Pregnant women; pooled observational studies relating maternal blood zinc concentration to infant birth weight (not an administered exposure)
Association of selenium, zinc and copper concentrations during pregnancy with birth weight: A systematic review and meta-analysis.2022PMID:34823102Permalink
Decreases interleukin-6 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Zn could decrease IL-6 levels (standardised mean difference (SMD) = -0·76 pg/ml; 95 % CI -1·28, -0·24; P = 0·004).”
Quoted verbatim from Profiling inflammatory cytokines following zinc supplementation: a systematic review and meta-analysis of controlled trials.. - Study
- meta-analysis
- Population
- Subjects aged over 15 years in controlled trials of zinc supplementation
Effect -0.76 standardised mean difference, 95% CI -1.28 to -0.24
Profiling inflammatory cytokines following zinc supplementation: a systematic review and meta-analysis of controlled trials.2021PMID:33468279Permalink
Inhibits NLRP3
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Conversely, zinc supplementation (with ZnCl2) in LPS-primed BMDMs blocked established NLRP3 activators, including silica, by inhibiting IL-1β release (F(5,12) = 122.0, p < 0.001), ASC oligomerization, caspase-1 and gasdermin D cleavage (Bii, C).”
Quoted verbatim from Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation.. - Study
- in vitro · not in humans
- Population
- LPS-primed mouse bone-marrow-derived macrophages stimulated with silica
Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation.2021PMID:33597269Permalink
Decreases triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Zinc supplementation significantly reduced TG (WMD = - 17.41 mg/dL; 95% CI: - 22.60, - 12.22; P < 0.001), TC (WMD: - 19.60 mg/dL; 95% CI: - 28.46, - 10.73, P < 0.001), LDL-C (WMD = - 8.80 mg/dL; 95% CI: - 14.80, - 2.81; P = 0.004), and BMI (WMD = - 0.53 kg/m2; 95% CI: - 1.05, - 0.01; P = 0.046) but not BW (WMD: - 0.51 kg, 95 % CI: - 1.99, 0.97, P = 0.498).”
Quoted verbatim from Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.. - Study
- meta-analysis
- Population
- Patients with type 2 diabetes mellitus; 19 RCTs pooled
Effect -17.41 mean difference, 95% CI -22.6 to -12.22
Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.2024PMID:38224402Permalink
Decreases total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Meta-analysis showed that zinc supplementation significantly decreased plasma levels of triglyceride (SMD - 0.66, 95% CI - 1.27, - 0.06), very-low-density lipoprotein (SMD - 1.59, 95% CI - 2.86, - 0.31), and total cholesterol (SMD - 0.65, 95% CI - 1.15, - 0.15).”
Quoted verbatim from Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Participants in 20 randomized or controlled trials of zinc supplementation (1141 in the intervention groups overall)
Effect -0.65 standardised mean difference, 95% CI -1.15 to -0.15
Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials.2020PMID:31494808Permalink
Decreases diarrhoea duration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“Zinc supplemented patients had 12% shorter duration of diarrhoea than control patients (64.1 v 72.8 h, P=0.028) and 11% less stool output (1.6 v 1.8 kg/day, P=0.039).”
Quoted verbatim from Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial.. - Study
- RCT
- Dose
- 30 mg elemental zinc per day until recovery
- Population
- Children aged 3-14 years with cholera at Dhaka Hospital, Bangladesh, all given erythromycin for three days in both arms
Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial.2008PMID:18184631Permalink
Decreases glycated haemoglobin (HbA1c)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Zinc supplementation significantly reduced glycemic indices: including two-hour postprandial glucose (2hpp) (mean difference (MD): -34.34 mg/dl; 95%CI: -51.61∼ -17.07), fast blood sugar (FBS) (MD: -23.32 mg/dl; 95% CI: -33.81∼ -12.83), and hemoglobin A1c (HbA1c) (MD: -0.47; 95% CI: -0.71∼ -0.23).”
Quoted verbatim from Effect of zinc supplementation in the management of type 2 diabetes: A grading of recommendations assessment, development, and evaluation-assessed, dose-response meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults with type 2 diabetes, pooled across randomized trials of oral zinc against placebo; trials with co-supplementation excluded
Effect -0.47 mean difference, 95% CI -0.71 to -0.23
Effect of zinc supplementation in the management of type 2 diabetes: A grading of recommendations assessment, development, and evaluation-assessed, dose-response meta-analysis of randomized controlled trials.2024PMID:37183697Permalink
Increases type 2 diabetes incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“When stratified by the clinical cutoff for zinc, participants with sufficient zinc levels (≥ 725.5 ng/g for men, ≥ 686.3 ng/g for women) had higher odds of type 2 diabetes compared with those having zinc deficiency (OR: 1.72, 95% CI: 1.07, 2.76).”
Quoted verbatim from Serum Manganese, Cobalt, Copper, Zinc, Selenium, and Iodine Levels, and the Incidence of Type 2 Diabetes: A Nested Case-control Study.. - Study
- case-control
- Population
- Japanese health-checkup adults free of diabetes at baseline, nested case-control (325 cases, 611 matched controls); baseline endogenous serum zinc by ICP-MS, sufficient versus deficient by IZiNCG cutoffs
Effect 1.72 odds ratio, 95% CI 1.07 to 2.76
Serum Manganese, Cobalt, Copper, Zinc, Selenium, and Iodine Levels, and the Incidence of Type 2 Diabetes: A Nested Case-control Study.2026PMID:42000964Permalink
Decreases all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“Participants randomly assigned to receive zinc had lower mortality than those not taking zinc (RR, 0.73; 95% CI, 0.61-0.89).”
Quoted verbatim from Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13.. - Study
- RCT
- Population
- AREDS participants (age-related eye disease), factorial randomisation to antioxidants, zinc, antioxidants plus zinc, or placebo; zinc-assigned arms (zinc alone and with antioxidants) compared with all not assigned zinc
Effect 0.73 risk ratio, 95% CI 0.61 to 0.89
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13.2004PMID:15136320Permalink
Decreases triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Combining 9 effect sizes from 9 RCTs, we found a significant lowering effect of zinc supplementation on serum levels of TG (weighted mean difference (WMD): -17.08, 95% CI: -30.59, -3.58 mg/dL, P = 0.01) and TC (WMD: -26.16, 95% CI: -49.69, -2.62 mg/dL, P = 0.02).”
Quoted verbatim from Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Patients with type 2 diabetes mellitus; 9 randomized controlled trials, 424 patients overall
Effect -17.08 mean difference, 95% CI -30.59 to -3.58
Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.2020PMID:32451277Permalink
Decreases total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Combining 9 effect sizes from 9 RCTs, we found a significant lowering effect of zinc supplementation on serum levels of TG (weighted mean difference (WMD): -17.08, 95% CI: -30.59, -3.58 mg/dL, P = 0.01) and TC (WMD: -26.16, 95% CI: -49.69, -2.62 mg/dL, P = 0.02).”
Quoted verbatim from Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Patients with type 2 diabetes mellitus; 9 randomized controlled trials, 424 patients overall
Effect -26.16 mean difference, 95% CI -49.69 to -2.62
Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.2020PMID:32451277Permalink
Decreases preterm birth incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Zinc supplementation resulted in a small reduction in preterm birth (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.76 to 0.97 in 16 RCTs; 16 trials of 7637 women).”
Quoted verbatim from Zinc supplementation for improving pregnancy and infant outcome.. - Study
- meta-analysis
- Participants
- 7,637
- Population
- Pregnant women in randomised trials of zinc supplementation in pregnancy, pooled across 16 trials
Effect 0.86 risk ratio, 95% CI 0.76 to 0.97
Zinc supplementation for improving pregnancy and infant outcome.2015PMID:25927101Permalink
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“The results of the meta-analysis displayed a significant reduction in circulating CRP levels (WMD: - 1.68 mg/l; 95% CI: - 2.4 to - 0.9, P = <0.001) following zinc supplementation.”
Quoted verbatim from The effect of zinc supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults in 8 randomized controlled trials of zinc supplementation
Effect -1.68 mean difference, 95% CI -2.4 to -0.9
The effect of zinc supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials.2018PMID:30012497Permalink
Decreases all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×5“Overall, compared with control intervention in neonatal sepsis, zinc supplementation is able to significantly reduce mortality rate (risk ratio (RR) = 0.48; 95% confidence intervals (CIs) = 0.25-0.94; p = .03) and improve serum zinc (mean difference (MD) = 81.97; 95% CI = 34.57-129.37; p = .0007), but has no remarkable influence on hospital stay (MD = -4.51; 95% CI = -15.08 to 6.05; p = .40) and the number of expired patients (RR = 0.63; 95% CI = 0.24-1.65; p = .35).”
Quoted verbatim from Efficacy of zinc supplementation for neonatal sepsis: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Neonates with sepsis; four pooled randomised trials of zinc supplementation against a control intervention
Effect 0.48 risk ratio, 95% CI 0.25 to 0.94
Efficacy of zinc supplementation for neonatal sepsis: a systematic review and meta-analysis.2019PMID:29103346Permalink
Decreases oesophageal cancer incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Taken together, our analysis indicates that increased dietary intake of total iron and zinc, as well as decreased heme iron intake, may be associated with a lower risk of developing esophageal cancer.”
Quoted verbatim from Increased total iron and zinc intake and lower heme iron intake reduce the risk of esophageal cancer: A dose-response meta-analysis.. - Study
- meta-analysis
- Population
- Participants in 20 observational studies (4855 cases among 1,387,482 participants) of dietary intake and esophageal cancer; dose-response meta-analysis of dietary zinc intake
Increased total iron and zinc intake and lower heme iron intake reduce the risk of esophageal cancer: A dose-response meta-analysis.2018PMID:30442229Permalink
Decreases hospital length of stay
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The meta-analysis found that oral zinc supplementation group experienced a lower length of hospital stay than the control group (mean difference, -0.43 days; 95% confidence interval, -0.65 to -0.22; P < 0.0001; heterogeneity, I2 = 20%).”
Quoted verbatim from Zinc as a potential prophylactic adjuvant therapy for prolonged hospitalization: A systematic review and meta-analysis of an umbrella of randomized controlled trials.. - Study
- meta-analysis
- Population
- Hospitalized patients of any age and cause of admission, pooled across eight randomized trials; control received placebo and/or standard therapy
Effect -0.43 mean difference, 95% CI -0.65 to -0.22
Zinc as a potential prophylactic adjuvant therapy for prolonged hospitalization: A systematic review and meta-analysis of an umbrella of randomized controlled trials.2025PMID:39435877Permalink
Decreases incident depression
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The present meta-analysis indicates inverse associations between dietary zinc and iron intake and risk of depression.”
Quoted verbatim from Dietary zinc and iron intake and risk of depression: A meta-analysis.. - Study
- meta-analysis
- Dose
- highest versus lowest dietary zinc intake
- Population
- Adults in 9 observational studies (cohort and cross-sectional) of dietary zinc intake, highest versus lowest intake
Dietary zinc and iron intake and risk of depression: A meta-analysis.2017PMID:28189077Permalink
What did not
38 findings
No detected effect on plasma citrulline concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Median plasma citrulline concentrations did not change from baseline following short-term zinc or placebo supplementation (0.4 (−2.2 – 2.6) µmol/L) and did not differ by supplementation group (P = 0.48); change in plasma citrulline concentration was not correlated with change in plasma zinc concentration (P = 0.11).”
Quoted verbatim from Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation.. - Study
- RCT
- Duration
- 3 weeks
- Dose
- 5 mg zinc as zinc sulfate daily (dispersible tablet or liquid)
- Population
- Apparently healthy breastfed children aged 6 to 23 months in rural Burkina Faso; subset with CRP below 10 mg/L; both zinc sulfate forms combined versus placebo
Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation.2013PMID:23689263Industry fundedPermalink
No detected effect on health-related quality of life
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“There was no significant effect of zinc or zinc plus probiotic supplements on total quality of life and its other subscales in comparison to the placebo.”
Quoted verbatim from Effects of zinc and probiotic co-supplementation on inflammation, gastrointestinal symptoms, quality of life, and mood in irritable bowel syndrome patients.. - Study
- RCT
- Duration
- 3 months
- Dose
- zinc gluconate tablet, 20 mg elemental zinc once daily after breakfast
- Population
- Adults aged 20-60 with Rome IV irritable bowel syndrome, 90-day trial; zinc gluconate arm compared with placebo
Effects of zinc and probiotic co-supplementation on inflammation, gastrointestinal symptoms, quality of life, and mood in irritable bowel syndrome patients.2026PMID:42162021Industry fundedPermalink
No detected effect on Mini-Mental State Examination total score
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The mean differences between treatment and placebo groups were not statistically significant for any outcome (A: CC2, p = 1; B: CDR-Sob, p = 1; C: MMSE, p = 1).”
Quoted verbatim from Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial.. - Study
- RCT
- Duration
- 6 months
- Dose
- elemental zinc as zinc sulfate tablets, 67.5 mg/day week 1, 135 mg/day weeks 2-12, 67.5 mg/day weeks 13-24
- Population
- Adults aged 60 or older with mild cognitive impairment due to Alzheimer's disease; analysis of the original randomised groups (zinc vs placebo) at 24 weeks
Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial.2025PMID:41008575Permalink
No detected effect on type 2 diabetes incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“After pooling data from both studies, we found that total zinc intake was not significantly associated with the incidence of T2DM (OR = 0.95, 95% CI: 0.82–1.11).”
Quoted verbatim from Zinc Intake and Status and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Dose
- total zinc intake (diet plus supplements), highest versus lowest quantile
- Population
- Adults free of diabetes at baseline in two large prospective cohorts (Swedish MDCS and American NHS); highest versus lowest total zinc intake from diet and supplements
Effect 0.95 odds ratio, 95% CI 0.82 to 1.11
Zinc Intake and Status and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.2019PMID:31071930Permalink
No detected effect on sperm concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“However, there were no significant effects of zinc supplementation on the sperm viability, sperm concentration, sperm count or percentage of abnormal sperm morphology (and).”
Quoted verbatim from Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Infertile men in the pooled studies of zinc supplementation on sperm parameters
Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis.2016PMID:26932683Permalink
No detected effect on low birth weight incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“We found that delivering up to 21 mg of zinc daily during pregnancy has no significant effect on birth weights of offspring (p = 0.94; Figure S25) or the prevalence of low birth weight (p = 0.83; Figure S26).”
Quoted verbatim from The Effect of Low Dose Iron and Zinc Intake on Child Micronutrient Status and Development during the First 1000 Days of Life: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Dose
- zinc up to 21 mg daily
- Population
- Pregnant women in six pooled randomised and quasi-randomised trials of zinc at doses up to 21 mg daily; controls received no supplement, placebo, a lower zinc dose, or the same micronutrients without zinc
The Effect of Low Dose Iron and Zinc Intake on Child Micronutrient Status and Development during the First 1000 Days of Life: A Systematic Review and Meta-Analysis.2016PMID:27916873Permalink
Show the remaining 32
No detected effect on subjective fatigue
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The scores of quality of life and fatigue questionnaires were not different between the groups during the chemotherapy cycles (Table 3).”
Quoted verbatim from Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer.. - Study
- RCT
- Duration
- 4 months
- Dose
- 35 mg elemental zinc as zinc sulfate (154 mg per capsule) after breakfast and after dinner, 70 mg per day
- Population
- Patients with colorectal adenocarcinoma receiving chemotherapy (CAPOX, capecitabine or 5-fluorouracil plus folinic acid), 24 completers, FACIT-F fatigue scale completed before each of four chemotherapy cycles
Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer.2017PMID:28444084Permalink
No detected effect on health-related quality of life
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“The scores of quality of life and fatigue questionnaires were not different between the groups during the chemotherapy cycles (Table 3).”
Quoted verbatim from Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer.. - Study
- RCT
- Duration
- 4 months
- Dose
- 35 mg elemental zinc as zinc sulfate (154 mg per capsule) after breakfast and after dinner, 70 mg per day
- Population
- Patients with colorectal adenocarcinoma receiving chemotherapy (CAPOX, capecitabine or 5-fluorouracil plus folinic acid), 24 completers, FACIT-F quality of life completed before each of four chemotherapy cycles
Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer.2017PMID:28444084Permalink
No detected effect on prostate cancer incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“We did not find statistically significant associations for zinc supplement and risk of overall, localized, low- or intermediate-grade prostate cancer.”
Quoted verbatim from Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study.. - Study
- cohort
- Dose
- self-reported supplemental zinc use, categories 1-24, 25-74 and >=75 mg/day, and duration up to >=15 years
- Population
- Men in the Health Professionals Follow-up Study (47,240 men without prior cancer), supplemental zinc use compared with never-users, median follow-up 28.3 years; overall prostate cancer, localized and low- or intermediate-grade subtypes
Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study.2022PMID:36326979Permalink
No detected effect on birth weight
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“We found that delivering up to 21 mg of zinc daily during pregnancy has no significant effect on birth weights of offspring (p = 0.94; Figure S25) or the prevalence of low birth weight (p = 0.83; Figure S26).”
Quoted verbatim from The Effect of Low Dose Iron and Zinc Intake on Child Micronutrient Status and Development during the First 1000 Days of Life: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Dose
- zinc up to 21 mg daily
- Population
- Pregnant women in eight pooled randomised and quasi-randomised trials of zinc at doses up to 21 mg daily; controls received no supplement, placebo, a lower zinc dose, or the same micronutrients without zinc
The Effect of Low Dose Iron and Zinc Intake on Child Micronutrient Status and Development during the First 1000 Days of Life: A Systematic Review and Meta-Analysis.2016PMID:27916873Permalink
No detected effect on all-cause mortality
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull resultreplicated ×2“In post-hoc analyses, we found no statistically significant difference in mortality by zinc vs placebo study group (adjusted hazard ratio, 1.80; 95% CI, 0.88-3.65; P =.10).”
Quoted verbatim from Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial.. - Study
- RCT
- Dose
- zinc gluconate 15 mg elemental zinc daily (men) or 12 mg (women) for 18 months
- Population
- Antiretroviral-naive adults with HIV and heavy alcohol use in St Petersburg, Russia; sucrose-plus-riboflavin placebo, riboflavin given to both arms
Effect 1.8 hazard ratio, 95% CI 0.88 to 3.65
Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial.2020PMID:32383748Permalink
No detected effect on adverse event occurrence (oral or enteral supplement)
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull result“The meta-analysis of adverse event rates showed no statistically significant difference between the zinc supplementation group and the placebo group (odds ratio [OR] = 2.536; 95% CI = 0.78 to 8.26; p = 0.122; I2 = 0%) Figure 9.”
Quoted verbatim from Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- Women aged 13 to 27 years with primary dysmenorrhea; pooled across six randomised trials of zinc supplementation (gluconate or sulfate) against placebo
Effect 2.536 odds ratio, 95% CI 0.78 to 8.26
Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.2024PMID:39683510Industry fundedPermalink
No detected effect on fasting blood glucose
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull result“Zinc supplementation did not significantly affect FBG (MD = −0.61; 95% CI −1.83 to 0.60; p = 0.32), with considerable heterogeneity (I 2 = 95%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect -0.61 mean difference, 95% CI -1.83 to 0.6
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
No detected effect on all-cause mortality
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull resultreplicated ×2“Overall, there was no significant difference in mortality between the zinc and placebo groups (table 3).”
Quoted verbatim from Effect of daily zinc supplementation on child mortality in southern Nepal: a community-based, cluster randomised, placebo-controlled trial.. - Study
- RCT
- Dose
- 10 mg elemental zinc as zinc sulphate daily (half tablet under 12 months)
- Population
- Children aged 1-35 months in rural southern Nepal, cluster-randomised; all children also received vitamin A supplementation twice per year
Effect of daily zinc supplementation on child mortality in southern Nepal: a community-based, cluster randomised, placebo-controlled trial.2007PMID:17920918Industry fundedPermalink
No detected effect on HDL cholesterol
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull result“There was no effect of zinc supplementation on HDL cholesterol for either low- or high-dose supplementation.”
Quoted verbatim from Effects of Dose and Duration of Zinc Interventions on Risk Factors for Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Dose
- up to 75 mg/d elemental zinc; low <25 mg/d and high >=25 mg/d strata
- Population
- Participants (healthy, obese, type 2 diabetes, prediabetes, haemodialysis and other groups, children to older adults) in randomised trials of zinc supplements up to 75 mg/d versus placebo or control, pooled within low-dose and high-dose strata
Effects of Dose and Duration of Zinc Interventions on Risk Factors for Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis.2021PMID:32722790Industry fundedPermalink
No detected effect on retinopathy of prematurity incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Enteral zinc supplementation may have little or no effect on common morbidities such as bronchopulmonary dysplasia (RR 0.66, 95% CI 0.31 to 1.40, 1 study, 193 infants; low-certainty evidence), retinopathy of prematurity (RR 0.14, 95% CI 0.01 to 2.70, 1 study, 193 infants; low-certainty evidence), bacterial sepsis (RR 1.11, 95% CI 0.60 to 2.04, 2 studies, 293 infants; moderate-certainty evidence), or necrotising enterocolitis (RR 0.08, 95% CI 0.00 to 1.33, 1 study, 193 infants; low-certainty evidence).”
Quoted verbatim from Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.. - Study
- meta-analysis
- Participants
- 193
- Population
- Hospitalised preterm infants given enteral zinc versus placebo or no supplementation; single study
Effect 0.14 risk ratio, 95% CI 0.01 to 2.7
Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.2021PMID:33710626Permalink
No detected effect on necrotising enterocolitis incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Enteral zinc supplementation may have little or no effect on common morbidities such as bronchopulmonary dysplasia (RR 0.66, 95% CI 0.31 to 1.40, 1 study, 193 infants; low-certainty evidence), retinopathy of prematurity (RR 0.14, 95% CI 0.01 to 2.70, 1 study, 193 infants; low-certainty evidence), bacterial sepsis (RR 1.11, 95% CI 0.60 to 2.04, 2 studies, 293 infants; moderate-certainty evidence), or necrotising enterocolitis (RR 0.08, 95% CI 0.00 to 1.33, 1 study, 193 infants; low-certainty evidence).”
Quoted verbatim from Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.. - Study
- meta-analysis
- Participants
- 193
- Population
- Hospitalised preterm infants given enteral zinc versus placebo or no supplementation; single study
Effect 0.08 risk ratio, 95% CI 0 to 1.33
Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.2021PMID:33710626Permalink
No detected effect on preterm birth incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“The evidence suggests that zinc supplementation may result in little or no difference in reducing preterm births (risk ratio (RR) 0.87, 95% confidence interval (CI) 0.74 to 1.03; 21 studies, 9851 participants; low-certainty evidence).”
Quoted verbatim from Zinc supplementation for improving pregnancy and infant outcome.. - Study
- meta-analysis
- Participants
- 9,851
- Population
- Pregnant women randomised before 27 weeks' gestation to zinc supplementation versus placebo or no zinc; 21 studies
Effect 0.87 risk ratio, 95% CI 0.74 to 1.03
Zinc supplementation for improving pregnancy and infant outcome.2021PMID:33724446Permalink
No detected effect on tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“There was no significant change in TNF-α (SMD = 0·42 pg/ml; 95 % CI -0·31, 1·16; P = 0·257) and IL-2 levels (SMD = 1·64 pg/ml; 95 % CI -1·31, 4·59; P = 0·277) following Zn supplementation.”
Quoted verbatim from Profiling inflammatory cytokines following zinc supplementation: a systematic review and meta-analysis of controlled trials.. - Study
- meta-analysis
- Population
- Subjects aged over 15 years in controlled trials of zinc supplementation
Effect 0.42 standardised mean difference, 95% CI -0.31 to 1.16
Profiling inflammatory cytokines following zinc supplementation: a systematic review and meta-analysis of controlled trials.2021PMID:33468279Permalink
No detected effect on gastric cancer incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Comparing the highest with lowest categories, higher zinc intake was significantly associated with reduced colorectal cancer risk (pooled RR = 0.80, 95% CI: 0.70-0.92; p = 0.002), while zinc intake was not statistically associated with gastric cancer risk (pooled RR = 0.91, 95% CI: 0.64-1.29; p = 0.581) or esophageal cancer risk (pooled RR = 0.72, 95% CI: 0.44-1.17; p = 0.187).”
Quoted verbatim from Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Adults in observational studies; highest versus lowest category of dietary zinc intake
Effect 0.91 risk ratio, 95% CI 0.64 to 1.29
Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis.2014PMID:24148607Permalink
No detected effect on oesophageal cancer incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Comparing the highest with lowest categories, higher zinc intake was significantly associated with reduced colorectal cancer risk (pooled RR = 0.80, 95% CI: 0.70-0.92; p = 0.002), while zinc intake was not statistically associated with gastric cancer risk (pooled RR = 0.91, 95% CI: 0.64-1.29; p = 0.581) or esophageal cancer risk (pooled RR = 0.72, 95% CI: 0.44-1.17; p = 0.187).”
Quoted verbatim from Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Adults in observational studies; highest versus lowest category of dietary zinc intake
Effect 0.72 risk ratio, 95% CI 0.44 to 1.17
Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis.2014PMID:24148607Permalink
No detected effect on body mass
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Zinc supplementation significantly reduced TG (WMD = - 17.41 mg/dL; 95% CI: - 22.60, - 12.22; P < 0.001), TC (WMD: - 19.60 mg/dL; 95% CI: - 28.46, - 10.73, P < 0.001), LDL-C (WMD = - 8.80 mg/dL; 95% CI: - 14.80, - 2.81; P = 0.004), and BMI (WMD = - 0.53 kg/m2; 95% CI: - 1.05, - 0.01; P = 0.046) but not BW (WMD: - 0.51 kg, 95 % CI: - 1.99, 0.97, P = 0.498).”
Quoted verbatim from Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.. - Study
- meta-analysis
- Population
- Patients with type 2 diabetes mellitus; 19 RCTs pooled
Effect -0.51 mean difference, 95% CI -1.99 to 0.97
Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.2024PMID:38224402Permalink
No detected effect on total leukocyte count
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Zinc supplementation had no significant effect on WBC (SMD: -0.66; 95% CI: -1.67 to 0.36, p = 0.204), lymphocyte (WMD: 1.86; 95% CI: -0.86 to 4.58, p = 0.181), monocyte levels (SMD: -0.16; 95% CI: -0.07 to 0.39, p = 0.167), CD3 (SMD: 0.37; 95% CI: -0.49 to 1.22, p = 0.399).”
Quoted verbatim from Zinc supplementation and immune factors in adults: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- Adults in randomised trials of zinc supplementation (35 RCTs, 1995 participants across all immune outcomes)
Effect -0.66 standardised mean difference, 95% CI -1.67 to 0.36
Zinc supplementation and immune factors in adults: a systematic review and meta-analysis of randomized clinical trials.2022PMID:33356467Permalink
No detected effect on body mass index
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“A meta-analysis of 41 RCTs (44 effect sizes) indicated that zinc supplementation had no significant overall effect on body mass index (BMI) (WMD: 0.02 kg/m²; p = 0.889), fat mass (FM) (WMD: −0.08 kg; p = 0.794), fat-free mass (FFM) (WMD: 0.41 kg; p = 0.669), adiponectin (WMD: 1.27 µg/mL; p = 0.184), or leptin (WMD: 1.82 ng/mL; p = 0.165).”
Quoted verbatim from Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults in randomised controlled trials of zinc supplementation (pooled, general population)
Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:41617950Permalink
No detected effect on all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“Moderate to low certainty evidence showed that enteral zinc supplementation had little or no effect on mortality (risk ratio 0.73, 95% confidence interval [CI] 0.46 to 1.16), but increased weight (MD 378.57, 95% CI 275.26 to 481.88), length (MD 2.92, 95% CI 1.53 to 4.31), head growth (MD 0.56, 95% CI 0.23 to 0.90), and decreased diarrhea (RR 0.81; 95% CI 0.68 to 0.97).”
Quoted verbatim from Enteral Zinc Supplementation in Preterm or Low Birth Weight Infants: A Systematic Review and Meta-analysis.. - Study
- meta-analysis
- Population
- Human-milk-fed preterm or low birth weight infants in randomised or quasi-experimental trials of enteral zinc versus no zinc
Effect 0.73 risk ratio, 95% CI 0.46 to 1.16
Enteral Zinc Supplementation in Preterm or Low Birth Weight Infants: A Systematic Review and Meta-analysis.2022PMID:35921675Permalink
No detected effect on hospital length of stay
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Zinc supplementation in children with severe pneumonia also showed a non-significant effect on the duration of hospitalization stay as compared to the control (RR 1.04; 95% CI 0.89 to 1.22).”
Quoted verbatim from Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age.. - Study
- meta-analysis
- Population
- Children aged 2 to 59 months with severe pneumonia, zinc as an adjunct to standard antibiotic therapy given in both arms
Effect 1.04 risk ratio, 95% CI 0.89 to 1.22
Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age.2011PMID:21975768Permalink
No detected effect on serum leptin
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“The analysis suggested that zinc supplementation exerts no significant effect on overall serum leptin (WMD: 0.74 ng/ml; 95% CI: -1.39 to 2.87, p=0.49).”
Quoted verbatim from The Effect of Zinc Supplementation on Serum Leptin Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Human adults; 6 randomized controlled trials with 7 treatment arms, overall estimate across all trials
Effect 0.74 mean difference, 95% CI -1.39 to 2.87
The Effect of Zinc Supplementation on Serum Leptin Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2019PMID:31408896Permalink
No detected effect on glutathione peroxidase activity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Zn supplementation did not have beneficial effects on glutathione peroxidase (GPx) activity (SMD = -0.34 U/g; 95% CI: -0.93, 0.25; P = 0.258).”
Quoted verbatim from Clinical efficacy of zinc supplementation in improving antioxidant defense system: A comprehensive systematic review and time-response meta-analysis of controlled clinical trials.. - Study
- meta-analysis
- Population
- Participants in human controlled clinical trials of zinc supplementation, 4 to 24 weeks
Effect -0.34 standardised mean difference, 95% CI -0.93 to 0.25
Clinical efficacy of zinc supplementation in improving antioxidant defense system: A comprehensive systematic review and time-response meta-analysis of controlled clinical trials.2021PMID:34102185Permalink
No detected effect on diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“However, zinc supplementation had no significant effects on DBP (WMD - 0.88 mmHg; 95% CI - 2.04 to 0.29; P = 0.14).”
Quoted verbatim from The effect of zinc supplementation on blood pressure: a systematic review and dose-response meta-analysis of randomized-controlled trials.. - Study
- meta-analysis
- Population
- Adults in nine randomized clinical trials of oral zinc supplementation
Effect -0.88 mean difference, 95% CI -2.04 to 0.29
The effect of zinc supplementation on blood pressure: a systematic review and dose-response meta-analysis of randomized-controlled trials.2020PMID:32090294Permalink
No detected effect on parkinson's disease incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“The pooled RRs of Parkinson's disease for moderate or high intake of zinc, and copper were not statistically different (P > 0.05).”
Quoted verbatim from Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.. - Study
- meta-analysis
- Dose
- moderate or high dietary zinc intake versus lowest
- Population
- Participants in five observational studies (126,507 individuals) of dietary intake; moderate or high versus lowest intake
Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.2015PMID:26265293Permalink
No detected effect on serum leptin
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“A meta-analysis of 41 RCTs (44 effect sizes) indicated that zinc supplementation had no significant overall effect on body mass index (BMI) (WMD: 0.02 kg/m²; p = 0.889), fat mass (FM) (WMD: −0.08 kg; p = 0.794), fat-free mass (FFM) (WMD: 0.41 kg; p = 0.669), adiponectin (WMD: 1.27 µg/mL; p = 0.184), or leptin (WMD: 1.82 ng/mL; p = 0.165).”
Quoted verbatim from Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults in randomised controlled trials of zinc supplementation (pooled, general population)
Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:41617950Permalink
No detected effect on breast cancer incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“No overall association was seen between zinc and breast cancer risk.”
Quoted verbatim from Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study.. - Study
- case-control
- Population
- Women in the Malmo Diet and Cancer Study, Sweden: 1186 incident breast cancer cases matched to 1186 controls; zinc taken as baseline serum zinc, dietary zinc intake including supplements, and their combination
Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study.2021PMID:34224055Permalink
No detected effect on fat mass
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“A meta-analysis of 41 RCTs (44 effect sizes) indicated that zinc supplementation had no significant overall effect on body mass index (BMI) (WMD: 0.02 kg/m²; p = 0.889), fat mass (FM) (WMD: −0.08 kg; p = 0.794), fat-free mass (FFM) (WMD: 0.41 kg; p = 0.669), adiponectin (WMD: 1.27 µg/mL; p = 0.184), or leptin (WMD: 1.82 ng/mL; p = 0.165).”
Quoted verbatim from Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults in randomised controlled trials of zinc supplementation (pooled, general population)
Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:41617950Permalink
No detected effect on lean body mass
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“A meta-analysis of 41 RCTs (44 effect sizes) indicated that zinc supplementation had no significant overall effect on body mass index (BMI) (WMD: 0.02 kg/m²; p = 0.889), fat mass (FM) (WMD: −0.08 kg; p = 0.794), fat-free mass (FFM) (WMD: 0.41 kg; p = 0.669), adiponectin (WMD: 1.27 µg/mL; p = 0.184), or leptin (WMD: 1.82 ng/mL; p = 0.165).”
Quoted verbatim from Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults in randomised controlled trials of zinc supplementation (pooled, general population)
Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:41617950Permalink
No detected effect on serum albumin
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Of four studies evaluating the management of cirrhosis, two analyzed the effect of zinc supplementation on serum albumin levels, with no statistical difference between zinc and placebo groups.”
Quoted verbatim from Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Adults with cirrhosis; two trials of zinc supplementation versus placebo within a meta-analysis of randomized trials in chronic liver disease
Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis.2020PMID:31611064Permalink
No detected effect on birth weight
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“No significant difference was found in the birth weights between the cases supplemented with 20 mg elemental zinc and controls receiving oral placebos (p=0.57).”
Quoted verbatim from Oral zinc supplementation in pregnant women and its effect on birth weight: a randomised controlled trial.. - Study
- RCT
- Dose
- 20 mg elemental zinc, oral
- Population
- Pregnant women in Pakistan, a zinc deficient area
Oral zinc supplementation in pregnant women and its effect on birth weight: a randomised controlled trial.2005PMID:15724045Permalink
No detected effect on hospital length of stay
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Overall, compared with control intervention in neonatal sepsis, zinc supplementation is able to significantly reduce mortality rate (risk ratio (RR) = 0.48; 95% confidence intervals (CIs) = 0.25-0.94; p = .03) and improve serum zinc (mean difference (MD) = 81.97; 95% CI = 34.57-129.37; p = .0007), but has no remarkable influence on hospital stay (MD = -4.51; 95% CI = -15.08 to 6.05; p = .40) and the number of expired patients (RR = 0.63; 95% CI = 0.24-1.65; p = .35).”
Quoted verbatim from Efficacy of zinc supplementation for neonatal sepsis: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Neonates with sepsis; pooled randomised trials of zinc supplementation against a control intervention
Effect -4.51 mean difference, 95% CI -15.08 to 6.05
Efficacy of zinc supplementation for neonatal sepsis: a systematic review and meta-analysis.2019PMID:29103346Permalink
No detected effect on body mass
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Zn intake was not associated with weight, length, MUAC, head circumference, and LAZ in the pooled analyses.”
Quoted verbatim from Effect of Zinc Intake on Growth in Infants: A Meta-analysis.. - Study
- meta-analysis
- Population
- Infants in 19 randomized controlled trials of zinc intake; pooled analysis across all trials
Effect of Zinc Intake on Growth in Infants: A Meta-analysis.2016PMID:25365524Permalink
What it touches on the way
Mechanistic reach
13 entities
13 entities reached.
0 reported hops13 assembled from the scaffold
- SLC39A14ProteinUNIPROT:Q15043transported byInferred only104 paths46 endpoints
- SLC30A1ProteinUNIPROT:Q9Y6M5transported byInferred only54 paths18 endpoints
- SLC39A8ProteinUNIPROT:Q9C0K1transported byInferred only33 paths11 endpoints
- SLC11A2ProteinUNIPROT:P49281transported byInferred only14 paths7 endpoints
- NLRP3ProteinUNIPROT:Q96P20inhibitsInferred only13 paths13 endpoints
- SLC11A1ProteinUNIPROT:P49279transported byInferred only9 paths9 endpoints
- TRPM7ProteinUNIPROT:Q96QT4transported byInferred only5 paths5 endpoints
- SLC39A1ProteinUNIPROT:Q9NY26transported byInferred only4 paths2 endpoints
- TRPA1ProteinUNIPROT:O75762transported byInferred only2 paths2 endpoints
- SLC30A3ProteinUNIPROT:Q99726transported byInferred only2 paths2 endpoints
- SLC30A9ProteinUNIPROT:Q6PML9transported byInferred only1 path1 endpoint
- SLC39A11ProteinUNIPROT:Q8N1S5transported byInferred only1 path1 endpoint
Show the remaining 1
What the reference databases state
Statements
388 statements
388 statements · 3 reference databases · Subject: Zn(2+) · Sources: Human-GEM, Rhea, UniProt · Rows fetched: 300
- AARS1 requires the cofactor Zn(2+)ProteinUniProt P49588Inferred only
- AARS2 requires the cofactor Zn(2+)ProteinUniProt Q5JTZ9Inferred only
- AARSD1 requires the cofactor Zn(2+)ProteinUniProt Q9BTE6Inferred only
- ACE requires the cofactor Zn(2+)ProteinUniProt P12821Inferred only
- ACE2 requires the cofactor Zn(2+)ProteinUniProt Q9BYF1Inferred only
- ACER1 requires the cofactor Zn(2+)ProteinUniProt Q8TDN7Inferred only
- ACER2 requires the cofactor Zn(2+)ProteinUniProt Q5QJU3Inferred only
- ACER3 requires the cofactor Zn(2+)ProteinUniProt Q9NUN7Inferred only
- ACMSD requires the cofactor Zn(2+)ProteinUniProt Q8TDX5Inferred only
- ACP7 requires the cofactor Zn(2+)ProteinUniProt Q6ZNF0Inferred only
- ACY1 requires the cofactor Zn(2+)ProteinUniProt Q03154Inferred only
- ACY3 requires the cofactor Zn(2+)ProteinUniProt Q96HD9Inferred only
Show the remaining 376
- ADA requires the cofactor Zn(2+)ProteinUniProt P00813Inferred only
- ADA2 requires the cofactor Zn(2+)ProteinUniProt Q9NZK5Inferred only
- ADAM10 requires the cofactor Zn(2+)ProteinUniProt O14672Inferred only
- ADAM12 requires the cofactor Zn(2+)ProteinUniProt O43184Inferred only
- ADAM15 requires the cofactor Zn(2+)ProteinUniProt Q13444Inferred only
- ADAM17 requires the cofactor Zn(2+)ProteinUniProt P78536Inferred only
- ADAM19 requires the cofactor Zn(2+)ProteinUniProt Q9H013Inferred only
- ADAM21 requires the cofactor Zn(2+)ProteinUniProt Q9UKJ8Inferred only
- ADAM28 requires the cofactor Zn(2+)ProteinUniProt Q9UKQ2Inferred only
- ADAM30 requires the cofactor Zn(2+)ProteinUniProt Q9UKF2Inferred only
- ADAM33 requires the cofactor Zn(2+)ProteinUniProt Q9BZ11Inferred only
- ADAM8 requires the cofactor Zn(2+)ProteinUniProt P78325Inferred only
- ADAM9 requires the cofactor Zn(2+)ProteinUniProt Q13443Inferred only
- ADAMDEC1 requires the cofactor Zn(2+)ProteinUniProt O15204Inferred only
- ADAMTS1 requires the cofactor Zn(2+)ProteinUniProt Q9UHI8Inferred only
- ADAMTS10 requires the cofactor Zn(2+)ProteinUniProt Q9H324Inferred only
- ADAMTS12 requires the cofactor Zn(2+)ProteinUniProt P58397Inferred only
- ADAMTS13 requires the cofactor Zn(2+)ProteinUniProt Q76LX8Inferred only
- ADAMTS15 requires the cofactor Zn(2+)ProteinUniProt Q8TE58Inferred only
- ADAMTS16 requires the cofactor Zn(2+)ProteinUniProt Q8TE57Inferred only
- ADAMTS18 requires the cofactor Zn(2+)ProteinUniProt Q8TE60Inferred only
- ADAMTS19 requires the cofactor Zn(2+)ProteinUniProt Q8TE59Inferred only
- ADAMTS2 requires the cofactor Zn(2+)ProteinUniProt O95450Inferred only
- ADAMTS20 requires the cofactor Zn(2+)ProteinUniProt P59510Inferred only
- ADAMTS4 requires the cofactor Zn(2+)ProteinUniProt O75173Inferred only
- ADAMTS5 requires the cofactor Zn(2+)ProteinUniProt Q9UNA0Inferred only
- ADAMTS6 requires the cofactor Zn(2+)ProteinUniProt Q9UKP5Inferred only
- ADAMTS7 requires the cofactor Zn(2+)ProteinUniProt Q9UKP4Inferred only
- ADAMTS8 requires the cofactor Zn(2+)ProteinUniProt Q9UP79Inferred only
- ADAMTS9 requires the cofactor Zn(2+)ProteinUniProt Q9P2N4Inferred only
- ADAT2 requires the cofactor Zn(2+)ProteinUniProt Q7Z6V5Inferred only
- ADH1A requires the cofactor Zn(2+)ProteinUniProt P07327Inferred only
- ADH1B requires the cofactor Zn(2+)ProteinUniProt P00325Inferred only
- ADH1C requires the cofactor Zn(2+)ProteinUniProt P00326Inferred only
- ADH4 requires the cofactor Zn(2+)ProteinUniProt P08319Inferred only
- ADH5 requires the cofactor Zn(2+)ProteinUniProt P11766Inferred only
- ADH6 requires the cofactor Zn(2+)ProteinUniProt P28332Inferred only
- ADH7 requires the cofactor Zn(2+)ProteinUniProt P40394Inferred only
- AFG3L2 requires the cofactor Zn(2+)ProteinUniProt Q9Y4W6Inferred only
- AGBL2 requires the cofactor Zn(2+)ProteinUniProt Q5U5Z8Inferred only
- AGBL4 requires the cofactor Zn(2+)ProteinUniProt Q5VU57Inferred only
- AGBL5 requires the cofactor Zn(2+)ProteinUniProt Q8NDL9Inferred only
- AGTPBP1 requires the cofactor Zn(2+)ProteinUniProt Q9UPW5Inferred only
- AICDA requires the cofactor Zn(2+)ProteinUniProt Q9GZX7Inferred only
- ALAD requires the cofactor Zn(2+)ProteinUniProt P13716Inferred only
- ALPG requires the cofactor Zn(2+)ProteinUniProt P10696Inferred only
- ALPI requires the cofactor Zn(2+)ProteinUniProt P09923Inferred only
- ALPL requires the cofactor Zn(2+)ProteinUniProt P05186Inferred only
- ALPP requires the cofactor Zn(2+)ProteinUniProt P05187Inferred only
- AMDHD1 requires the cofactor Zn(2+)ProteinUniProt Q96NU7Inferred only
- AMPD1 requires the cofactor Zn(2+)ProteinUniProt P23109Inferred only
- AMPD2 requires the cofactor Zn(2+)ProteinUniProt Q01433Inferred only
- AMPD3 requires the cofactor Zn(2+)ProteinUniProt Q01432Inferred only
- AMZ1 requires the cofactor Zn(2+)ProteinUniProt Q400G9Inferred only
- AMZ2 requires the cofactor Zn(2+)ProteinUniProt Q86W34Inferred only
- ANPEP requires the cofactor Zn(2+)ProteinUniProt P15144Inferred only
- AOPEP requires the cofactor Zn(2+)ProteinUniProt Q8N6M6Inferred only
- APIP requires the cofactor Zn(2+)ProteinUniProt Q96GX9Inferred only
- APOBEC1 requires the cofactor Zn(2+)ProteinUniProt P41238Inferred only
- APOBEC2 requires the cofactor Zn(2+)ProteinUniProt Q9Y235Inferred only
- APOBEC3A requires the cofactor Zn(2+)ProteinUniProt P31941Inferred only
- APOBEC3B requires the cofactor Zn(2+)ProteinUniProt Q9UH17Inferred only
- APOBEC3C requires the cofactor Zn(2+)ProteinUniProt Q9NRW3Inferred only
- APOBEC3D requires the cofactor Zn(2+)ProteinUniProt Q96AK3Inferred only
- APOBEC3F requires the cofactor Zn(2+)ProteinUniProt Q8IUX4Inferred only
- APOBEC3G requires the cofactor Zn(2+)ProteinUniProt Q9HC16Inferred only
- APOBEC3H requires the cofactor Zn(2+)ProteinUniProt Q6NTF7Inferred only
- APOBEC4 requires the cofactor Zn(2+)ProteinUniProt Q8WW27Inferred only
- ARAF requires the cofactor Zn(2+)ProteinUniProt P10398Inferred only
- ASAH2 requires the cofactor Zn(2+)ProteinUniProt Q9NR71Inferred only
- ASPA requires the cofactor Zn(2+)ProteinUniProt P45381Inferred only
- BHMT requires the cofactor Zn(2+)ProteinUniProt Q93088Inferred only
- BHMT2 requires the cofactor Zn(2+)ProteinUniProt Q9H2M3Inferred only
- BKGD requires the cofactor Zn(2+)ProteinUniProt Q9H0W9Inferred only
- BLM requires the cofactor Zn(2+)ProteinUniProt P54132Inferred only
- BLVRA requires the cofactor Zn(2+)ProteinUniProt P53004Inferred only
- BMP1 requires the cofactor Zn(2+)ProteinUniProt P13497Inferred only
- BMX requires the cofactor Zn(2+)ProteinUniProt P51813Inferred only
- BRAF requires the cofactor Zn(2+)ProteinUniProt P15056Inferred only
- BRCC3 requires the cofactor Zn(2+)ProteinUniProt P46736Inferred only
- BTK requires the cofactor Zn(2+)ProteinUniProt Q06187Inferred only
- CA1 requires the cofactor Zn(2+)ProteinUniProt P00915Inferred only
- CA12 requires the cofactor Zn(2+)ProteinUniProt O43570Inferred only
- CA13 requires the cofactor Zn(2+)ProteinUniProt Q8N1Q1Inferred only
- CA14 requires the cofactor Zn(2+)ProteinUniProt Q9ULX7Inferred only
- CA2 requires the cofactor Zn(2+)ProteinUniProt P00918Inferred only
- CA4 requires the cofactor Zn(2+)ProteinUniProt P22748Inferred only
- CA5A requires the cofactor Zn(2+)ProteinUniProt P35218Inferred only
- CA5B requires the cofactor Zn(2+)ProteinUniProt Q9Y2D0Inferred only
- CA6 requires the cofactor Zn(2+)ProteinUniProt P23280Inferred only
- CA7 requires the cofactor Zn(2+)ProteinUniProt P43166Inferred only
- CA9 requires the cofactor Zn(2+)ProteinUniProt Q16790Inferred only
- CAD requires the cofactor Zn(2+)ProteinUniProt P27708Inferred only
- CARS1 requires the cofactor Zn(2+)ProteinUniProt P49589Inferred only
- CARS2 requires the cofactor Zn(2+)ProteinUniProt Q9HA77Inferred only
- CCS requires the cofactor Zn(2+)ProteinUniProt O14618Inferred only
- CDA requires the cofactor Zn(2+)ProteinUniProt P32320Inferred only
- CDADC1 requires the cofactor Zn(2+)ProteinUniProt Q9BWV3Inferred only
- CDO1 requires the cofactor Zn(2+)ProteinUniProt Q16878Inferred only
- CENPV requires the cofactor Zn(2+)ProteinUniProt Q7Z7K6Inferred only
- CGAS requires the cofactor Zn(2+)ProteinUniProt Q8N884Inferred only
- CHD4 requires the cofactor Zn(2+)ProteinUniProt Q14839Inferred only
- CNDP1 requires the cofactor Zn(2+)ProteinUniProt Q96KN2Inferred only
- COQ4 requires the cofactor Zn(2+)ProteinUniProt Q9Y3A0Inferred only
- CPA1 requires the cofactor Zn(2+)ProteinUniProt P15085Inferred only
- CPA2 requires the cofactor Zn(2+)ProteinUniProt P48052Inferred only
- CPA3 requires the cofactor Zn(2+)ProteinUniProt P15088Inferred only
- CPA4 requires the cofactor Zn(2+)ProteinUniProt Q9UI42Inferred only
- CPA5 requires the cofactor Zn(2+)ProteinUniProt Q8WXQ8Inferred only
- CPA6 requires the cofactor Zn(2+)ProteinUniProt Q8N4T0Inferred only
- CPB1 requires the cofactor Zn(2+)ProteinUniProt P15086Inferred only
- CPB2 requires the cofactor Zn(2+)ProteinUniProt Q96IY4Inferred only
- CPD requires the cofactor Zn(2+)ProteinUniProt O75976Inferred only
- CPE requires the cofactor Zn(2+)ProteinUniProt P16870Inferred only
- CPM requires the cofactor Zn(2+)ProteinUniProt P14384Inferred only
- CPN1 requires the cofactor Zn(2+)ProteinUniProt P15169Inferred only
- CPO requires the cofactor Zn(2+)ProteinUniProt Q8IVL8Inferred only
- CPSF3 requires the cofactor Zn(2+)ProteinUniProt Q9UKF6Inferred only
- CPXM1 requires the cofactor Zn(2+)ProteinUniProt Q96SM3Inferred only
- CPZ requires the cofactor Zn(2+)ProteinUniProt Q66K79Inferred only
- DBR1 requires the cofactor Zn(2+)ProteinUniProt Q9UK59Inferred only
- DCD requires the cofactor Zn(2+)ProteinUniProt P81605Inferred only
- DCT requires the cofactor Zn(2+)ProteinUniProt P40126Inferred only
- DCTD requires the cofactor Zn(2+)ProteinUniProt P32321Inferred only
- DNPEP requires the cofactor Zn(2+)ProteinUniProt Q9ULA0Inferred only
- DPEP1 requires the cofactor Zn(2+)ProteinUniProt P16444Inferred only
- DPEP2 requires the cofactor Zn(2+)ProteinUniProt Q9H4A9Inferred only
- DPP3 requires the cofactor Zn(2+)ProteinUniProt Q9NY33Inferred only
- DPYS requires the cofactor Zn(2+)ProteinUniProt Q14117Inferred only
- DUSP12 requires the cofactor Zn(2+)ProteinUniProt Q9UNI6Inferred only
- ECE1 requires the cofactor Zn(2+)ProteinUniProt P42892Inferred only
- ECE2 requires the cofactor Zn(2+)ProteinUniProt P0DPD6Inferred only
- ECEL1 requires the cofactor Zn(2+)ProteinUniProt O95672Inferred only
- ELAC1 requires the cofactor Zn(2+)ProteinUniProt Q9H777Inferred only
- ELAC2 requires the cofactor Zn(2+)ProteinUniProt Q9BQ52Inferred only
- ENPEP requires the cofactor Zn(2+)ProteinUniProt Q07075Inferred only
- ENPP1 requires the cofactor Zn(2+)ProteinUniProt P22413Inferred only
- ENPP2 requires the cofactor Zn(2+)ProteinUniProt Q13822Inferred only
- ENPP3 requires the cofactor Zn(2+)ProteinUniProt O14638Inferred only
- ENPP4 requires the cofactor Zn(2+)ProteinUniProt Q9Y6X5Inferred only
- ENPP5 requires the cofactor Zn(2+)ProteinUniProt Q9UJA9Inferred only
- ENPP6 requires the cofactor Zn(2+)ProteinUniProt Q6UWR7Inferred only
- ENPP7 requires the cofactor Zn(2+)ProteinUniProt Q6UWV6Inferred only
- ERAP1 requires the cofactor Zn(2+)ProteinUniProt Q9NZ08Inferred only
- ERAP2 requires the cofactor Zn(2+)ProteinUniProt Q6P179Inferred only
- ERMP1 requires the cofactor Zn(2+)ProteinUniProt Q7Z2K6Inferred only
- FA2H requires the cofactor Zn(2+)ProteinUniProt Q7L5A8Inferred only
- FNTB requires the cofactor Zn(2+)ProteinUniProt P49356Inferred only
- FOLH1 requires the cofactor Zn(2+)ProteinUniProt Q04609Inferred only
- GALT requires the cofactor Zn(2+)ProteinUniProt P07902Inferred only
- GDA requires the cofactor Zn(2+)ProteinUniProt Q9Y2T3Inferred only
- GLO1 requires the cofactor Zn(2+)ProteinUniProt Q04760Inferred only
- HAGH requires the cofactor Zn(2+)ProteinUniProt Q16775Inferred only
- HAGHL requires the cofactor Zn(2+)ProteinUniProt Q6PII5Inferred only
- HDAC1 requires the cofactor Zn(2+)ProteinUniProt Q13547Inferred only
- HDAC2 requires the cofactor Zn(2+)ProteinUniProt Q92769Inferred only
- HDAC3 requires the cofactor Zn(2+)ProteinUniProt O15379Inferred only
- HDAC6 requires the cofactor Zn(2+)ProteinUniProt Q9UBN7Inferred only
- HFM1 requires the cofactor Zn(2+)ProteinUniProt A2PYH4Inferred only
- HRG requires the cofactor Zn(2+)ProteinUniProt P04196Inferred only
- HTN1 requires the cofactor Zn(2+)ProteinUniProt P15515Inferred only
- IDE requires the cofactor Zn(2+)ProteinUniProt P14735Inferred only
- INTS11 requires the cofactor Zn(2+)ProteinUniProt Q5TA45Inferred only
- ITK requires the cofactor Zn(2+)ProteinUniProt Q08881Inferred only
- KDM1B requires the cofactor Zn(2+)ProteinUniProt Q8NB78Inferred only
- KEL requires the cofactor Zn(2+)ProteinUniProt P23276Inferred only
- LACC1 requires the cofactor Zn(2+)ProteinUniProt Q8IV20Inferred only
- LACTB2 requires the cofactor Zn(2+)ProteinUniProt Q53H82Inferred only
- LAP3 requires the cofactor Zn(2+)ProteinUniProt P28838Inferred only
- LMLN requires the cofactor Zn(2+)ProteinUniProt Q96KR4Inferred only
- LNPEP requires the cofactor Zn(2+)ProteinUniProt Q9UIQ6Inferred only
- LTA4H requires the cofactor Zn(2+)ProteinUniProt P09960Inferred only
- LVRN requires the cofactor Zn(2+)ProteinUniProt Q6Q4G3Inferred only
- MAN2A1 requires the cofactor Zn(2+)ProteinUniProt Q16706Inferred only
- MAN2A2 requires the cofactor Zn(2+)ProteinUniProt P49641Inferred only
- MAN2B1 requires the cofactor Zn(2+)ProteinUniProt O00754Inferred only
- MAN2B2 requires the cofactor Zn(2+)ProteinUniProt Q9Y2E5Inferred only
- MAPDA requires the cofactor Zn(2+)ProteinUniProt Q6DHV7Inferred only
- MATCAP1 requires the cofactor Zn(2+)ProteinUniProt Q68EN5Inferred only
- MATCAP2 requires the cofactor Zn(2+)ProteinUniProt Q8NCT3Inferred only
- MBLAC2 requires the cofactor Zn(2+)ProteinUniProt Q68D91Inferred only
- MBTPS2 requires the cofactor Zn(2+)ProteinUniProt O43462Inferred only
- MCM8 requires the cofactor Zn(2+)ProteinUniProt Q9UJA3Inferred only
- MCM9 requires the cofactor Zn(2+)ProteinUniProt Q9NXL9Inferred only
- MEP1A requires the cofactor Zn(2+)ProteinUniProt Q16819Inferred only
- MEP1B requires the cofactor Zn(2+)ProteinUniProt Q16820Inferred only
- METAP1 requires the cofactor Zn(2+)ProteinUniProt P53582Inferred only
- METAP1D requires the cofactor Zn(2+)ProteinUniProt Q6UB28Inferred only
- METAP2 requires the cofactor Zn(2+)ProteinUniProt P50579Inferred only
- MGMT requires the cofactor Zn(2+)ProteinUniProt P16455Inferred only
- MIPEP requires the cofactor Zn(2+)ProteinUniProt Q99797Inferred only
- MKNK2 requires the cofactor Zn(2+)ProteinUniProt Q9HBH9Inferred only
- MME requires the cofactor Zn(2+)ProteinUniProt P08473Inferred only
- MMEL1 requires the cofactor Zn(2+)ProteinUniProt Q495T6Inferred only
- MMP1 requires the cofactor Zn(2+)ProteinUniProt P03956Inferred only
- MMP10 requires the cofactor Zn(2+)ProteinUniProt P09238Inferred only
- MMP11 requires the cofactor Zn(2+)ProteinUniProt P24347Inferred only
- MMP12 requires the cofactor Zn(2+)ProteinUniProt P39900Inferred only
- MMP13 requires the cofactor Zn(2+)ProteinUniProt P45452Inferred only
- MMP14 requires the cofactor Zn(2+)ProteinUniProt P50281Inferred only
- MMP15 requires the cofactor Zn(2+)ProteinUniProt P51511Inferred only
- MMP16 requires the cofactor Zn(2+)ProteinUniProt P51512Inferred only
- MMP17 requires the cofactor Zn(2+)ProteinUniProt Q9ULZ9Inferred only
- MMP19 requires the cofactor Zn(2+)ProteinUniProt Q99542Inferred only
- MMP2 requires the cofactor Zn(2+)ProteinUniProt P08253Inferred only
- MMP20 requires the cofactor Zn(2+)ProteinUniProt O60882Inferred only
- MMP21 requires the cofactor Zn(2+)ProteinUniProt Q8N119Inferred only
- MMP23B requires the cofactor Zn(2+)ProteinUniProt O75900Inferred only
- MMP24 requires the cofactor Zn(2+)ProteinUniProt Q9Y5R2Inferred only
- MMP25 requires the cofactor Zn(2+)ProteinUniProt Q9NPA2Inferred only
- MMP26 requires the cofactor Zn(2+)ProteinUniProt Q9NRE1Inferred only
- MMP28 requires the cofactor Zn(2+)ProteinUniProt Q9H239Inferred only
- MMP3 requires the cofactor Zn(2+)ProteinUniProt P08254Inferred only
- MMP7 requires the cofactor Zn(2+)ProteinUniProt P09237Inferred only
- MMP8 requires the cofactor Zn(2+)ProteinUniProt P22894Inferred only
- MMP9 requires the cofactor Zn(2+)ProteinUniProt P14780Inferred only
- MOCS3 requires the cofactor Zn(2+)ProteinUniProt O95396Inferred only
- MPI requires the cofactor Zn(2+)ProteinUniProt P34949Inferred only
- MSRB1 requires the cofactor Zn(2+)ProteinUniProt Q9NZV6Inferred only
- MSRB2 requires the cofactor Zn(2+)ProteinUniProt Q9Y3D2Inferred only
- MSRB3 requires the cofactor Zn(2+)ProteinUniProt Q8IXL7Inferred only
- MTR requires the cofactor Zn(2+)ProteinUniProt Q99707Inferred only
- NAALAD2 requires the cofactor Zn(2+)ProteinUniProt Q9Y3Q0Inferred only
- NAALADL1 requires the cofactor Zn(2+)ProteinUniProt Q9UQQ1Inferred only
- NAPEPLD requires the cofactor Zn(2+)ProteinUniProt Q6IQ20Inferred only
- NGLY1 requires the cofactor Zn(2+)ProteinUniProt Q96IV0Inferred only
- NLN requires the cofactor Zn(2+)ProteinUniProt Q9BYT8Inferred only
- NMNAT1 requires the cofactor Zn(2+)ProteinUniProt Q9HAN9Inferred only
- NPEPL1 requires the cofactor Zn(2+)ProteinUniProt Q8NDH3Inferred only
- NPEPPS requires the cofactor Zn(2+)ProteinUniProt P55786Inferred only
- NQO2 requires the cofactor Zn(2+)ProteinUniProt P16083Inferred only
- NR4A1 requires the cofactor Zn(2+)ProteinUniProt P22736Inferred only
- NRDC requires the cofactor Zn(2+)ProteinUniProt O43847Inferred only
- NT5E requires the cofactor Zn(2+)ProteinUniProt P21589Inferred only
- NUDT12 requires the cofactor Zn(2+)ProteinUniProt Q9BQG2Inferred only
- NUDT3 requires the cofactor Zn(2+)ProteinUniProt O95989Inferred only
- NUP153 requires the cofactor Zn(2+)ProteinUniProt P49790Inferred only
- OMA1 requires the cofactor Zn(2+)ProteinUniProt Q96E52Inferred only
- PAM requires the cofactor Zn(2+)ProteinUniProt P19021Inferred only
- PAPPA requires the cofactor Zn(2+)ProteinUniProt Q13219Inferred only
- PAPPA2 requires the cofactor Zn(2+)ProteinUniProt Q9BXP8Inferred only
- PDE1A requires the cofactor Zn(2+)ProteinUniProt P54750Inferred only
- Zn(2+) is transported by SLC11A1ProteinRhea RHEA:28839Inferred only
- Zn(2+) is transported by SLC11A2ProteinRhea RHEA:71195Inferred only
- Zn(2+) is transported by SLC11A2ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC30A1ProteinRhea RHEA:72627Inferred only
- Zn(2+) is transported by SLC30A1ProteinHuman-GEM MAR06370Inferred only
- Zn(2+) is transported by SLC30A1ProteinRhea RHEA:82863Inferred only
- Zn(2+) is transported by SLC30A10ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC30A2ProteinRhea RHEA:72627Inferred only
- Zn(2+) is transported by SLC30A3ProteinRhea RHEA:72627Inferred only
- Zn(2+) is transported by SLC30A4ProteinRhea RHEA:72627Inferred only
- Zn(2+) is transported by SLC30A5ProteinRhea RHEA:72627Inferred only
- Zn(2+) is transported by SLC30A6ProteinHuman-GEM MAR09199Inferred only
- Zn(2+) is transported by SLC30A7ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC30A7ProteinHuman-GEM MAR09199Inferred only
- Zn(2+) is transported by SLC30A8ProteinRhea RHEA:72627Inferred only
- Zn(2+) is transported by SLC30A9ProteinRhea RHEA:72627Inferred only
- Zn(2+) is transported by SLC39A1ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A1ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC39A10ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A10ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC39A11ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A12ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A13ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A14ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC39A14ProteinRhea RHEA:62252Inferred only
- Zn(2+) is transported by SLC39A2ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC39A2ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A3ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A3ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC39A4ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC39A4ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A5ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A5ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC39A6ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC39A6ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A7ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by SLC39A7ProteinHuman-GEM MAR09200Inferred only
- Zn(2+) is transported by SLC39A8ProteinRhea RHEA:62264Inferred only
- Zn(2+) is transported by SLC39A8ProteinRhea RHEA:62252Inferred only
- Zn(2+) is transported by SLC39A8ProteinHuman-GEM MAR05989Inferred only
- Zn(2+) is transported by SLC39A9ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by TMEM163ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by TRPA1ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by TRPM3ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by TRPM6ProteinRhea RHEA:29351Inferred only
- Zn(2+) is transported by TRPM7ProteinRhea RHEA:29351Inferred only
Reactions
14 reactions
Transported by SLC39A14 or SLC11A2 or SLC39A8 or SLC39A5 or SLC39A6 or SLC39A3 or SLC39A1 or SLC39A4 or SLC39A2 or SLC39A10
Reaction pageLeft to rightBalancedextracellular space, cytosol
Human-GEM MAR05989CC BY 4.0Reference data
Transported by SLC30A1
Reaction pageLeft to rightBalancedcytosol, extracellular space
Human-GEM MAR06370CC BY 4.0Reference data
Reaction pageReversibleBalance undeterminableextracellular space
Human-GEM MAR09080CC BY 4.0Reference data
Transported by SLC30A6 or SLC30A7
Reaction pageLeft to rightBalancedcytosol, Golgi apparatus
Human-GEM MAR09199CC BY 4.0Reference data
Transported by SLC39A7
Reaction pageReversibleBalancedcytosol, endoplasmic reticulum
Human-GEM MAR09200CC BY 4.0Reference data
Zn(2+)+ATP(4-)+waterZn(2+)+ADP(3-)+hydrogenphosphate+hydron
Reaction pageDirection not assertedBalanced
Rhea RHEA:20621CC BY 4.0Reference data
Transported by SLC11A1
Reaction pageDirection not assertedBalanced
Rhea RHEA:28839CC BY 4.0Reference data
Transported by TRPA1 or SLC39A6 or SLC39A12 or SLC39A4 or SLC30A10 or SLC39A5 or SLC39A11 or SLC30A7 or TMEM163 or SLC39A7 or SLC39A13 or TRPM7 and 7 more alternatives
Reaction pageReversibleBalanced
Rhea RHEA:29351CC BY 4.0Reference data
Zn(2+)+ATP(4-)+waterZn(2+)+ADP(3-)+hydrogenphosphate+hydron
Reaction pageDirection not assertedBalanced
Rhea RHEA:29795CC BY 4.0Reference data
Zn(2+)+2hydrogencarbonateZn(2+)+2hydrogencarbonate
Transported by SLC39A14 or SLC39A8
Reaction pageLeft to rightBalanced
Rhea RHEA:62252CC BY 4.0Reference data
selenite+Zn(2+)+hydrogencarbonateselenite+Zn(2+)+hydrogencarbonate
Transported by SLC39A8
Reaction pageDirection not assertedBalanced
Rhea RHEA:62264CC BY 4.0Reference data
Transported by SLC11A2
Reaction pageLeft to rightBalanced
Rhea RHEA:71195CC BY 4.0Reference data
On the label
Labelled products
13,678 products
Source: NIH DSLD · Ingredient: Zn(2+) · 13,678 products · Declared amount per serving: 0.005–84.6 mg (932 products) · Showing 1,000 of 13,678
961 labels state an amount39 do not
- 1st PhormM-Factor HeroZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 3 Capsule(s)DSLD:12881
- 21 Super-VitaVitamins With Minerals Tablets (21 Vitamins And Minerals)0.25 mgper 1 Tablet(s)DSLD:13537
- 21st CenturyCalcium PlusZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 2 Caplet(s)DSLD:11140
- 21st CenturyDiabetic Support FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 3 Tablet(s)DSLD:11189
- 21st CenturyHealthy EyesZinc Oxide · Zinc (Form: as Zinc Oxide)40 mgper 1 Tablet(s)DSLD:11392
- 21st CenturyHealthy EyesZinc Oxide · Zinc (Form: as Zinc Oxide)40 mgper 1 Tablet(s)DSLD:11394
- 21st CenturyHealthy Eyes Super VisionZinc Oxide · Zinc (Form: as Zinc Oxide)69.6 mgper 2 Tablet(s)DSLD:11396
- 21st CenturyOne Daily ActiveZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:11548
- 21st CenturyOne Daily Adults 50+Zinc Oxide · Zinc (Form: as Zinc Oxide)22.5 mgper 1 Tablet(s)DSLD:11549
- 21st CenturyOne Daily Cholesterol Health With PolicosanolZinc Oxide · Zinc (Form: from Zinc Oxide)15 mgper 1 Tablet(s)DSLD:11550
- 21st CenturyOne Daily EnergyZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:11552
- 21st CenturyOne Daily MaximumZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:11558
Show the remaining 13,666
- 21st CenturyOne Daily Men's HealthZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:11559
- 21st CenturyOne Daily Weight ControlZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:11560
- 21st CenturyOne Daily Women'sZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:11561
- 21st CenturyOne Daily Women's 50+Zinc Oxide · Zinc (Form: as Zinc Oxide)22.5 mgper 1 Tablet(s)DSLD:11497
- 21st CenturyPreNatalZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 1 Tablet(s)DSLD:11562
- 21st Century Zoo FriendsCompleteZinc Oxide · Zinc (Form: from Zinc Oxide)7.5 mgper 1 Tablet(s)DSLD:11637
- 365 Everyday ValueAdult Multi for MenZinc Citrate · Zinc (Form: as Zinc Citrate)20 mgper 1 Tablet(s)DSLD:12017
- 365 Everyday ValueAdult Multi with IronZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:184071
- 365 Everyday ValueKid's Gummy Multi-VitaminZinc Citrate · Zinc (Form: as Zinc Citrate)2.4 mgper 1 Gummy(ies)DSLD:184073
- Advanced BionutritionalsUltimate Bone SupportZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)15 mgper 2 Tablet(s)DSLD:12885
- Advanced Nutrition SystemsIso T-DriveZinc Picolinate · Zinc (Form: as Zinc Picolinate)3 mgper 2 Capsule(s)DSLD:180444
- Advanced Nutrition SystemsIso T-DriveZinc Picolinate · Zinc (Form: as Zinc Picolinate)3 mgper 2 Capsule(s)DSLD:180477
- AdvoCareCitriZinc Lemon-LimeZinc Citrate · Zinc (Form: as Zinc Citrate)3 mgper 1 Chew(s)DSLD:177554
- AdvoCareCore Nutrition SystemZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: L-OptiZinc))24 mgper 1 4-Packet Strip(s)DSLD:177397
- AdvoCareHerbal Cleanse P.M.Zinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))2 mgper 2 Caplet(s)DSLD:177797
- AdvoCareMNS 3Zinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))15 mgper 2 Packet(s)DSLD:177961
- AdvoCareMNS EZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))15 mgper 1 Packet(s)DSLD:177964
- AdvoCareSleepWorks Lavender SpearmintZinc Gluconate · Zinc (Form: as Zinc Gluconate)5 mgper 2 fl. Oz.DSLD:178347
- Aidan ProductsInfla-KineZinc Oxide · Zinc (Form: as Zinc Oxide)20 mgper 2 Capsule(s)DSLD:179921
- AirborneAirborne CitrusZinc Oxide · Zinc (Form: as Zinc Oxide)8 mgper 1 Tablet(s)DSLD:18102
- AirborneAirborne Kids Assorted Fruit FlavorsZinc Oxide · Zinc (Form: as Zinc Oxide)0.67 mgper 2 Gummie(s)DSLD:180572
- AirborneAirborne Kids Assorted Fruit FlavorsZinc Oxide · Zinc (Form: as Zinc Oxide)0.67 mgper 2 Gummie(s)DSLD:180579
- AirborneAirborne Original Lemon LimeZinc Sulfate · Zinc (Form: as Zinc Sulfate)8 mgper 1 Tablet(s)DSLD:180581
- Airborne OriginalAirborne BerryZinc Sulfate · Zinc (Form: as Zinc Sulfate)8 mgper 1 Tablet(s)DSLD:180214
- Airborne OriginalAirborne CitrusZinc Sulfate · Zinc (Form: as Zinc Sulfate)8 mgper 1 Tablet(s)DSLD:180213
- Airborne OriginalAirborne Lemon-LimeZinc Sulfate · Zinc (Form: as Zinc Sulfate)8 mgper 1 Tablet(s)DSLD:180346
- Airborne OriginalAirborne Very BerryZinc Sulfate · Zinc (Form: as Zinc Sulfate)8 mgper 1 Tablet(s)DSLD:180349
- Airborne OriginalAirborne Very BerryZinc Sulfate · Zinc (Form: as Zinc Sulfate)8 mgper 1 Tablet(s)DSLD:180456
- Airborne OriginalAirborne Very BerryZinc Sulfate · Zinc (Form: as Zinc Sulfate)8 mgper 1 Tablet(s)DSLD:180457
- Airborne PlusAirborne Zesty OrangeZinc Oxide · Zinc (Form: as Zinc Oxide)8 mgper 5 Gram(s)DSLD:180345
- Airborne PlusBeta-Immune Booster Very BerryZinc Oxide · Zinc (Form: as Zinc Oxide)8 mgper 5 Gram(s)DSLD:178355
- Airborne PlusBeta-Immune Booster Zesty OrangeZinc Oxide · Zinc (Form: as Zinc Oxide)8 mgper 5 Gram(s)DSLD:178352
- Airborne PlusBeta-Immune Booster Zesty OrangeZinc Oxide · Zinc (Form: as Zinc Oxide)8 mgper 5 Gram(s)DSLD:180206
- Airborne PlusProbiotic Assorted Fruit FlavorsZinc Oxide · Zinc (Form: as Zinc Oxide)1 mgper 3 Gummie(s)DSLD:180210
- AlconI-Caps AREDS FormulaZinc Oxide34.8 mgper 2 Tablet(s)DSLD:17019
- AlconI-Caps AREDS FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)34.8 mgper 1 Softgel(s)DSLD:17025
- AlconI-Caps Lutein & ZeaxanthinZinc Acetate · Zinc (Form: as Zinc Acetate)60 mgper 2 Tablet(s)DSLD:18976
- AlconI-Caps MV84.6 mgper 2 Tablet(s)DSLD:17676
- AlconI-Caps MV42.3 mgper 2 Tablet(s)DSLD:18979
- Allergy Research GroupMetabolic Co-FactorZinc Picolinate · Zinc (Form: as Zinc Picolinate)30 mgper 6 Capsule(s)DSLD:184081
- Allergy Research GroupOcuDyneZinc Citrate · Zinc (Form: as Zinc Citrate)25 mgper 4 Capsule(s)DSLD:183969
- AltrumCold Season Zinc Lozenges Cherry FlavorZinc Citrate30 mgper 1 Lozenge(s)DSLD:17215
- American HealthNutri-MegaZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 2 Softgel(s)DSLD:16693
- American HealthNutri-MegaZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 2 Softgel(s)DSLD:16695
- Amneal PharmaceuticalsPrenatal Plus Vitamin And Mineral TabletZinc Oxide25 mgper 1 Tablet(s)DSLD:12055
- AnimalAnimal PakZinc Oxide · Zinc (Form: as Zinc Oxide)30 mgper 1 Packet(s)DSLD:174541
- ANS PerformanceFortitudeamount not statedper 4 Capsule(s)DSLD:14568
- AnutraAnutra Grain0.7 mgper 2.5 TbspDSLD:12805
- AnutraOmega-3s Antioxidants0.2 mgper 2 Capsule(s)DSLD:12796
- Axis LabsHypertest XTRZinc Aspartate · Zinc (Form: from Zinc L-Methionine, and Zinc Aspartate)30 mgper 6 Capsule(s)DSLD:182733
- Bariatric AdvantageMulti Formula With AntioxidantsZinc Picolinate · Zinc (Form: from Zinc Picolinate)15 mgper 6 Capsule(s)DSLD:11997
- Bausch & LombOcuvite Eye Health FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)9 mgper 1 Softgel(s)DSLD:17099
- Bausch & LombOcuvite Eye+Multi23 mgper 2 Tablet(s)DSLD:17096
- Bausch & LombPreserVision LuteinZinc Oxide34.8 mgper 1 Softgel(s)DSLD:17137
- Bausch & LombPreserVision LuteinZinc Oxide34.8 mgper 1 Softgel(s)DSLD:17138
- BayerFlintstones Gummies Complete2.5 mgper 1 Gummy(ies)DSLD:12227
- BayerFlintstones Sour Gummies Complete1.25 mgper 1 Gummy(ies)DSLD:12000
- Bayer CitacalCitracal plus Bone Density Builder7.5 mgper 2 Tablet(s)DSLD:17233
- Bayer CitracalCitracal Calcium Citrate + Magnesium & Minerals7.5 mgper 2 Caplet(s)DSLD:177866
- Bayer One A DayEnergy15 mgper 1 Tablet(s)DSLD:178021
- Bayer One A DayMen's 50+ Healthy Advantage24 mgper 1 Tablet(s)DSLD:178055
- Bayer One A DayMen's Health Formula15 mgper 1 Tablet(s)DSLD:17190
- Bayer One A DayMen's Health Formula15 mgper 1 Tablet(s)DSLD:17213
- Bayer One A DayMen's Health Formula15 mgper 1 Tablet(s)DSLD:178058
- Bayer One A DayMen's VitaCraves Gummies5 mgper 2 Gummy(ies)DSLD:17230
- Bayer One A DayTeen Advantage for Her Complete Multivitamin15 mgper 1 Caplet(s)DSLD:17231
- Bayer One A DayTeen Advantage for Him Complete Multivitamin15 mgper 1 Caplet(s)DSLD:17214
- Bayer One A DayVitaCraves Gummies5 mgper 2 Gummy(ies)DSLD:17176
- Bayer One A DayVitaCraves Gummies5 mgper 2 Gummy(ies)DSLD:17177
- Bayer One A DayVitaCraves Gummies +Immunity Support5 mgper 2 Gummy(ies)DSLD:17178
- Bayer One A DayVitaCraves Men's Multi Gummies5 mgper 2 Gummie(s)DSLD:178126
- Bayer One A DayWomen's 2O Mixed Berry Flavor15 mgper 1 Packet(s)DSLD:12230
- Bayer One A DayWomen's 50+ Healthy Advantage24 mgper 1 Tablet(s)DSLD:178201
- Bayer One A DayWomen's Formula15 mgper 1 Tablet(s)DSLD:17183
- Bayer One A DayWomen's Formula15 mgper 1 Tablet(s)DSLD:17222
- Bayer One A DayWomen's Formula15 mgper 1 Tablet(s)DSLD:178212
- Bayer One A DayWomen's Prenatal 115 mgper 1 Softgel(s)DSLD:178392
- Bayer One A DayWomen's Prenatal with DHA15 mgper 1 Tablet(s)DSLD:178394
- Bayer One A Day AdultVitaCraves Energy Support Multi Gummies Cola Lime Flavor5 mgper 4 Gummie(s)DSLD:178113
- Bayer One A Day KidsBatman Complete Multivitamin Gummies2.5 mgper 1 Gummy(ies)DSLD:178024
- Bayer One A Day KidsHello Kitty Complete Multivitamin Gummies2.5 mgper 1 Gummy(ies)DSLD:178052
- BergaMetBergaFemmeZinc Oxide3 mgper 1 Tablet(s)DSLD:181685
- BergaMet NAUltimate MemoryZinc Glycinate · Zinc (Form: as Zinc Glycinate)6 mgper 1 Tablet(s)DSLD:182198
- Beyond HumanBlood Sugar SupportZinc Oxide7.5 mgper 1 Capsule(s)DSLD:181927
- BiochemMC Mineral Complex EnhancerZinc Picolinate · Zinc (Form: as Zinc Picolinate)2.2 mgper 1.96 Gram(s)DSLD:183824
- BiochemP+ 100% Plant Protein Lean Vanilla Flavor2.7 mgper 32.2 Gram(s)DSLD:183675
- BiochemP+ 100% Plant Protein Mood Vanilla Flavor2.8 mgper 32.4 Gram(s)DSLD:183934
- Biofarma Natural CMDMaxibilobaSulfato de zinc monohidratado (Form: equivalente a 5 mg de zinc)13.73 mgper 1 Tablet(s)DSLD:12935
- BioSource LabsWhole Food MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 3 Tablet(s)DSLD:174998
- Bluebonnet100% Natural Dual-Action Protein Natural ChocolateCasein · Zinc (Form: from Whey, and Casein) Note: Mineral and vitamin content is based on an average; amounts may vary.600 mcgper 34 Gram(s)DSLD:179935
- Bluebonnet100% Natural Dual-Action Protein Natural ChocolateCasein · Zinc (Form: from Whey, and Casein) Note: Mineral and vitamin content is based on an average; amounts may vary.600 mcgper 34 Gram(s)DSLD:179938
- Bluebonnet100% Natural Dual-Action Protein Natural ChocolateCasein · Zinc (Form: from Whey, and Casein) Note: Vitamin and mineral content is based on an average; amounts may vary.600 mcgper 34 Gram(s)DSLD:179941
- Bluebonnet100% Natural Dual-Action Protein Natural French VanillaCasein · Zinc (Form: from Whey, and Casein) Note: Mineral content is based on an average; amounts may vary.500 mcgper 34 Gram(s)DSLD:179930
- Bluebonnet100% Natural Dual-Action Protein Natural French VanillaCasein · Zinc (Form: from Whey, and Casein) Note: Mineral content is based on an average; amounts may vary.500 mcgper 34 Gram(s)DSLD:179933
- Bluebonnet100% Natural Dual-Action Protein Natural Original FlavorCasein · Zinc (Form: from Whey, and Casein) Note: Mineral content is based on an average; amounts may vary.500 mcgper 34 Gram(s)DSLD:179868
- Bluebonnet100% Natural Dual-Action Protein Natural Original FlavorCasein · Zinc (Form: from Whey, and Casein) Note: Mineral content is based on an average; amounts may vary.500 mcgper 34 Gram(s)DSLD:179881
- Bluebonnet100% Natural Dual-Action Protein Natural Original FlavorCasein · Zinc (Form: from Whey, and Casein) Note: Mineral content is based on an average; amounts may vary.500 mcgper 34 Gram(s)DSLD:179912
- BluebonnetGSX FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Capsule(s)DSLD:179159
- BluebonnetGSX FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Capsule(s)DSLD:179170
- BluebonnetMaxi OneZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)10 mgper 1 Caplet(s)DSLD:177475
- BluebonnetMaxi TwoZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)20 mgper 2 Caplet(s)DSLD:177519
- BluebonnetMaxi TwoZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)20 mgper 2 Caplet(s)DSLD:177530
- BluebonnetMaxi Two Iron-FreeZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)20 mgper 2 Caplet(s)DSLD:177608
- BluebonnetMaxi Two Iron-FreeZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)20 mgper 2 Caplet(s)DSLD:177609
- BluebonnetMPX 1000 Prostate SupportZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)20 mgper 2 Capsule(s)DSLD:179209
- BluebonnetMPX 1000 Prostate SupportZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)20 mgper 2 Capsule(s)DSLD:179227
- BluebonnetMulti Vita SoftgelsZinc Picolinate · Zinc (Form: as Zinc Picolinate)20 mgper 2 Softgel(s)DSLD:177618
- BluebonnetMulti Vita SoftgelsZinc Picolinate · Zinc (Form: as Zinc Picolinate)20 mgper 2 Softgel(s)DSLD:177617
- BluebonnetSuper Vita-CoQ10 FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177532
- BluebonnetSuper Vita-CoQ10 FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177533
- BluebonnetSuper Vita-CoQ10 FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177535
- BluebonnetSuper Vita-CoQ10 FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177536
- BluebonnetUltimate Hair & Nail FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)25 mgper 3 Capsule(s)DSLD:179115
- BluebonnetUltimate Hair & Nail FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)25 mgper 3 Capsule(s)DSLD:179124
- BluebonnetVeggie ChoiceZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)30 mgper 3 Caplet(s)DSLD:177732
- Bluebonnet Early Promise PrenatalGentle MultipleZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)15 mgper 2 Caplet(s)DSLD:177853
- Bluebonnet Super EarthAntiOxidantZinc Amino Acid Chelate · Zinc (Form: Zinc Amino Acid Chelate) Note: elemental20 mgper 2 Caplet(s)DSLD:177813
- Bluebonnet Super EarthAntiOxidantZinc Amino Acid Chelate · Zinc (Form: Zinc Amino Acid Chelate) Note: elemental20 mgper 2 Caplet(s)DSLD:177815
- Bluebonnet Super EarthBrewer's Yeast PowderZinc Note: Vitamin and mineral content is based on an average; amounts may vary.5 mgper 30 Gram(s)DSLD:179302
- Bluebonnet Super EarthLiquid Multinutrient Formula Natural Tropical Fruit FlavorZinc Gluconate · Zinc (Form: as Zinc Gluconate)11 mgper 2 TbspDSLD:177417
- Bluebonnet Super EarthMultiNutrientZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177507
- Bluebonnet Super EarthMultiNutrientZinc Picolinate · Zinc (Form: Zinc Picolinate) Note: elemental15 mgper 6 Mini-Caplet(s)DSLD:177442
- Bluebonnet Super EarthMultiNutrientZinc Picolinate · Zinc (Form: Zinc Picolinate) Note: elemental15 mgper 6 Mini-Caplet(s)DSLD:177460
- Bluebonnet Super EarthMultiNutrientZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 6 Mini-Caplet(s)DSLD:177462
- Bluebonnet Super EarthMultiNutrientZinc Picolinate · Zinc (Form: Zinc Picolinate) Note: elemental15 mgper 6 Mini-Caplet(s)DSLD:177464
- Bluebonnet Super EarthMultiNutrientZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177508
- Bluebonnet Super EarthMultiNutrientZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177511
- Bluebonnet Super EarthMultiNutrientZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177516
- Bluebonnet Super EarthMultiNutrientZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177517
- Bluebonnet Super EarthMultiNutrient Iron FreeZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Caplet(s)DSLD:177494
- Bluebonnet Super EarthOrganic VeggieProtein ChocolateZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 31 Gram(s)DSLD:178734
- Bluebonnet Super EarthOrganic VeggieProtein ChocolateZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 31 Gram(s)DSLD:180122
- Bluebonnet Super EarthOrganic VeggieProtein Chocolate MochaZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 31 Gram(s)DSLD:180097
- Bluebonnet Super EarthOrganic VeggieProtein Chocolate MochaZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 31 Gram(s)DSLD:180124
- Bluebonnet Super EarthOrganic VeggieProtein Chocolate MochaZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 31 Gram(s)DSLD:180128
- Bluebonnet Super EarthOrganic VeggieProtein Natural Original FlavorZinc Note: Mineral content is based on an average; amounts may vary.1.6 mgper 27 Gram(s)DSLD:180057
- Bluebonnet Super EarthOrganic VeggieProtein VanillaZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 32 Gram(s)DSLD:180066
- Bluebonnet Super EarthOrganic VeggieProtein VanillaZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 32 Gram(s)DSLD:180103
- Bluebonnet Super EarthOrganic VeggieProtein Vanilla ChaiZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 30 Gram(s)DSLD:180070
- Bluebonnet Super EarthOrganic VeggieProtein Vanilla ChaiZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 30 Gram(s)DSLD:180072
- Bluebonnet Super EarthOrganic VeggieProtein Vanilla ChaiZinc Note: Mineral content is based on an average; amounts may vary.1.5 mgper 30 Gram(s)DSLD:180119
- Bluebonnet Super EarthSingle 1 DailyZinc Picolinate · Zinc (Form: as Zinc Picolinate)5 mgper 1 Caplet(s)DSLD:177574
- Bluebonnet Super EarthSingle 1 DailyZinc Picolinate · Zinc (Form: as Zinc Picolinate)5 mgper 1 Caplet(s)DSLD:177572
- Bluebonnet Super EarthSingle 1 DailyZinc Picolinate · Zinc (Form: as Zinc Picolinate)5 mgper 1 Caplet(s)DSLD:177576
- Bluebonnet Super EarthSingle 1 Daily Iron FreeZinc Picolinate · Zinc (Form: as Zinc Picolinate)5 mgper 1 Caplet(s)DSLD:177559
- Bluebonnet Super EarthSingle 1 Daily Iron FreeZinc Picolinate · Zinc (Form: as Zinc Picolinate)5 mgper 1 Caplet(s)DSLD:177568
- Bluebonnet Super EarthSingle 1 Daily Iron FreeZinc Picolinate · Zinc (Form: as Zinc Picolinate)5 mgper 1 Caplet(s)DSLD:177571
- Bluebonnet Super Earth Rainforest AnimalzWhole Food Based MultipleZinc Amino Acid Chelate · Zinc (Form: Zinc Amino Acid Chelate) Note: elemental3 mgper 2 Animal Shaped Chewable(s)DSLD:12923
- Body BasicsActra-SX 500 Energizeramount not statedper 1 Capsule(s)DSLD:17726
- BodyBuilding.com Foundation SeriesMultiVitaminZinc Oxide · Zinc (Form: as Zinc Oxide)50 mgper 2 Capsule(s)DSLD:175062
- Bodybuilding.com Platinum SeriesMulticoreZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 1 Packet(s)DSLD:175353
- BodyTechZMA TechZinc (Form: as Zinc Mono-L-Methionine Sulfate, and Zinc Aspartate)30 mgper 3 Capsule(s)DSLD:184015
- BodyTechZMA TechZinc (Form: as Zinc Mono-L-Methionine Sulfate, and Zinc Aspartate)30 mgper 3 Capsule(s)DSLD:184024
- CaltrateCaltrate 600+D3 Plus Minerals7.5 mgper 1 Tablet(s)DSLD:202243
- CarlsonSuper 1 DailyZinc Glycinate · Zinc (Form: from Zinc Glycinate)15 mgper 1 Tablet(s)DSLD:19660
- CellucorCOR-Performance ZMAZinc (Form: as Zinc Mono-L-Methionine Sulfate, and Zinc Aspartate)30 mgper 4 Capsule(s)DSLD:18932
- CentrumCentrum Adults Under 5011 mgper 1 Tablet(s)DSLD:17139
- CentrumCentrum Flavor Burst Kids Grape & Blue Raspberry2.5 mgper 2 Chew(s)DSLD:174643
- CentrumCentrum Men Under 5011 mgper 1 Tablet(s)DSLD:17144
- CentrumCentrum Men Under 5011 mgper 1 Tablet(s)DSLD:18988
- CentrumCentrum Silver Adults 50+11 mgper 1 Tablet(s)DSLD:18940
- CentrumCentrum Silver Adults 50+11 mgper 1 Tablet(s)DSLD:18997
- CentrumCentrum Silver Chewables Citrus Berry15 mgper 1 Tablet(s)DSLD:18924
- CentrumCentrum Silver Women 50+15 mgper 1 Tablet(s)DSLD:18918
- CentrumCentrum Silver Women 50+15 mgper 1 Tablet(s)DSLD:18935
- CentrumCentrum Women Under 508 mgper 1 Tablet(s)DSLD:17148
- CentrumCentrum Women Under 508 mgper 1 Tablet(s)DSLD:18913
- CentrumCentrum Women Under 508 mgper 1 Tablet(s)DSLD:18934
- ChampBevMuscle Milk Banana Creme Shake3 mgper 11 fl. Oz.DSLD:14419
- ChampBevMuscle Milk Banana Creme Shake5 mgper 17 fl. Oz.DSLD:14447
- ChampBevMuscle Milk Chocolate Milk Shake3 mgper 11 fl. Oz.DSLD:14479
- ChampBevMuscle Milk Chocolate Milk Shake5 mgper 17 fl. Oz.DSLD:14485
- ChampBevMuscle Milk Cookies 'N' Creme Shake3 mgper 11 fl. Oz.DSLD:14491
- ChampBevMuscle Milk Vanilla Creme Shake3 mgper 11 fl. Oz.DSLD:14529
- CHK NutritionChewable Kids' MultiZinc Oxide · Zinc (Form: as Zinc Oxide)3 mgper 2 Tablet(s)DSLD:174166
- Complete H2O MineralsBalanced Life Concentrate600 mcgper 0.5 Ounce(s)DSLD:180080
- Complete H2O MineralsUltimate Zinc Concentrate10 mcgper 0.5 mLDSLD:180078
- Complete H2O MineralsVan-Chr-Zin Concentrate0.75 mgper 0.33 TbspDSLD:180185
- Complete H2O MineralsZinc Concentrate2.25 mgper 0.33 TbspDSLD:180199
- Complete H2O MineralsZinc Extra Strength Concentrate9 mgper 0.33 TbspDSLD:180203
- ComplexinComplexin Super SupplementZinc Amino Acid Chelate · Zinc (Form: as Zinc Oxide, and Zinc Amino Acid Chelate)5 mgper 3 Capsule(s)DSLD:180964
- CoralCal Magamount not statedper 3 Capsule(s)DSLD:16138
- CoralCoral Complex 3amount not statedper 3 Capsule(s)DSLD:16142
- CoralCoral Complex 3amount not statedper 3 Capsule(s)DSLD:16144
- CoralCoral Complex 3amount not statedper 3 Capsule(s)DSLD:16148
- CoralCoral Complex 3amount not statedper 3 Capsule(s)DSLD:16150
- Core NutritionalsMRP Blueberry Crumb Cake3.65 mgper 68 Gram(s)DSLD:183358
- Corr-Jensen LabsDreamweaver Advanced Sleep FormulaAspartate · Zinc Aspartate (Form: 20% Aspartate)10 mgper 1 Softgel(s)DSLD:14838
- Country FarmsLiving Foods Multi-VitaminZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 1 Vegetarian Tablet(s)DSLD:181010
- Country FarmsSuper Greens Protein Shake Tahitian Vanilla FlavorZinc Bisglycinate Chelate · Zinc (Form: as Zinc Oxide, and Zinc Bisglycinate Chelate)5.25 mgper 1 Gram(s)DSLD:181025
- Country LifeDaily Multi-SorbZinc Picolinate · Zinc (Form: as Zinc Picolinate)10 mgper 2 Softgel(s)DSLD:13808
- Country LifeDolphin Pals Multivitamin & MineralZinc Citrate · Zinc (Form: as Zinc Citrate)4.4 mgper 3 Gummy(ies)DSLD:13402
- Country LifeKids Liquid Dolphin Pals Multivitamin & Mineral Complex Berry SplashZinc Gluconate · Zinc (Form: as Zinc Gluconate)5 mgper 1 tspDSLD:13430
- Country LifeMulti-100(zinc) aspartate · Zinc (Form: as (zinc) oxide, (zinc) citrate, (zinc) lysinate, (zinc) taurinate, (zinc) aspartate)20 mgper 1 Tablet(s)DSLD:13945
- Country LifeSuperior Vitamin C 1000 mgZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 1 Tablet(s)DSLD:13899
- Country LifeTall Tree Natural Orange & Pineapple FlavorZinc Citrate · Zinc (Form: as Zinc Citrate)2 mgper 1 Wafer(s)DSLD:13407
- Country LifeTarget-Mins Total MinsZinc Alpha-Ketoglutarate · Zinc (Form: as Zinc Citrate, Zinc Histidinate, Zinc Alpha-Ketoglutarate, Zinc Picolinate)15 mgper 2 Tablet(s)DSLD:179483
- Country LifeWell-Max With NACZinc Citrate · Zinc (Form: as zinc glycinate, zinc citrate)25 mgper 3 Tablet(s)DSLD:13987
- Country LifeZinc Lozenges With Vitamin C Lemon FlavorZinc Citrate · Zinc (Form: as Zinc Gluconate, Zinc Citrate)23 mgper 1 Lozenge(s)DSLD:13754
- Country Life Realfood OrganicsYour Daily NutritionOrganic Food Blend · Zinc (Form: from Organic Food Blend)0.005 mgper 1 Tablet(s)DSLD:13971
- CRC The Carter-Reed CompanyRelacore ExtraZinc Oxide · Zinc (Form: as Zinc Oxide)3.3 mgper 2 Capsule(s)DSLD:17961
- CVS PharmacyDaily Menopause15 mgper 1 Tablet(s)DSLD:18193
- CVS PharmacyDaily Multiple For Men 50+Zinc Oxide · Zinc (Form: as Zinc Oxide)22.5 mgper 1 Tablet(s)DSLD:12089
- CVS PharmacyDaily Multiple For Women 50+Zinc Oxide · Zinc (Form: as Zinc Oxide)22.5 mgper 1 Tablet(s)DSLD:18147
- CVS PharmacyDaily Multiple For Women 50+Zinc Oxide · Zinc (Form: as Zinc Oxide)22.5 mgper 1 Tablet(s)DSLD:18156
- CVS PharmacyDaily Multiple USP For MenZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:18161
- CVS PharmacyDaily Multiple USP For MenZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:18170
- CVS PharmacyDaily Multiple USP For WomenZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:18138
- CVS PharmacyDaily Multiple USP For WomenZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:18196
- CVS PharmacyNatural Calcium, Magnesium & Zinc USPZinc Sulfate · Zinc (Form: as Zinc Sulfate)5 mgper 1 Caplet(s)DSLD:12010
- CVS PharmacyProtectavision Eye Health FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)34.8 mgper 1 Softgel(s)DSLD:18264
- CVS PharmacySpectravite Advanced FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Tablet(s)DSLD:12012
- CVS PharmacySpectravite Ultra Women's Health SeniorZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:18269
- CVS PharmacyVision FormulaZinc Oxide · Zinc (Form: from Zinc Oxide)40 mgper 1 Tablet(s)DSLD:18283
- CytoSportMuscle Milk Brownie BatterZinc Oxide · Zinc (Form: as Zinc Oxide)5 mgper 70 Gram(s)DSLD:14467
- CytoSportMuscle Milk Collegiate Chocolate Milk Shake3 mgper 11 fl. Oz.DSLD:14534
- CytoSportMuscle Milk Collegiate Vanilla Creme Shake3 mgper 11 fl. Oz.DSLD:14584
- CytoSportMuscle Milk Light Banana Creme5 mgper 50 Gram(s)DSLD:14588
- CytoSportMuscle Milk Light Cake Batter5 mgper 50 Gram(s)DSLD:14597
- CytoSportMuscle Milk Light Chocolate Milk5 mgper 50 Gram(s)DSLD:14600
- CytoSportMuscle Milk Light Chocolate Milk5 mgper 50 Gram(s)DSLD:14607
- CytoSportMuscle Milk Light Peanut Butter Chocolate5 mgper 50 Gram(s)DSLD:14613
- CytoSportMuscle Milk Light Vanilla Creme5 mgper 50 Gram(s)DSLD:14616
- CytoSportMuscle Milk Orange Cremeamount not statedper 75 Gram(s)DSLD:14498
- CytoSportMuscle Milk Strawberry Bananaamount not statedper 75 Gram(s)DSLD:14522
- Designs for HealthHTN ComplexTRAACS Zinc Glycinate Chelate15 mgper 2 Capsule(s)DSLD:12952
- DinosaursMultiSaurus Vitamins & Minerals Mixed BerryZinc Gluconate · Zinc (Form: as Zinc Gluconate)1 mgper 1 Tablet(s)DSLD:13509
- Doctor GilmoreEssentials Complete MultivitaminZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 1 Tablet(s)DSLD:182051
- dotFITActiveMVZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 mgper 1 Tablet(s)DSLD:12980
- Douglas LaboratoriesA.R.M.D. Eye SupportZinc Oxide · Zinc (Form: as Zinc Oxide)80 mgper 2 Tablet(s)DSLD:10365
- Douglas LaboratoriesA.R.M.D. Eye Support BetaZinc Oxide · Zinc (Form: as Zinc Oxide)80 mgper 2 Tablet(s)DSLD:10358
- Douglas LaboratoriesA.R.M.D. Eye Support BetaZinc Oxide · Zinc (Form: as Zinc Oxide)80 mgper 2 Tablet(s)DSLD:10364
- Douglas LaboratoriesADDtendOpti-Zinc · Zinc (Form: as Opti-Zinc (Alt. Name: Zinc Monomethionine))6 mgper 6 Capsule(s)DSLD:10334
- Douglas LaboratoriesBasic AntioxZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)10 mgper 1 Packet(s)DSLD:10794
- Douglas LaboratoriesBasic Preventive 1 (Plus Iron And Copper)Zinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)20 mgper 6 Tablet(s)DSLD:10777
- Douglas LaboratoriesBasic Preventive 2 (Iron And Copper Free)Zinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)20 mgper 6 Tablet(s)DSLD:10782
- Douglas LaboratoriesBasic Preventive 3Zinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)20 mgper 6 Tablet(s)DSLD:10784
- Douglas LaboratoriesBasic Preventive 5 Plus Extra Vitamin DZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate Note: U.S. Patent Number 4,599,152 Albion Laboratories)20 mgper 6 Tablet(s)DSLD:10673
- Douglas LaboratoriesBasic Preventive 5 Plus Extra Vitamin DZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)20 mgper 6 Tablet(s)DSLD:10791
- Douglas LaboratoriesBasics Plus With CopperZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate Note: U.S. Patent Number 4,599,152 Albion Laboratories)10 mgper 1 Packet(s)DSLD:10769
- Douglas LaboratoriesC-Plex PowderZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)3 mgper 10 Gram(s)DSLD:10808
- Douglas LaboratoriesEssential-4 Nutrition PackZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)13 mgper 1 Packet(s)DSLD:10038
- Douglas LaboratoriesGlucoPackzinc amino acid chelate · Zinc (Form: as zinc amino acid chelate Note: U.S. Patent No. 4,599,152 Albion Laboratories.)10 mgper 1 Packet(s)DSLD:10869
- Douglas LaboratoriesLDA FormulaZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate Note: U.S. Patent Number 4,599,152 Albion Laboratories)20 mgper 9 Vegetarian Capsule(s)DSLD:10489
- Douglas LaboratoriesLongevity Support PackZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)13 mgper 1 Pack(s)DSLD:10041
- Douglas LaboratoriesNutri-Immuno Pack With HerbsZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)13 mgper 10 Capsule(s)DSLD:10048
- Douglas LaboratoriesOcu-Min ForteZinc Picolinate · Zinc (Form: from Zinc Picolinate)30 mgper 6 Tablet(s)DSLD:10104
- Douglas LaboratoriesSight Smart (Multivitamin + Lutein)Zinc Chelate · Zinc (Form: as Zinc Chelate)15 mgper 1 Tablet(s)DSLD:10511
- Douglas LaboratoriesUltra 5-HTP FormulaZinc Picolinate · Zinc (Form: from Zinc Picolinate)10 mgper 2 Capsule(s)DSLD:10298
- Douglas LaboratoriesUltra Cardio Multivitamin Iron FreeZinc Chelate · Zinc (Form: as Zinc Chelate)15 mgper 1 Tablet(s)DSLD:10589
- Douglas LaboratoriesUltra Cardio Support PackZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)13 mgper 1 Packet(s)DSLD:10045
- Douglas LaboratoriesUltra PreventiveZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)25 mgper 8 Tablet(s)DSLD:176643
- Douglas LaboratoriesUltra Preventive Forte-ChelZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)30 mgper 9 Tablet(s)DSLD:10212
- Douglas LaboratoriesUltra Preventive Forte-Chel (Capsules)Zinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)30 mgper 15 Capsule(s)DSLD:10186
- Douglas LaboratoriesUltra Preventive IXZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)25 mgper 7 Tablet(s)DSLD:10250
- Douglas LaboratoriesUltra Preventive IXZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)25 mgper 7 Tablet(s)DSLD:10256
- Douglas LaboratoriesUltra Preventive IX With Vitamin KZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)25 mgper 7 Tablet(s)DSLD:10257
- Douglas LaboratoriesUltra Preventive IX With Vitamin KZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)25 mgper 7 Tablet(s)DSLD:10259
- Douglas LaboratoriesUltra Preventive N.A.Zinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)2 mgper 1 Capsule(s)DSLD:10073
- Douglas LaboratoriesUltra Preventive N.A.Zinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)2 mgper 1 Capsule(s)DSLD:10074
- Douglas LaboratoriesUltra Preventive World FormulaZinc Note: elemental3.125 mgper 2 Vegetarian Capsule(s)DSLD:10716
- Douglas LaboratoriesUltra Preventive-Beta With Copper & Iron With Natural Mixed CarotenoidsL-OptiZinc · Zinc (Form: as L-OptiZinc)30 mgper 6 Tablet(s)DSLD:10089
- Douglas LaboratoriesUltra Preventive-Beta With Copper With Natural Mixed CarotenoidsL-OptiZinc · Zinc (Form: as L-OptiZinc)30 mgper 6 Tablet(s)DSLD:10087
- Douglas LaboratoriesUltra Preventive-Beta With Copper With Natural Mixed CarotenoidsL-OptiZinc · Zinc (Form: as L-OptiZinc)30 mgper 6 Tablet(s)DSLD:10088
- Douglas LaboratoriesUltra-Male X Daily CapsulesZinc Krebs Cycle Chelates · Zinc (Form: from Zinc Krebs Note: Krebs = Citrate, Fumarate, Malate, Glutarate and Succinate Complex.)10 mgper 2 Capsule(s)DSLD:10303
- Douglas LaboratoriesUltra-Male X Daily CapsulesZinc Krebs Cycle Chelates · Zinc (Form: from Zinc Krebs Note: Krebs = Citrate, Fumarate, Malate, Glutarate and Succinate Complex.)10 mgper 2 Capsule(s)DSLD:10305
- Douglas LaboratoriesVita-Big KidsZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)5 mgper 6 Capsule(s)DSLD:10215
- Douglas LaboratoriesVita-KidsZinc Aspartate · Zinc (Form: from Zinc Aspartate)2 mgper 2 Tablet(s)DSLD:10502
- Douglas LaboratoriesVita-Kids ImmuneZinc Gluconate · Zinc (Form: as Zinc Gluconate)3 mgper 5 mLDSLD:10438
- Douglas LaboratoriesZinc-Stat13.5 mgper 1 tspDSLD:10091
- Dr. LaMar's ProductsAloeAminos Power Nutritionamount not statedper 4 Ounce(s)DSLD:180440
- Dr. LaMar's ProductsCreation Mineral Boostamount not statedper 1 Ounce(s)DSLD:180819
- Dr. LaMar's ProductsUltimate Saltamount not statedper 1 Not PresentDSLD:180358
- Dr. Mann PharmaVivioptal Capsulas Vitamina y MineralesZinc Note: Oligoelement401 mcgper 1 Capsule(s)DSLD:13091
- Dr. SinatraHeart Healthy Multivitamin MenZinc Oxide · Zinc (Form: as Zinc Oxide)20 mgper 3 Tablet(s)DSLD:178533
- Dr. SinatraHeart Healthy Multivitamin MenZinc Oxide · Zinc (Form: as Zinc Oxide)20 mgper 3 Tablet(s)DSLD:178564
- Dr. SinatraHeart Healthy Multivitamin WomenZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 3 Tablet(s)DSLD:178748
- Dr. WhitakerVision EssentialsZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 4 Capsule(s)DSLD:178657
- Dr. WhitakerVision EssentialsZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 4 Capsule(s)DSLD:178660
- Dr. WhitakerVision Essentials GoldZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 4 Capsule(s)DSLD:178653
- Dr. WhitakerVision Essentials GoldZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 4 Capsule(s)DSLD:178656
- Dr. XuVitaliChiZinc Oxide · Zinc (Form: as Zinc Oxide)2 mgper 2 Capsule(s)DSLD:178578
- DS Driven SportsTriazoleZinc Aspartate · Zinc (Form: from Zinc Aspartate)5 mgper 3 Capsule(s)DSLD:17790
- Dymatize NutritionElite Fusion 7 Mochaccino Rush5 mgper 44 Gram(s)DSLD:18731
- EagleVision FormulaZinc Aspartate25 mgper 2 Capsule(s)DSLD:181971
- EBOOSTEBOOST Natural Super BerryZinc Citrate · Zinc (Form: as Zinc Citrate)2 mgper 2 fl. Oz.DSLD:17804
- Emergen-C1,000 MG Vitamin C Cranberry-PomegranateZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 8.3 Gram(s)DSLD:15823
- Emergen-C1,000 MG Vitamin C Lite Citrus FlavoredZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 3.8 Gram(s)DSLD:15827
- Emergen-C1,000 MG Vitamin C MangosteenZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 9.4 Gram(s)DSLD:15830
- Emergen-C1,000 mg Vitamin C TangerineZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 9.4 Gram(s)DSLD:15844
- Emergen-C1,000 MG Vitamin C TropicalZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 9 Gram(s)DSLD:15847
- Emergen-CBlue 1000 mg Vitamin C Triple BerryZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 8.4 Gram(s)DSLD:15820
- Emergen-CFive Calories 1000 mg Vitamin C Mandarin OrangeZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 5.4 Gram(s)DSLD:15854
- Emergen-CFive Calories 1000 mg Vitamin C Peach-Passion FruitZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 4.7 Gram(s)DSLD:15866
- Emergen-CFive Calories 1000 mg Vitamin C Strawberry-KiwiZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 4.8 Gram(s)DSLD:15868
- Emergen-CHeart Health Black CherryZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 9 Gram(s)DSLD:15870
- Emergen-CImmune Plus System Support With Vitamin D Blueberry-AcaiZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)10 mgper 8.7 Gram(s)DSLD:15877
- Emergen-CImmune Plus System Support With Vitamin D CitrusZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)10 mgper 8.7 Gram(s)DSLD:15876
- Emergen-CJoint Health TangerineZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 9.3 Gram(s)DSLD:15880
- Emergen-CKidz Vitamin C 250 mg Fruit GrapeZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 9.4 Gram(s)DSLD:15888
- Emergen-CKidz Vitamin C 250 mg Fruit OrangeZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 9.4 Gram(s)DSLD:15895
- Emergen-CKidz Vitamin C 250 mg Fruit PunchZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 9.2 Gram(s)DSLD:15883
- Emergen-CMSM Lite Citrus Flavored Fizzy Drink MixZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 4.8 Gram(s)DSLD:15896
- Emergen-CMulti Vitamin+ Apricot-Mangoamount not statedper 9.4 Gram(s)DSLD:15919
- Emergen-CMulti Vitamin+ Cherry-Pomegranateamount not statedper 9.4 Gram(s)DSLD:15923
- Emergen-CPink 1,000 mg Vitamin C Pink LemonadeZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 9.4 Gram(s)DSLD:15831
- Emergen-CPlanet 1000 mg Vitamin C Dragon FruitZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 8.7 Gram(s)DSLD:15834
- Emergen-CVitamin D & Calcium2 mgper 8.8 Gram(s)DSLD:1178
- Emergen-CVitamin D & Calcium Mixed BerryZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)2 mgper 8.8 Gram(s)DSLD:15925
- Energique NutritionEnervimin Stress FocusZinc Aspartate20 mgper 4 Tablet(s)DSLD:13107
- EqualineCentury Complete Multivitamin/Multimineral Supplement11 mgper 1 Tablet(s)DSLD:12192
- EqualineChildren's Multivitamin6 mgper 0.5 Tablet(s)DSLD:12018
- Equate1,000 mg Vitamin C OrangeZinc Gluconate · Zinc (Form: as Zinc Gluconate)2 mgper 9.1 Gram(s)DSLD:178902
- EquateChildren's Multivitamin Gummies1.3 mgper 1 Gummy(ies)DSLD:178520
- EquateChildren's Multivitamin Gummies1.3 mgper 1 Gummy(ies)DSLD:178679
- EquateComplete MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Tablet(s)DSLD:18989
- EquateComplete Multivitamin Adilts Under 5011 mgper 1 Tablet(s)DSLD:18994
- EquateComplete Multivitamin Adults 50+11 mgper 1 Tablet(s)DSLD:178537
- EquateComplete Multivitamin Adults 50+11 mgper 1 Tablet(s)DSLD:178555
- EquateDaily Men's Adult Gummy5 mgper 2 Gummie(s)DSLD:178691
- EquateEye Health Adult GummyZinc Citrate9 mgper 2 Gummie(s)DSLD:178596
- EquateImmune Support Adult GummyZinc Sulfate · Zinc (Form: as Zinc Sulfate)2.5 mgper 3 Gummie(s)DSLD:178675
- EquateImmune Support Orange FlavorZinc Sulfate · Zinc (Form: as Zinc Sulfate)8 mgper 1 Tablet(s)DSLD:17954
- EquateMen's Adult Gummy Natural Berry FlavorsZinc Chelate · Zinc (Form: as Zinc Chelate)3.8 mgper 2 Gummy Vitamin(s)DSLD:178685
- EquateMen's Daily Adult Gummy5 mgper 2 Gummie(s)DSLD:178687
- EquateOne Daily Men's Adult Gummy5 mgper 2 Gummie(s)DSLD:178919
- EquateOne Daily PrenatalZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Softgel(s)DSLD:178711
- EquateOne Daily Women's Adult Gummy2.5 mgper 2 Gummie(s)DSLD:178730
- EquateWomen's Daily Adult Gummy2.5 mgper 2 Gummie(s)DSLD:178727
- Esmond NaturalABC Plus SeniorZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Caplet(s)DSLD:179136
- Esmond NaturalLiquid Joint Elixir10 mgper 1 fl. Oz.DSLD:179116
- Esmond NaturalOptimal Solutions Hair, Skin & NailsZinc Gluconate · Zinc (Form: as Zinc Gluconate)7.5 mgper 3 Caplet(s)DSLD:179112
- Esmond NaturalVisible EyesZinc Citrate · Zinc (Form: as Zinc Citrate)30 mgper 2 Tablet(s)DSLD:179133
- Essential SourceBomba VZinc Chelate · Zinc (Form: as Zinc Chelate)50 mgper 2 Tablet(s)DSLD:176316
- Everett LaboratoriesSelect-OB +DHAZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Caplet(s)DSLD:13114
- Exotic OxyJuiceMalibu Miracle0.75 mgper 6 TbspDSLD:12439
- Exotic OxyJuiceUltra Malibu Miracle Weight Management Program0.75 mgper 6 TbspDSLD:12470
- FINAFLEXActive MultiZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 4 Capsule(s)DSLD:177865
- FINAFLEXActive MultiZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 4 Capsule(s)DSLD:177761
- Finest NaturalCalcium Magnesium & Zinc5 mgper 1 Tablet(s)DSLD:13249
- Finest NaturalMen's 50+ AdvancedZinc Oxide · Zinc (Form: as Zinc Oxide)22.5 mgper 1 Capsule(s)DSLD:13254
- Focus FactorBrain & VisionZinc Ascorbate · Zinc (Form: as Zinc Citrate, and Zinc Ascorbate)10 mgper 4 Tablet(s)DSLD:175969
- Focus FactorFocus Factor Extra StrengthZinc Ascorbate · Zinc (Form: as Zinc Citrate, and Zinc Ascorbate)10 mgper 4 Tablet(s)DSLD:176012
- Focus FactorFOCUSfactorZinc Ascorbate10 mgper 4 Tablet(s)DSLD:181003
- Formutech NutritionTest-RX50 mgper 1 Tablet(s)DSLD:183224
- Garden of LifeImmune Balance Daily5 mgper 2 Caplet(s)DSLD:13186
- Garden of LifeRAW One For Women4 mgper 1 Capsule(s)DSLD:174605
- Garden Of LifeRAW One For Men15 mgper 1 Capsule(s)DSLD:174600
- Garden of Life MyKind OrganicsMen's Multi 40+ Organic BerryZinc Note: Certified Organic Real Food Vitamin Blend1.5 mgper 4 Gummy(ies)DSLD:173803
- Garden of Life MyKind OrganicsWomen's Multi 40+ Organic BerryZinc Note: Certified Organic Real Food Vitamin Blend1.5 mgper 4 Gummy(ies)DSLD:173916
- Garden Of Life MyKind OrganicsMen's Multi Organic BerryZinc Note: Certified Organic Real Food Vitamin Blend1.5 mgper 4 Gummy(ies)DSLD:173888
- Garden Of Life MyKind OrganicsWomen's Multi Organic BerryZinc Note: Certified Organic Real Food Vitamin Blend1.5 mgper 4 Gummy(ies)DSLD:173918
- Gaspari NutritionAnatropinZinc Aspartate · Zinc (Form: as Zinc Aspartate)10 mgper 3 Capsule(s)DSLD:18409
- Gaspari NutritionAnatropin Test BoosterZinc Aspartate · Zinc (Form: as Zinc Aspartate)10 mgper 1 Capsule(s)DSLD:18431
- Genceutic NaturalsPlant Head Men's FormulaZinc Sulfate · Zinc (Form: as Zinc Sulfate)3 mgper 31 Gram(s)DSLD:184738
- Genceutic NaturalsPlant Head Original GreensZinc Sulfate · Zinc (Form: as Zinc Sulfate)3 mgper 8.5 Gram(s)DSLD:184227
- Genesis Products IncZinc SulfateZinc Sulfate Monohydrate · Zinc (Form: Zinc Sulfate Monohydrate) Note: Equivalent to 220 mg Zinc Sulfate Heptahydrate50 mgper 1 Capsule(s)DSLD:15783
- Geri-CareAdult High Potency Multi-Vitamin Multi-Mineral Liquid3 mgper 1 TbspDSLD:176990
- Geri-CareOne-Daily Multi-Vitamin And Mineral SupplementZinc Oxide · Zinc (Form: as Zinc Oxide)4 mgper 0.5 Gram(s)DSLD:177004
- GlucoflexGlucosamine & Chondroitin Sulfate (CSA)Zinc Glycinate · Zinc (Form: as Zinc Glycinate)15 mgper 2 Caplet(s)DSLD:180633
- GNC AMP Advanced Muscle PerformanceMega Men Sport MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 2 Mocha Brown Caplet(s)DSLD:183541
- GNC Beyond RawRe-Feed Double ChocolateZinc Arginate · Zinc (Form: as Zinc Arginate)30 mgper 46 Gram(s)DSLD:13217
- GNC Beyond RawRe-Feed Vanilla Ice CreamZinc Arginate · Zinc (Form: as Zinc Arginate)30 mgper 45 Gram(s)DSLD:13228
- GNC Beyond RawRebel Black CherryZinc Aspartate · Zinc (Form: as Zinc Aspartate)30 mgper 7.3 Gram(s)DSLD:19516
- GNC Mega MenMega Men 50 PlusZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 2 Caplet(s)DSLD:15713
- GNC Mega MenMega Men CitrusZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 2 TbspDSLD:14015
- GNC Mega MenSport Milk ChocolateZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 36 Gram(s)DSLD:1060
- GNC Mega MenSport Vanilla BeanZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 36 Gram(s)DSLD:1061
- GNC Men'sUltra Saw Palmetto FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Softgel(s)DSLD:14234
- GNC Preventive NutritionCell ProtectorOptiZinc(R) Brand MonoMethionine-bound Zinc · Zinc (Form: as OptiZinc(R) Brand MonoMethionine-bound Zinc)15 mgper 2 Caplet(s)DSLD:1846
- GNC Preventive NutritionLiver FormulaZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 3 Caplet(s)DSLD:1851
- GNC Preventive NutritionOcular FormulaZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 2 Tablet(s)DSLD:1836
- GNC Pro PerformanceComplete Vegan Gainer Natural ChocolateZinc Citrate · Zinc (Form: as Zinc Citrate)2.5 mgper 72.5 Gram(s)DSLD:175409
- GNC Pro PerformanceLean Muscle Meal Chocolateamount not statedper 69 Gram(s)DSLD:16801
- GNC Pro PerformanceLean Muscle Meal Vanillaamount not statedper 68 Gram(s)DSLD:16846
- GNC Pro Performance AMPAmplified Endurance Booster Blue Raspberry7 mgper 60 Gram(s)DSLD:18529
- GNC Pro Performance AMPWomen's Ultra Mega Active Without IronZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 2 Light Green Caplet(s)DSLD:176166
- GNC SuperFoodsUltra Mega Green Women's Multivitamin20 mgper 2 Light Green Caplet(s)DSLD:176181
- GNC SuperFoodsUltra Mega Green Women's Multivitamin20 mgper 2 Light Green Caplet(s)DSLD:176249
- GNC Total Lean AdvancedLean Shake Burn Cookies & CreamZinc Oxide · Zinc (Form: as Zinc Oxide)3.75 mgper 23.25 Gram(s)DSLD:182149
- GNC Women's Ultra MegaActive Milk ChocolateZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 35 Gram(s)DSLD:1062
- GNC Women's Ultra MegaActive Vanilla CremeZinc Oxide15 mgper 35 Gram(s)DSLD:1063
- GNC Women's Ultra MegaEnergy And MetabolismZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 2 Caplet(s)DSLD:12031
- GNC Women's Ultra MegaUltra Mega CitrusZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 30 mLDSLD:14391
- GNC Women's Ultra MegaWomen's Ultra Mega With ProbioticsZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 4 Capsule(s)DSLD:1658
- GNC Women's Ultra MegaWomen's Ultra Mega Without Iron & IodineZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 2 Caplet(s)DSLD:15697
- Goliath LabsGoliath Multi VitaminZinc Aspartate · Zinc (Form: as Zinc Aspartate)20 mgper 4 Tablet(s)DSLD:12360
- Goliath LabsTestoFreakZinc L-Monomethionine · Zinc (Form: as Zinc L-Monomethionine) (Alt. Name: L-OptiZinc)15 mgper 2 Capsule(s)DSLD:177420
- Goliath LabsTribuloidZinc L-Monomethionine · Zinc (Form: as Zinc L-Monomethionine) (Alt. Name: OptiZinc)20 mgper 2 Capsule(s)DSLD:177389
- Goliath LabsVitamonsterZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 2 Tablet(s)DSLD:177347
- Greens TodayJoint Formula French Vanilla FlavorZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 15 Gram(s)DSLD:11568
- Greens TodayVegan FormulaZinc Glycinate Chelate · Zinc Chelazome (Form: as zinc glycinate chelate)15 mgper 17 Gram(s)DSLD:11471
- Greens++PlusShake Raw Chocolate700 mcgper 42 Gram(s)DSLD:180959
- Greens++PlusShake Raw Vanilla300 mcgper 41 Gram(s)DSLD:180971
- Greens+ OrganicsOmega 3 Chia Raw Seed1.1 mgper 15 Gram(s)DSLD:180846
- HealFastPost-Op & Injury Recovery Support FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 4 Tablet(s)DSLD:176433
- HealFastPre-Op Healing Optimization FormulaZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 3 Tablet(s)DSLD:176426
- Health Thru Nutrition NaturallyPhysician's MultiVitamin FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Caplet(s)DSLD:177596
- Health Thru Nutrition NaturallyUltraBetic Multi-VitaminZinc Glycinate · Zinc (Form: as Zinc Glycinate)15 mgper 1 Caplet(s)DSLD:177716
- Healthy ItemsLiposomal Pain-Less10 mgper 1 TbspDSLD:11444
- Herbal CleanUltra Eliminex Tropical Fruit FlavorZinc Amino Acid Chelate10 mgper 32 fl. Oz.DSLD:183340
- Hero Nutritionals Slice of Life OrganicsMen's CompleteZinc Oxide · Zinc (Form: as Zinc Oxide Note: USP)7.5 mgper 3 Slice(s)DSLD:181082
- Hero Nutritionals Slice of Life OrganicsPrenatal PlusZinc Gluconate · Zinc (Form: as Zinc Gluconate Note: USP)4 mgper 3 Slice(s)DSLD:181091
- Hero Nutritionals Slice of Life OrganicsWomen's CompleteZinc Oxide · Zinc (Form: as Zinc Oxide Note: USP)7.5 mgper 3 Slice(s)DSLD:181134
- Hero Nutritionals Yummi BearsMulti-Vitamin & MineralZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 mgper 1 Gummy(ies)DSLD:13419
- Hero Nutritionals Yummi BearsMulti-Vitamin & MineralZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 mgper 1 Gummy(ies)DSLD:18500
- Hero Nutritionals Yummi Bears Organics SuperMulti + OmegaZinc Gluconate · Zinc (Form: as Zinc Gluconate Note: USP)3.3 mgper 3 Bear(s)DSLD:181163
- Hero Nutritionals Yummi Bears Sugar FreeMulti-Vitamin & MineralZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 mgper 1 Gummy(ies)DSLD:14399
- Hi-Tech PharmaceuticalsHi-Tech Multi-Vitamin With MineralsZinc Chelate · Zinc (Form: as Zinc Chelate)8 mgper 1 Tablet(s)DSLD:10291
- Hi-Tech PharmaceuticalsImmune-RxZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 2 Tablet(s)DSLD:10275
- Hi-Tech PharmaceuticalsNitroPro Double Dutch Chocolate - FlavorZinc Oxide7.5 mgper 92 Gram(s)DSLD:10248
- Hi-Tech PharmaceuticalsNitroPro Fresh Strawberry Milkshake - FlavorZinc Oxide7.5 mgper 92 Gram(s)DSLD:10253
- Hi-Tech PharmaceuticalsNitroPro Orange Creamsicle - FlavorZinc Oxide7.5 mgper 92 Gram(s)DSLD:10251
- Hi-Tech PharmaceuticalsNitroPro Vanilla Milkshake - FlavorZinc Oxide7.5 mgper 92 Gram(s)DSLD:10254
- High THigh TZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)1.5 mgper 2 Capsule(s)DSLD:181625
- High THigh T Black Hardcore FormulationZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)1.5 mgper 4 Capsule(s)DSLD:181684
- High THigh T Black Hardcore Formulation Caffeine FreeZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)1.5 mgper 4 Capsule(s)DSLD:181711
- High THigh T Senior + Prostate SupportZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)15 mgper 3 Capsule(s)DSLD:181631
- High THigh T WomenZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)1.5 mgper 2 Capsule(s)DSLD:181665
- Higher NatureBrighter Day Natural Blackcurrant Flavour5 mgper 1 Tablet(s)DSLD:178216
- Higher NatureKeep Sharp2.5 mgper 1 Jelly(s)DSLD:178205
- HydroxycutHydroxycut Gummies Mixed FruitZinc Citrate · Zinc (Form: as Zinc Citrate)3.9 mgper 3 Gummie(s)DSLD:182418
- HydroxycutHydroxycut PlatinumZinc Oxide · Zinc (Form: as Zinc Oxide)4.4 mgper 1 Capsule(s)DSLD:182543
- i-HealthPrenatal Multivitamin TabletZinc Oxide · Zinc (Form: as Zinc Oxide)20 mgper 1 Prenatal Multivitamin Tablet(s)DSLD:182723
- Indiana Botanic GardensZinc + A & CTRAACS Zinc Glycinate Chelate · Zinc (Form: as TRAACS Zinc Glycinate Chelate)12 mgper 1 Lozenge(s)DSLD:18254
- Innate Response FormulasClear Response VanillaZinc Glycinate · Zinc (Form: as Zinc Glycinate)10 mgper 27 Gram(s)DSLD:177902
- Innate Response FormulasComplete Multi PowderZinc Bisglycinate · Zinc (Form: as Zinc Bisglycinate Complex)15 mgper 6.5 Gram(s)DSLD:177941
- Innate Response FormulasDysBio-GIFoodState Nutrient · Zinc (Form: as Zinc Picolinate, FoodState Nutrient (Form: sources: Saccharomyces cerevisiae Genus: Saccharomyces Species: cerevisiae))2.5 mgper 3 Capsule(s)DSLD:177826
- Innate Response FormulasFood Multi III BioMax5 mgper 3 Tablet(s)DSLD:178023
- Innate Response FormulasFood Multi III BioMax5 mgper 3 Tablet(s)DSLD:178029
- Innate Response FormulasOne Daily CapZinc Bisglycinate · Zinc (Form: as Zinc Bisglycinate Complex)15 mgper 1 Capsule(s)DSLD:177868
- Innate Response FormulasWomen Over 40Zinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)8 mgper 2 Tablet(s)DSLD:178001
- Innate Response FormulasWomen's MultiZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)7.5 mgper 2 Tablet(s)DSLD:178005
- Innate Response FormulasWomen's One DailyZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)7.5 mgper 1 Tablet(s)DSLD:178016
- Innovus PharmaceuticalsProstaGorxZinc Oxide15 mgper 3 Capsule(s)DSLD:181998
- Integrative TherapeuticsClinical Nutrients 45 - Plus WomenZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 3 Tablet(s)DSLD:184957
- Integrative TherapeuticsClinical Nutrients 50-Plus Men Iron-FreeZinc Gluconate · Zinc (Form: as Zinc Gluconate)18 mgper 4 Tablet(s)DSLD:185018
- Integrative TherapeuticsClinical Nutrients For MenZinc Gluconate · Zinc (Form: as Zinc Gluconate)16 mgper 3 Tablet(s)DSLD:184898
- Integrative TherapeuticsClinical Nutrients For WomenZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 3 Tablet(s)DSLD:184848
- Integrative TherapeuticsOsteoprime ForteZinc Picolinate · Zinc (Form: as Zinc Picolinate)20 mgper 4 Tablet(s)DSLD:184966
- IVL Institute For Vibrant LivingAdult Food-Based MultiZinc Citrate · Zinc (Form: as Zinc Citrate)5 mgper 1 Tablet(s)DSLD:15316
- IVL Institute For Vibrant LivingAll Day Energy Greens0.6 mgper 10 Gram(s)DSLD:175000
- IVL Institute For Vibrant LivingCal-Mag-Zinc With Vitamin DZinc Amino Acid Chelate · Zinc (Form: as Zinc Oxide, Zinc Amino Acid Chelate)25 mgper 2 Tablet(s)DSLD:15379
- IVL Institute For Vibrant LivingChewable Kids' MultiZinc Oxide · Zinc (Form: as Zinc Oxide)3 mgper 2 Tablet(s)DSLD:15380
- IVL Institute For Vibrant LivingFood Based Women's Multi Comprehensive FormulaZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 2 Tablet(s)DSLD:15433
- IVL Institute For Vibrant LivingSecretagogue hGH Plus Raspberry Lemonade FlavorZinc L-Monomethionine · Zinc (Form: as zinc l-monomethionine)0.6 mgper 13.5 Gram(s)DSLD:15601
- IVL Institute For Vibrant LivingVShakeZinc Oxide · Zinc (Form: as Zinc Oxide)4 mgper 37.45 Gram(s)DSLD:15648
- KRKABlue Tablet3 mgper 1 Tablet(s)DSLD:13919
- KrogerComplete11 mgper 1 Tablet(s)DSLD:12166
- KrogerPrenatal Support Prenatal Vitamins25 mgper 1 Tablet(s)DSLD:12175
- L'il CrittersFruit n' Honey Complete Multivitamin Natural Berry FlavorZinc Gluconate · Zinc (Form: as Zinc Gluconate)1.35 mgper 1 Gummy(ies)DSLD:176873
- L'il CrittersFruit n' Honey Vitamin C Plus Vitamin D & ZincZinc Gluconate · Zinc (Form: as Zinc Gluconate)3 mgper 2 Gummy Bear(s)DSLD:176884
- L'il CrittersImmune C Plus Zinc & EchinaceaZinc Gluconate · Zinc (Form: as Zinc Gluconate)3 mgper 2 Gummy(ies)DSLD:174547
- Labrada NutritionLean Body Vanilla Ice Cream Flavoramount not statedper 70 Gram(s)DSLD:183391
- Lee Haney's Nutritional Support SystemsCompetitive MassZinc Methionine · Zinc (Form: as Zinc Methionine)3.25 mgper 65 Gram(s)DSLD:12990
- Lee Haney's Nutritional Support SystemsLife's Vitality Multi Vitamin/Mineral ComplexZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)15 mgper 1 Tablet(s)DSLD:13008
- Lee Haney's Nutritional Support SystemsParasite DetoxZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)5 mgper 2 Capsule(s)DSLD:13013
- LG SciencesMMV3 Strength Complexamount not statedper 1 Capsule(s)DSLD:1894
- Life ExtensionLife Extension Mix TabletsL-OptiZinc Zinc Mono-L-Methionine Sulfate · Zinc (Form: as Zinc Citrate, L-OptiZinc Zinc Mono-L-Methionine Sulfate)35 mgper 8 Tablet(s)DSLD:182627
- Life ExtensionLife Extension Mix Tablets with Extra NiacinL-OptiZinc Zinc Mono-L-Methionine Sulfate · Zinc (Form: as Zinc Citrate, L-OptiZinc Zinc Mono-L-Methionine Sulfate)35 mgper 8 Tablet(s)DSLD:182633
- Life ExtensionLife Extension Mix Tablets without CopperL-OptiZinc Zinc Mono-L-Methionine Sulfate · Zinc (Form: as Zinc Citrate, L-OptiZinc Zinc Mono-L-Methionine Sulfate)35 mgper 8 Tablet(s)DSLD:182644
- Life ExtensionOne-Per-Day TabletsL-OptiZinc Zinc Mono-L-Methionine Sulfate · Zinc (Form: as Zinc Citrate, L-OptiZinc Zinc Mono-L-Methionine Sulfate)25 mgper 1 Tablet(s)DSLD:182576
- Life ExtensionTwo-Per-Day CapsulesL-OptiZinc Zinc Mono-L-Methionine Sulfate · Zinc (Form: as Zinc Citrate, L-OptiZinc Zinc Mono-L-Methionine Sulfate)25 mgper 2 Capsule(s)DSLD:182714
- LifeLinkD3ZO High Potency Vitamin D3 25KZinc Orotate · Zinc (Form: as zinc orotate)15 mgper 1 Capsule(s)DSLD:11739
- LifeLinkFormula CS PlusZinc Orotate · Zinc (Form: as zinc orotate)15 mgper 3 Tablet(s)DSLD:11875
- LifeLinkOsteo Forte Orotate 00Zinc Orotate · Zinc (Form: as zinc orotate)5.5 mgper 1 Tablet(s)DSLD:11815
- LifeLinkPlatformZinc Ascorbate20 mgper 6 Caplet(s)DSLD:11852
- LifeLinkZinc Orotate 316Zinc Orotate · Zinc (Form: as zinc orotate)55 mgper 1 Tablet(s)DSLD:11808
- Lifestyle Fitness & NutritionDaily Complete Multi-Vitamin/Mineral ComplexZinc Amino Acid Chelate · Zinc (Form: as {Zinc} Amino Acid Chelate)15 mgper 1 Tablet(s)DSLD:16970
- Lifestyle Fitness & NutritionJoint RecoveryZinc Amino Acid Chelate200 mcgper 1 Tablet(s)DSLD:18567
- Loomis EnzymesNo WheyZinc Citrate · Zinc (Form: from Zinc Citrate)2 mgper 12 Gram(s)DSLD:176839
- Loomis EnzymesNo Wheyamount not statedper 12 Gram(s)DSLD:176839
- Lyfe FuelAll-In-One Daily Essentials Shake ChocolateZinc Sulfate · Zinc (Form: from Zinc Sulfate)8 mgper 32 Gram(s)DSLD:177010
- Lyfe FuelAll-In-One Daily Essentials Shake Vanilla ChaiZinc Sulfate · Zinc (Form: from Zinc Sulfate)8 mgper 32 Gram(s)DSLD:177043
- Lyfe FuelClean & Lean Recovery Shake Chocolate2.3 mgper 37 Gram(s)DSLD:177048
- Lyfe FuelClean & Lean Recovery Shake Vanilla Chai2.3 mgper 37 Gram(s)DSLD:177058
- Martin Avenue PharmacyAdrenal Health Support With Adrenal Gland ConcentrateZinc Aspartate · Zinc (Form: from Zinc Aspartate Complex)15 mgper 1 Capsule(s)DSLD:18749
- Martin Avenue PharmacyAntiOxidant Essentials With Vitamins C & Emonomethionine · Zinc (Form: as monomethionine) Note: From OptiZinc(R), a unique, patented 1:1 complex of zinc and methionine that increases zinc absorption and acts as an antioxidant.15 mgper 2 Tablet(s)DSLD:18770
- Martin Avenue PharmacyBone Health Support With Iprilflavone, Soy, And Calciummonomethionine · Zinc (Form: as monomethionine) Note: From L-OptiZinc(R), a patented form of zinc.5 mgper 2 Tablet(s)DSLD:18799
- Martin Avenue PharmacyBone Total HealthZinc Aspartate · Zinc (Form: from Zinc Aspartate Complex)20 mgper 4 Tablet(s)DSLD:18801
- Martin Avenue PharmacyVision Health Support With Bilberry And Luteinmonomethionine · Zinc (Form: as monomethionine) Note: From L-OptiZinc(R), a patented form of zinc.5 mgper 2 Capsule(s)DSLD:19520
- Marz SpraysC SprayZinc Citrate · Zinc (Form: as Zinc Citrate)1.5 mgper 1.5 mLDSLD:16309
- Meaningful Beauty WellnessComplete Beauty ComplexZinc Gluconate · Zinc (Form: as Zinc Gluconate)30 mgper 2 Tablet(s)DSLD:178254
- MegaFoodBalanced MineralsSaccharomyces cerevisiae · Zinc (Form: mineral bound S. cerevisiae Genus: S. Species: cerevisiae)15 mgper 3 Tablet(s)DSLD:177319
- MegaFoodKids Daily B-Centered8 mgper 1.07 Gram(s)DSLD:177500
- MegaFoodWomen's One Daily California BlendRice Amino Acid Chelate7.9 mgper 1 Tablet(s)DSLD:177369
- MegaFoodWomen's One Daily California BlendRice Amino Acid Chelate7.9 mgper 1 Tablet(s)DSLD:178051
- MegaFoodWomen's One Daily California BlendRice Amino Acid Chelate7.9 mgper 1 Tablet(s)DSLD:178096
- MegaFoodZincSaccharomyces cerevisiae · Zinc (Form: mineral bound S. cerevisiae Genus: S. Species: cerevisiae)22.5 mgper 1 Tablet(s)DSLD:177233
- MelaleucaVitality 6 Essentials + HeartZinc Amino Acid Oligofructose Complex · Zinc (Form: as Zinc Amino Acid Oligofructose Complex)7.5 mgper 1 Packet(s)DSLD:13664
- MelaleucaVitality TotalZinc Amino Acid Oligofructose Complex · Zinc (Form: as Zinc Amino Acid Oligofructose Complex)37.5 mgper 1 Packet(s)DSLD:13621
- MET-RxActive Multi PacksZinc Gluconate · Zinc (Form: as Zinc Gluconate, and Zinc Oxide)55 mgper 1 Packet(s)DSLD:15488
- MET-RxMET-Rx Meal Replacement Cake Batteramount not statedper 72 Gram(s)DSLD:18120
- MET-RxMET-Rx Meal Replacement Extreme Chocolateamount not statedper 72 Gram(s)DSLD:18124
- MET-RxMET-Rx Meal Replacement Original Vanillaamount not statedper 72 Gram(s)DSLD:18128
- MET-RxRTD 51 Cookies & Cremeamount not statedper 1 Can(s)DSLD:181848
- MET-RxRTD 51 Creamy Vanillaamount not statedper 1 Can(s)DSLD:181825
- MET-RxRTD 51 Frosty Chocolateamount not statedper 1 Can(s)DSLD:181840
- MET-RxRTD 51 Peanut Butter Cupamount not statedper 1 Can(s)DSLD:181841
- MET-Rx 180(0)Essential MultiZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Tablet(s)DSLD:15767
- MET-Rx 180(0)Recovery Shake Chocolate2 mgper 42 Gram(s)DSLD:15765
- MET-Rx 180(0)Recovery Shake Vanilla2 mgper 42 Gram(s)DSLD:15757
- Metabolic NutritionProtiZyme Banana Cremeamount not statedper 35 Gram(s)DSLD:180076
- Metabolic NutritionProtiZyme Butter Pecan Cookieamount not statedper 35 Gram(s)DSLD:180086
- Metabolic NutritionProtiZyme Chocolate Cakeamount not statedper 35 Gram(s)DSLD:180089
- Metabolic NutritionProtiZyme Peanut Butter Cookieamount not statedper 35 Gram(s)DSLD:180100
- Metabolic NutritionProtiZyme Strawberry Cremeamount not statedper 35 Gram(s)DSLD:180105
- Metabolic NutritionProtiZyme Vanilla Cakeamount not statedper 35 Gram(s)DSLD:180108
- Metabolic NutritionRelaXitrolamount not statedper 1 Capsule(s)DSLD:178951
- Michael's Naturopathic ProgramsDaily Immune FactorsZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 1 Veggie Capsule(s)DSLD:174000
- Michael's Naturopathic ProgramsDaily Immune FactorsZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 1 Veggie Capsule(s)DSLD:174007
- Michael's Naturopathic ProgramsDaily Immune FactorsZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 1 Veggie Capsule(s)DSLD:174010
- Michael's Naturopathic ProgramsInternal SunshineZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))5 mgper 2 Veggie Capsule(s)DSLD:174100
- Michael's Naturopathic ProgramsInternal SunshineZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))5 mgper 2 Veggie Capsule(s)DSLD:174096
- Michael's Naturopathic ProgramsSkin FactorsZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))20 mgper 3 Tablet(s)DSLD:174279
- Michael's Naturopathic ProgramsUltimate Detox & CleanseZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))6 mgper 1 Vegetarian Tablet(s)DSLD:175289
- MicroTech Professional FormulationsCoral Calcium PlusZinc Citrate · Zinc (Form: as Zinc Citrate)8 mgper 4 Capsule(s)DSLD:1899
- Midway ImportingVital Fuerte Vitamins And Minerals Syrup2.02 mgper 1 tspDSLD:13691
- Miller Pharmacal GroupA/G - ProZinc Amino Acid Chelate2 mgper 2 Tablet(s)DSLD:12239
- Miller Pharmacal GroupMIL AdregenZinc Amino Acid Rice Chelate10 mgper 1 Tablet(s)DSLD:177104
- Miller Pharmacal GroupMIL AdregenZinc Amino Acid Rice Chelate10 mgper 1 Tablet(s)DSLD:177108
- Miller Pharmacal GroupTheramill ForteZinc Glycinate Chelate2.5 mgper 2 Capsule(s)DSLD:177113
- Moss NutritionCV SelectZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate Note: TRAACS)5 mgper 2 Capsule(s)DSLD:187437
- Moss NutritionCV SelectZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate Note: TRAACS)5 mgper 2 Capsule(s)DSLD:187446
- MRINO2 Red Hemo Surge Berry BlizzardZinc Oxide · Zinc (Form: as Zinc Oxide)5 mgper 12 Gram(s)DSLD:15824
- MRINO2 Red Hemo Surge CoconutZinc Oxide · Zinc (Form: as Zinc Oxide)5 mgper 12 Gram(s)DSLD:15846
- MRINO2 Red Hemo Surge Tropical FreezeZinc Oxide · Zinc (Form: as Zinc Oxide)5 mgper 12 Gram(s)DSLD:15838
- MRINO2 Red Hemo Surge WatermelonZinc Oxide · Zinc (Form: as Zinc Oxide)5 mgper 12 Gram(s)DSLD:15853
- MRI EnduranceEO2 Edge ColaZinc Oxide · Zinc (Form: as Zinc Oxide)20 mgper 15 Gram(s)DSLD:15791
- MRI EnduranceEO2 Edge Tropical PunchZinc Oxide · Zinc (Form: as Zinc Oxide)20 mgper 15 Gram(s)DSLD:15800
- MRI EnduranceEO2 VMAXZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 3 Tablet(s)DSLD:15859
- MRMCal-Mag-Zinc Liquid Orange-VanillaZinc Gluconate · Zinc (Form: from Zinc Gluconate)7.5 mgper 0.33 TbspDSLD:178626
- MRMCal-Mag-Zinc Liquid StrawberryZinc Gluconate · Zinc (Form: from Zinc Gluconate)7.5 mgper 0.33 TbspDSLD:178629
- MRMJoint Synergy Complete Orange-PineappleZinc Citrate · Zinc (Form: from Zinc Citrate)15 mgper 24 Gram(s)DSLD:178524
- MusclePharmBullet Proof Grape FusionZinc Aspartate · Zinc (Form: As {Zinc} Monomethionine, and {Zinc} aspartate)5 mgper 8 Gram(s)DSLD:17868
- MusclePharmZMA MaxZinc Aspartate · Zinc (Form: as {Zinc} Monomethionine, and {Zinc} Aspartate)7.5 mgper 1 Capsule(s)DSLD:17924
- MuscleTech Essential SeriesPlatinum Multi VitaminZinc Amino Acid Chelate · Zinc (Form: as Zinc Oxide, Zinc Amino Acid Chelate)9.5 mgper 3 Caplet(s)DSLD:182566
- MuscleTech Performance SeriesAnotest Fruit PunchZinc Gluconate · Zinc (Form: as Zinc Gluconate)7.5 mgper 7 Gram(s)DSLD:18092
- MuscleTech Performance SeriesMASS TECH Extreme 2000 Triple Chocolate BrownieZinc Oxide · Zinc (Form: as Zinc Oxide)8.4 mgper 285 Gram(s)DSLD:182773
- MuscleTech Performance SeriesMASS TECH Extreme 2000 Vanilla MilkshakeZinc Oxide · Zinc (Form: as Zinc Oxide)8.4 mgper 285 Gram(s)DSLD:182876
- MuscleTech Performance SeriesTest HDZinc Gluconate · Zinc (Form: as Zinc Gluconate)7.5 mgper 1 Caplet(s)DSLD:182807
- MuscleTech Performance SeriesTEST HD SUPER ELITEZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 3 Capsule(s)DSLD:182611
- MyTritionMultivitamin+EnergyZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Veggie Capsule(s)DSLD:175329
- Native RemediesNR Essentials Multivitamin For WomenZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)7.5 mgper 3 Capsule(s)DSLD:13805
- Natural ClinicianClinical DyspepsiaZinc Amino Acid Chelate7.5 mgper 1 Tablet(s)DSLD:18621
- Natural ClinicianClinical Immune Modulator BiodefenseZinc Amino Acid Chelate15 mgper 4 Capsule(s)DSLD:18628
- Natural ClinicianClinical Metabolic Syndrome X Nutritional FactorsZinc Amino Acid Chelate15 mgper 1 Capsule(s)DSLD:18642
- Natural ClinicianClinical Ocular CareZinc Amino Acid Chelate15 mgper 1 Capsule(s)DSLD:18648
- Natural ClinicianClinical Osteoporosis SupportZinc Amino Acid Chelate15 mgper 2 Capsule(s)DSLD:18651
- Natural ClinicianClinical Prostate SuppportZinc Amino Acid Chelate30 mgper 2 Capsule(s)DSLD:18677
- Natural FactorsGastro-AssistZinc L-Carnosine8 mgper 2 Vegetarian Capsule(s)DSLD:179381
- Natural FactorsSlimStyles Weight Loss Drink Mix Very StrawberryZinc Citrate6 mgper 31.5 Gram(s)DSLD:181578
- Natural Factors SlimStylesWeight Loss Drink Mix French VanillaZinc Citrate6 mgper 31 Gram(s)DSLD:179497
- Nature MadeC with A, E & Zinc Adult GummiesZinc Sulfate · Zinc (Form: as Zinc Sulfate)2.5 mgper 2 Gummy(ies)DSLD:12149
- Nature MadeDiabetes Health PackZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Packet(s)DSLD:179514
- Nature MadeDigestive Probiotics + Multivitamins Women's Dual ActionZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:180293
- Nature MadeHair, Skin, & NailsZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Softgel(s)DSLD:179960
- Nature MadeHair, Skin, & NailsZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Softgel(s)DSLD:180360
- Nature MadeHair, Skin, & NailsZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Softgel(s)DSLD:180367
- Nature MadeImmune Complex with Zinc Adult GummiesZinc Sulfate · Zinc (Form: as Zinc Sulfate)5 mgper 2 Gummie(s)DSLD:179985
- Nature MadeMaximin PackZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Packet(s)DSLD:179317
- Nature MadeMen's PackZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Packet(s)DSLD:179309
- Nature MadeMulti Adult Gummies7.5 mgper 2 Gummie(s)DSLD:180149
- Nature MadeMulti Adult GummiesZinc Sulfate · Zinc (Form: as Zinc Sulfate)7.5 mgper 2 Gummie(s)DSLD:180275
- Nature MadeMulti CompleteZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Softgel(s)DSLD:180237
- Nature MadeMulti Complete With IronZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:179537
- Nature MadeMulti DailyZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:179576
- Nature MadeMulti For Her 50+ No IronZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:179563
- Nature MadeMulti for Her plus Omega-3s Adult GummiesZinc Sulfate · Zinc (Form: as Zinc Sulfate)3.8 mgper 2 Gummie(s)DSLD:180302
- Nature MadeMulti for Her plus Omega-3s Adult GummiesZinc Sulfate · Zinc (Form: as Zinc Sulfate)3.8 mgper 2 Gummie(s)DSLD:180313
- Nature MadeMulti For Her With Iron & CalciumZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:179864
- Nature MadeMulti For HimZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:179550
- Nature MadeMulti For HimZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:179944
- Nature MadeMulti For HimZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Softgel(s)DSLD:180184
- Nature MadeMutli for Him plus Omega-3s Adult GummiesZinc Sulfate · Zinc (Form: as Zinc Sulfate)5.5 mgper 2 Gummie(s)DSLD:180141
- Nature MadePostnatal Multi + DHAZinc Oxide · Zinc (Form: as Zinc Oxide)12 mgper 1 Softgel(s)DSLD:179871
- Nature MadePostnatal Multi + DHAZinc Oxide · Zinc (Form: as Zinc Oxide)12 mgper 1 Softgel(s)DSLD:180109
- Nature MadePrenatal Multi + DHAZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 1 Softgel(s)DSLD:180222
- Nature MadePrenatal Multi + DHAZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Softgel(s)DSLD:180316
- Nature MadeStress B-ComplexZinc Sulfate · Zinc (Form: as Zinc Sulfate)23.9 mgper 1 Tablet(s)DSLD:179758
- Nature MadeStress B-ComplexZinc Sulfate · Zinc (Form: as Zinc Sulfate)23.9 mgper 1 Tablet(s)DSLD:180112
- Nature Made Kids FirstMultivitamin Chewable & Crushable Tablets OrangeZinc Oxide · Zinc (Form: as Zinc Oxide)4.1 mgper 1 Tablet(s)DSLD:179590
- Nature Made Kids FirstMultivitamin GummiesZinc Sulfate · Zinc (Form: as Zinc Sulfate)3.75 mgper 1 Gummy(ies)DSLD:179610
- Nature Made Kids FirstMultivitamin with Omega-3Zinc Sulfate · Zinc (Form: as Zinc Sulfate)1.9 mgper 1 Gummie(s)DSLD:179598
- Nature Made Kids FirstMultivitamin with Omega-3Zinc Sulfate · Zinc (Form: as Zinc Sulfate)1.9 mgper 1 Gummie(s)DSLD:179629
- Nature Made VitaMeltsZinc 15 mg Honey LemonZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:180249
- Nature's AnswerCoral Calcium 1000 mgZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)16 mgper 1 Capsule(s)DSLD:184962
- Nature's AnswerGlucosamine Chondroitin Wtih Tart CherryZinc Citrate · Zinc (Form: as Zinc Citrate)1.6 mgper 1 TbspDSLD:174838
- Nature's AnswerGlucosamine Chondroitin Wtih Tart CherryZinc Citrate · Zinc (Form: as Zinc Citrate)1.6 mgper 1 TbspDSLD:174850
- Nature's AnswerLiquid Calcium & Magnesium With Vitamin D, Zinc & BoronZinc Citrate · Zinc (Form: as Zinc Citrate)8 mgper 1 TbspDSLD:12544
- Nature's AnswerLiquid Glucosamine Chondroitin Orange FlavoredZinc Citrate · Zinc (Form: as Zinc Citrate)1.6 mgper 1 TbspDSLD:188848
- Nature's AnswerMale ComplexZinc Gluconate · Zinc (Form: as Zinc Gluconate)3 mgper 1 Capsule(s)DSLD:184766
- Nature's AnswerMaximum Strength Impressex Aphrodisiac Sexual Enhancer3 mgper 1 Capsule(s)DSLD:11565
- Nature's AnswerMulti-Daily Vitamins & MineralsZinc Chelate · Zinc (Form: as Zinc Chelate)10 mgper 1 Tablet(s)DSLD:16800
- Nature's AnswerSambucus ImmuneZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 1 tspDSLD:185235
- Nature's BountyCalcium Magnesium ZincZinc Citrate · Zinc (Form: as Zinc Gluconate, and Zinc Citrate)25 mgper 1 Caplet(s)DSLD:17181
- Nature's BountyHair, Skin & NailsZinc Gluconate · Zinc (Form: as Zinc Gluconate)7.5 mgper 3 Caplet(s)DSLD:17384
- Nature's BountyPrenatalZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 1 Tablet(s)DSLD:17152
- Nature's BountyVitamins For The HairZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 1 Tablet(s)DSLD:17131
- Nature's BountyYour Life Multi Green SouceZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 3 Caplet(s)DSLD:17328
- Nature's Bounty Optimal SolutionsTime Released Calcium 600 mgZinc Oxide · Zinc (Form: as Zinc Oxide)7.5 mgper 2 Tablet(s)DSLD:15885
- Nature's LifeProstate Maintain 600 PlusZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 2 Vegetarian Capsule(s)DSLD:13794
- Nature's MeasureEssential Minerals For Women & MenZinc Oxide · Zinc (Form: as Zinc Oxide)4 mgper 1 Tablet(s)DSLD:17070
- Nature's SunshineBowel DetoxZinc Gluconate2 mgper 2 Capsule(s)DSLD:18245
- Nature's WayAlive! Children's Chewable Multi-VitaminZinc Citrate · Zinc (Form: as Zinc Citrate)5 mgper 2 Chewable Tablet(s)DSLD:201803
- Nature's WayRapi-DefenseZinc Picolinate · Zinc (Form: as Zinc Picolinate)22 mgper 1 Capsule(s)DSLD:183953
- NatureSmartDisney My First Gummies Multi VitaminZinc Citrate · Zinc (Form: as Zinc Citrate)2 mgper 2 Gummy(ies)DSLD:12265
- New ChapterPerfect Energy MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide Note: from culture media)7.5 mgper 3 Tablet(s)DSLD:181233
- New ChapterPerfect Energy MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide Note: from culture media)7.5 mgper 3 Tablet(s)DSLD:181239
- New Chapter OrganicsEvery Man's One Daily15 mgper 1 Tablet(s)DSLD:17992
- New SunCal-Mag LiquidZinc Citrate · Zinc (Form: as Zinc Citrate)22.2 mgper 1 TbspDSLD:12457
- New SunCalcium/Mag. Hydroxyapatite Comb.Zinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)15 mgper 4 Tablet(s)DSLD:12451
- New SunChlorella From The Sun 1000 mg7 mcgper 1 Tablet(s)DSLD:11681
- New SunLiquid Multiple Vitamin And Mineral Tropical Orange FlavorZinc Amino Acid Chelate · Zinc (Form: from Zinc ACC)3 mgper 0.33 TbspDSLD:12453
- New SunUltra Zinc + LozengesZinc Gluconate · Zinc (Form: as Zinc Gluconate)12 mgper 0.5 Lozenge(s)DSLD:11786
- New SunVita ChewsZinc Amino Acid Chelate · Zinc (Form: from Zinc ACC)1.5 mgper 1 Tablet(s)DSLD:11710
- NikkenOsteoDenxZinc Oxide · Zinc (Form: from Zinc Oxide)15 mgper 1 Capsule(s)DSLD:11291
- Noor VitaminsAdult Multi-Gummies with Organic Fruit BlendZinc Citrate · Zinc (Form: as Zinc Citrate)5.4 mgper 3 Gummie(s)DSLD:183227
- Noor VitaminsChildren's GummiesZinc Citrate · Zinc (Form: as Zinc Citrate)2.7 mgper 1 Gummy(ies)DSLD:183290
- Noor VitaminsChildren's Multivitamin with Iron, Thiamine & NiacinZinc Oxide · Zinc (Form: as Zinc Oxide)5 mgper 1 Chewable Tablet(s)DSLD:183255
- Noor VitaminsComplete PrenatalZinc Oxide25 mgper 1 Tablet(s)DSLD:183341
- Noor VitaminsEnergy +15 mgper 1 Tablet(s)DSLD:183305
- Noor VitaminsMulti-Vitamin and MineralZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 1 Tablet(s)DSLD:183315
- Noor VitaminsPre & Post Natal DHA + Iron Fruit FlavoredZinc Citrate · Zinc (Form: as Zinc Citrate)3.75 mgper 3 Gummie(s)DSLD:183318
- Noor VitaminsPrenatal DHAZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Softgel(s)DSLD:183339
- NOWAlfalfa Powder2 %per 10 Gram(s)DSLD:12747
- NOWAntioxidant CapsZinc Monomethionine · Zinc (Form: from Zinc Picolinate, and (Zinc) Monomethionine)3 mgper 1 Capsule(s)DSLD:15471
- NOWAntioxidant CapsZinc Monomethionine · Zinc (Form: from Zinc Picolinate, and (Zinc) Monomethionine)3 mgper 1 Capsule(s)DSLD:15504
- NOWBone CalciumZinc Bisglycinate · Zinc (Form: from Zinc Bisglycinate Note: TRAACS)7.5 mgper 2 Tablet(s)DSLD:14667
- NOWC-1000 Mineral AscorbatesZinc Ascorbate · Zinc (Form: from Zinc Ascorbate)20 mgper 2 Tablet(s)DSLD:14364
- NOWHealthy Immune Seasonal Immune SupportTRAACS Zinc Glycinate Chelate · Zinc (Form: as TRAACS Zinc Glycinate Chelate)10 mgper 4.5 Gram(s)DSLD:15145
- NOWHealthy Immune Seasonal Immune SupportTRAACS Zinc Glycinate Chelate · Zinc (Form: as TRAACS Zinc Glycinate Chelate)10 mgper 4.5 Gram(s)DSLD:15189
- NOWMulti-Food Complex For Men30 mgper 2 Tablet(s)DSLD:15661
- NOWMulti-Food Complex For Women15 mgper 2 Tablet(s)DSLD:15654
- NOWMulti-Food Complex Vcaps For Men30 mgper 4 Vegetarian Capsule(s)DSLD:15658
- NOWMulti-Food Complex Vcaps For Women15 mgper 4 Vegetarian Capsule(s)DSLD:15619
- NOWPrenatal CapsZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)15 mgper 4 Capsule(s)DSLD:15526
- NOWSpecial OneZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)10 mgper 1 Tablet(s)DSLD:15678
- NOWSuperfruit Liquid Multi Acai FlavorZinc Glycinate Chelate · Zinc (Form: from Zinc Glycinate Chelate Note: (TRAACS(R)) (Albion))3 mgper 0.33 TbspDSLD:15366
- NOWTotal Well-BeingZinc Ascorbate · Zinc (Form: from Zinc Ascorbate)15 mgper 3 Tablet(s)DSLD:15208
- NOWTotal Well-BeingZinc Ascorbate · Zinc (Form: from Zinc Ascorbate)15 mgper 3 Tablet(s)DSLD:15211
- NOWUltimate Zinc-CZinc Amino Acid Chelate · Zinc (Form: from Zinc Glycinate, Zinc Amino Acid Chelate) Note: (TRAACS) (Albion)12 mgper 1 Lozenge(s)DSLD:14378
- NOWUltimate Zinc-CZinc Amino Acid Chelate · Zinc (Form: from Zinc Glycinate, Zinc Amino Acid Chelate) Note: (TRAACS) (Albion)12 mgper 1 Lozenge(s)DSLD:14382
- NOWVit-Min 100Zinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)15 mgper 1 Tablet(s)DSLD:15677
- NOWVit-Min 75+Zinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)15 mgper 1 Tablet(s)DSLD:15600
- NOWVit-Min 75+Zinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)15 mgper 1 Tablet(s)DSLD:15606
- NOWVit-Min 75+Zinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)15 mgper 1 Tablet(s)DSLD:15610
- NOWVitamin D-3 Immune Liposomal SprayZinc Glycinate Chelate · Zinc (Form: from Zinc Glycinate Chelate Note: (TRAACS(R)) (Albion))1 mgper 0.75 mLDSLD:14037
- NugenixNugenix Free Testosterone BoosterZinc Chelate · Zinc (Form: as Zinc Chelate)1 mgper 3 Capsule(s)DSLD:178074
- NugenixNugenix Testosterone MultivitaminZinc Monomethionine · Zinc (Form: as Zinc Monomethionine) (Alt. Name: OptiZinc)15 mgper 2 Tablet(s)DSLD:178154
- NuMedicaPower Greens Premium Natural BerryZinc Oxide · Zinc (Form: as Zinc Oxide)4.5 mgper 11.7 Gram(s)DSLD:182976
- NuMedicaThyrodex T-150Zinc Chelate5 mgper 1 Capsule(s)DSLD:181452
- NutraBioMuscle Matrix MRP Women's Formula Chocolate MilkshakeZinc Citrate8 mgper 22.29 Gram(s)DSLD:174729
- NutrabolicsHemotropin 2XCZinc Aspartate · Zinc (Form: as Zinc Aspartate)6 mgper 2 Capsule(s)DSLD:185278
- Nutrex Research Black SeriesT-UPZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 4 Capsule(s)DSLD:176467
- Nutri-RichPrenatal Multi+DHAZinc Amino Acid Chelate15 mgper 1 Softgel(s)DSLD:176556
- Nutri-RichRadiance BoostZinc Gluconate · Zinc (Form: as Zinc Gluconate)7.5 mgper 3 Softgel(s)DSLD:176527
- Nutri-RichThe Essential MultiZinc Glycinate15 mgper 1 Softgel(s)DSLD:176559
- NutriCologyOcuDyneZinc Citrate · Zinc (Form: as Zinc Citrate)25 mgper 4 Capsule(s)DSLD:184228
- NutriCologySuper Immuno ComplexZinc Citrate · Zinc (Form: as 52% Zinc Citrate, and as 48% Zinc Sulfate)23 mgper 1 Packet(s)DSLD:183928
- Nutrients for HealthErexalin V-Power MaxZinc Sulfate Monohydrate · Zinc (Form: as Zinc Sulphate Monohydrate)7.5 mgper 1 Capsule(s)DSLD:181012
- Nutrients for HealthProstate Health ComplexZinc Arginate · Zinc (Form: as Zinc Arginate)5 mgper 1 Capsule(s)DSLD:181022
- OL Olympian LabsDaily Essentials Complete FormulaZinc Amino Acid Chelate15 mgper 1 Tablet(s)DSLD:175957
- OL Olympian LabsDaily Essentials Women's Multi-VitaminZinc Amino Acid Chelate15 mgper 1 Tablet(s)DSLD:175953
- OL Olympian LabsVRL-XZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)20 mgper 4 Capsule(s)DSLD:175945
- ON Optimum NutritionOpti-MenZinc Citrate · Zinc (Form: as Zinc Citrate)30 mgper 3 Tablet(s)DSLD:17592
- ON Optimum NutritionOpti-WomenZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 2 Capsule(s)DSLD:17617
- OneBodeBalanceZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)30 mcgper 1 Capsule(s)DSLD:12779
- OneBodeBlendZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)3 mgper 2 Capsule(s)DSLD:12775
- OneBodeBuildZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)100 mcgper 5 Capsule(s)DSLD:12764
- OneBodeDefineZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)13 mcgper 3 Capsule(s)DSLD:12756
- OneBodeEscalateZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)50 mcgper 1 Capsule(s)DSLD:12745
- OneBodeFlexZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)10 mcgper 1 Capsule(s)DSLD:12751
- OneBodeRecoverZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)20 mgper 2 Capsule(s)DSLD:12753
- Optimum NutritionAfter Max Chocolate Sunday0.46 mgper 97 Gram(s)DSLD:17573
- Oregon HealthImmune SupportZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)25 mgper 3 Capsule(s)DSLD:180714
- Oregon HealthMulti-GuardZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)15 mgper 2 Capsule(s)DSLD:180726
- Oregon HealthMulti-GuardZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)15 mgper 2 Capsule(s)DSLD:180741
- OriginCalcium Magnesium Zinc USPZinc Citrate · Zinc (Form: as Zinc Gluconate, and Zinc Citrate)25 mgper 1 Tablet(s)DSLD:12314
- Ortho Molecular ProductsAlpha Base Capsules with IronTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 4 Capsule(s)DSLD:174158
- Ortho Molecular ProductsAlpha Base Capsules Without IronTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 4 Capsule(s)DSLD:174163
- Ortho Molecular ProductsAlpha Base Capsules Without IronTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 4 Capsule(s)DSLD:174168
- Ortho Molecular ProductsAlpha Base Capsules Without IronTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 4 Capsule(s)DSLD:174209
- Ortho Molecular ProductsAlpha Base Capsules Without IronTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 4 Capsule(s)DSLD:177705
- Ortho Molecular ProductsAlpha Base Capsules Without IronTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 4 Capsule(s)DSLD:177779
- Ortho Molecular ProductsAlpha Base Premier PacksTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 1 Packet(s)DSLD:176591
- Ortho Molecular ProductsAlpha Base Premier PacksTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 1 Packet(s)DSLD:176632
- Ortho Molecular ProductsCerenityTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 3 Capsule(s)DSLD:175543
- Ortho Molecular ProductsCerenity PMTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 4 Capsule(s)DSLD:175549
- Ortho Molecular ProductsCerenity PMTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 4 Capsule(s)DSLD:175552
- Ortho Molecular ProductsCereViveTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 4 Capsule(s)DSLD:175538
- Ortho Molecular ProductsGlutaShield ChocolateTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 1 Scoop(s)DSLD:175468
- Ortho Molecular ProductsGlutaShield VanillaTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 1 Scoop(s)DSLD:175478
- Ortho Molecular ProductsMitocoreTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 2 Capsule(s)DSLD:174406
- Ortho Molecular ProductsMitocoreTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 2 Capsule(s)DSLD:174394
- Ortho Molecular ProductsMucosagenTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 2 Capsule(s)DSLD:174488
- Ortho Molecular ProductsMucosagenTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 2 Capsule(s)DSLD:174498
- Ortho Molecular ProductsNK-StimTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 2 Capsule(s)DSLD:174458
- Ortho Molecular ProductsNK-StimTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)10 mgper 2 Capsule(s)DSLD:174472
- Ortho Molecular ProductsOcuviewTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)25 mgper 2 Capsule(s)DSLD:173954
- Ortho Molecular ProductsPrenatal Complete with DHATRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)20 mgper 3 Capsule(s)DSLD:175696
- Ortho Molecular ProductsProstatrol ForteTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)8 mgper 1 Capsule(s)DSLD:175509
- Ortho Molecular ProductsPyloricilZinc Carnosine · Zinc (Form: as Zinc Carnosine)8.5 mgper 1 Capsule(s)DSLD:174564
- Ortho Molecular ProductsReacted MultiminTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)25 mgper 1 Capsule(s)DSLD:175110
- Ortho Molecular ProductsReacted ZincTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)54 mgper 1 Capsule(s)DSLD:173832
- Ortho Molecular ProductsThyrotainTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)20 mgper 4 Capsule(s)DSLD:175692
- Ortho Molecular ProductsViracidTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)4 mgper 1 Capsule(s)DSLD:175516
- Ortho Molecular ProductsViracidTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)4 mgper 1 Capsule(s)DSLD:175520
- Osteo Bi-FlexOsteo Bi-Flex NutraJoint with Gelatin Drink Mix UnflavoredZinc Gluconate · Zinc (Form: as Zinc Gluconate)3 mgper 11 Gram(s)DSLD:11085
- P2LifeSport Multi-Vitamin for MenZinc Gluconate · Zinc (Form: as Zinc Oxide, & Zinc Gluconate)30 mgper 3 Capsule(s)DSLD:182804
- P2LifeSport Multi-Vitamin for WomenZinc Gluconate · Zinc (Form: as Zinc Oxide, & Zinc Gluconate)22.5 mgper 3 Capsule(s)DSLD:182960
- Pathway To HealingBasic Nutrient Support TabletZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 5 Tablet(s)DSLD:14984
- PerqueBone Guard Forte 20 TabsulesZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 2 Capsule(s)DSLD:18701
- PerqueBone Guard Forte 20 TabsulesZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 2 Capsule(s)DSLD:18708
- PerqueLife Guard Mini TabsulesZinc Picolinate · Zinc (Form: as {Zinc} Picolinate)12.5 mgper 2 Tabsule(s)DSLD:18782
- PerqueLife Guard Mini TabsulesZinc Picolinate · Zinc (Form: as {Zinc} Picolinate)12.5 mgper 2 Tabsule(s)DSLD:18785
- PerqueLife Guard Tabsules Without PABA Or FolicinZinc Picolinate25 mgper 3 Tabsule(s)DSLD:18772
- PerqueLiva Guard CapsulesZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 2 Capsule(s)DSLD:18790
- PerqueLiva Guard CapsulesZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 2 Capsule(s)DSLD:18791
- PerqueLiva Guard Forte SoftgelsZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 2 Softgel(s)DSLD:18787
- PerqueLiva Guard Forte SoftgelsZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 2 Softgel(s)DSLD:18789
- PerquePotent C Guard Buffered Ascorbate PowderZinc Ascorbate · Zinc (Form: as {zinc} ascorbate)600 mcgper 1 Rounded Half-Teaspoon(s)DSLD:18816
- PerquePotent C Guard Buffered Ascorbate PowderZinc Ascorbate · Zinc (Form: as {zinc} ascorbate)600 mcgper 1 Rounded Half-Teaspoon(s)DSLD:18820
- plntWhole Food Kid's Chewable Multivitamin Natural Cherry Berry Mixed Flavor1 mgper 2 Chewable Tablet(s)DSLD:181334
- plntWhole Food Men's Multivitamin15 mgper 4 Vegetarian Capsule(s)DSLD:181329
- plntWhole Food Prenatal Multivitamin7.5 mgper 3 Vegetarian Capsule(s)DSLD:181348
- plntWhole Food Women's 50+ Multivitamin10 mgper 4 Vegetarian Capsule(s)DSLD:180654
- plntWhole Food Women's Multivitamin10 mgper 4 Vegetarian Capsule(s)DSLD:180754
- ProbiogenAdults 55+ Probiotic MultiZinc Oxide · Zinc (Form: as Zinc Oxide)12 mgper 5.55 Gram(s)DSLD:180648
- Professional BotanicalsCo-ResistZinc Chelate10 mgper 2 Capsule(s)DSLD:199512
- ProJoba InternationalProJoba Super DailyZinc Amino Acid Chelate · Zinc (Form: as zinc gluconate, zinc amino acid chelate)15 mgper 3 Tablet(s)DSLD:12909
- Protocol For Life BalanceOrtho Multi For MenZinMax · Zinc (Form: from ZinMax(R) (Zinc Picolinate), and ZMA(R))30 mgper 2 Tablet(s)DSLD:11777
- Protocol For Life BalanceOrtho Multi For WomenZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)20 mgper 3 Vegetarian Capsule(s)DSLD:11791
- Protocol For Life BalanceOrtho Multi For WomenZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)20 mgper 3 Tablet(s)DSLD:11810
- Protocol For Life BalanceOrtho Multi For WomenZinc Amino Acid Chelate · Zinc (Form: from Zinc Amino Acid Chelate)20 mgper 3 Vegetarian Capsule(s)DSLD:15510
- Protocol For Life BalanceOrtho Multi Super Fruits Acai FlavorZinc Glycinate Chelate · Zinc (Form: from Zinc Glycinate Chelate Note: (TRAACS(R)) (Albion))3 mgper 0.33 TbspDSLD:15408
- Protocol For Life BalanceProtoClear Detoxification FormulaZinc Picolinate · Zinc (Form: from Zinc Picolinate)10 mgper 27.5 Gram(s)DSLD:11708
- Protocol For Life BalanceProtoClear Natural Orange FlavorZinc Picolinate · Zinc (Form: from Zinc Picolinate)10 mgper 55 Gram(s)DSLD:11725
- Protocol For Life BalanceProtoMeal Natural Berry FlavorZinc Glycinate Chelate · Zinc (Form: from Zinc Glycinate Chelate Note: (TRAACS(R)) (Albion))7.5 mgper 50 Gram(s)DSLD:15429
- Provida Labs5-Way Metabolic Fat Fighter15 mgper 2 Tablet(s)DSLD:13561
- PS ProSuppsKarbolic Super-Premium Muscle Fuel Orange BurstZinc Aspartate · Zinc (Form: as Zinc Aspartate)10 mgper 31.25 Gram(s)DSLD:17714
- PS ProSuppsKarbolic Super-Premium Muscle Fuel Power PunchZinc Aspartate · Zinc (Form: as Zinc Aspartate)10 mgper 31.25 Gram(s)DSLD:17708
- PS ProSuppsKarbolic Super-Premium Muscle Fuel Strawberry PopsicleZinc Aspartate · Zinc (Form: as Zinc Aspartate)10 mgper 31.25 Gram(s)DSLD:17707
- PS ProSuppsKarbolic Super-Premium Muscle Fuel Strawberry PopsicleZinc Aspartate · Zinc (Form: as Zinc Aspartate)10 mgper 31.25 Gram(s)DSLD:17716
- Pure AdvantageAid 4 JointsZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)10 mgper 4 Capsule(s)DSLD:180769
- Pure AdvantageMRP Chocolate4 mgper 69 Gram(s)DSLD:180795
- Pure AdvantageMRP Vanilla4 mgper 69 Gram(s)DSLD:180822
- Pure EncapsulationsAthletic NutrientsZinc Citrate · Zinc (Form: as Zinc Citrate)5 mgper 2 Capsule(s)DSLD:184296
- Pure EncapsulationsAthletic Pure PackZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 mgper 9 Capsule(s)DSLD:182730
- Pure EncapsulationsDaily ImmuneZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 2 Capsule(s)DSLD:182837
- Pure EncapsulationsDopaPlusZinc Picolinate · Zinc (Form: as Zinc Picolinate)10 mgper 3 Capsule(s)DSLD:182855
- Pure EncapsulationsEnergize Plus Pure PackZinc Picolinate · Zinc (Form: as Zinc Picolinate)7.5 mgper 7 Capsule(s)DSLD:184817
- Pure EncapsulationsLiquiNutrients Natural Lemon Creme FlavorZinc Gluconate · Zinc (Form: as Zinc Gluconate)12 mgper 2 tspDSLD:184821
- Pure EncapsulationsMen's Pure PackZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 mgper 8 Capsule(s)DSLD:183007
- Pure EncapsulationsPureDefense w/NACZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 mgper 2 Capsule(s)DSLD:183201
- Pure EncapsulationsPureFood NutrientsLactobacillus bulgaricus · Zinc (Form: from Lactobacillus bulgaricus Genus: Lactobacillus Species: bulgaricus)14 mgper 4 Capsule(s)DSLD:184827
- Pure EncapsulationsPureLean (with Stevia) Natural Vanilla Bean FlavorZinc Glycinate · Zinc (Form: as Zinc Glycinate)7.5 mgper 27 Gram(s)DSLD:188777
- Pure EncapsulationsPureLean Natural Chocolate FlavorZinc Glycinate · Zinc (Form: as Zinc Glycinate)7.5 mgper 37 Gram(s)DSLD:185315
- Pure EncapsulationsPureLean Natural Vanilla Bean FlavorZinc Glycinate · Zinc (Form: as Zinc Glycinate)7.5 mgper 34 Gram(s)DSLD:188758
- Pure EncapsulationsPureLean Pure PackZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 mgper 7 Capsule(s)DSLD:188790
- Pure EncapsulationsSeroPlusZinc Picolinate · Zinc (Form: as Zinc Picolinate)10 mgper 2 Capsule(s)DSLD:183280
- Pure EncapsulationsWomen's Pure PackZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 mgper 9 Capsule(s)DSLD:183301
- Pure VeganAdvanced VeganZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)10 mgper 2 Capsule(s)DSLD:180382
- Pure VeganVegan Complete Vanilla8 mgper 43 Gram(s)DSLD:180409
- Puritan's PrideBone Meal With Vitamin DZinc Gluconate · Zinc (Form: as Zinc Gluconate)0.08 mgper 4 Tablet(s)DSLD:12262
- RealDoseRealMeal GF Natural Chocolate FlavorTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 31.4 Gram(s)DSLD:182109
- RealDoseRealMeal GF Natural Vanilla FlavorTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)5 mgper 34.8 Gram(s)DSLD:182865
- Redcon1Boom StickZinc Aspartate30 mgper 3 Capsule(s)DSLD:179470
- RelivFit3 Active Vanilla Kick Natural Flavor4 mgper 18.35 Gram(s)DSLD:178495
- RelivInnergize! Natural Lemon Flavor4 mgper 19 Gram(s)DSLD:178487
- RelivNow For Kids Chocolate8 mgper 29 Gram(s)DSLD:178949
- RelivNow For Kids Vanilla7.5 mgper 29 Gram(s)DSLD:178955
- Renew LifeSkinny Gut Ultimate Shake Natural Chocolate FlavorZinc Oxide · Zinc (Form: as Zinc Oxide)4.5 mgper 41 Gram(s)DSLD:178306
- RidgeCrest HerbalsClearLungs Immune10 mgper 1 Capsule(s)DSLD:177302
- RidgeCrest HerbalsHair ReViveZinc Ascorbate · Zinc (Form: from Zinc Ascorbate)30 mgper 4 Capsule(s)DSLD:177327
- RidgeCrest HerbalsSinusClearZinc Ascorbate5 mgper 2 Capsule(s)DSLD:177331
- Rite Aid PharmacyOne Daily Women's with Vitamin D-3Zinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:181440
- Rite Aid PharmacyOne Daily Women's with Vitamin D-3Zinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:181542
- RivalusPromasil Soft Serve Vanilla20 mcgper 25 Gram(s)DSLD:17998
- RivalusPromasil Strawberry20 mgper 25 Gram(s)DSLD:14525
- RivalusRivalmenZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 3 Tablet(s)DSLD:182210
- Ronnie Cole Signature SeriesPro-Antium Double Chocolate Cookie2 %per 44 Gram(s)DSLD:18800
- Ronnie Cole Signature SeriesRessurect-P.M. Blue Razz DreamZinc Sulfate · Zinc (Form: as Zinc Sulfate)10 mgper 8 Gram(s)DSLD:14430
- Ronnie Coleman Signature SeriesResurrect-P.M. Midnight GrapeZinc Sulfate · Zinc (Form: as Zinc Sulfate)10 mgper 4 Gram(s)DSLD:14961
- Royal Guard2-Phase Dual Immune BoosterZinc Aspartate · Zinc (Form: as Zinc Aspartate)5 mgper 1 Tablet(s)DSLD:15515
- RugbyCerovite LiquidZinc Gluconate · Zinc (Form: as Zinc Gluconate)3 mgper 1 TbspDSLD:14446
- RugbyI-ViteZinc Oxide · Zinc (Form: as Zinc Oxide)40 mgper 1 Tablet(s)DSLD:14532
- Safeway CareCentury Senior 50+ Formula11 mgper 1 Tablet(s)DSLD:12216
- Safeway CareOne Daily Women's Formula15 mgper 1 Tablet(s)DSLD:12207
- SANSaw Palmetto ExtractZinc Oxide · Zinc (Form: as Zinc Oxide)1.5 mgper 1 Softgel(s)DSLD:175475
- Seeking HealthOptimal Multivitamin W/ IronZinc Bisglycinate Chelate · Zinc (Form: as Zinc Bisglycinate Chelate)15 mgper 4 Capsule(s)DSLD:174726
- Seeking HealthOptimal Prenatal ChocolateTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)20 mgper 43.2 Gram(s)DSLD:174745
- Seeking HealthOptimal Prenatal VanillaTRAACS Zinc Bisglycinate Chelate · Zinc (Form: as TRAACS Zinc Bisglycinate Chelate)20 mgper 36.4 Gram(s)DSLD:174748
- Sequel VegaComplete Whole Food Health Optimizer Berry FlavorZinc Citrate · Zinc (Form: as {Zinc} citrate)15 mgper 69 Gram(s)DSLD:18355
- Sequel VegaComplete Whole Food Health Optimizer Berry FlavorZinc Citrate · Zinc (Form: as {Zinc} citrate)15 mgper 69 Gram(s)DSLD:18356
- Sequel VegaComplete Whole Food Health Optimizer Natural FlavorZinc Citrate · Zinc (Form: as {Zinc} citrate)15 mgper 61 Gram(s)DSLD:18351
- Sequel VegaComplete Whole Food Health Optimizer Vanilla Chai FlavorZinc Citrate · Zinc (Form: as {Zinc} citrate)15 mgper 65 Gram(s)DSLD:18357
- ShakleeChewable Cal Mag PlusZinc Gluconate · Zinc (Form: as Zinc Gluconate)1.5 mgper 2 Tablet(s)DSLD:17540
- ShakleeVita-Lea Gold without Vitamin K FormulaZinc Gluconate · Zinc (Form: as Zinc Gluconate)22.5 mgper 2 Tablet(s)DSLD:17529
- ShakleeVita-Lea Iron FormulaZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 2 Tablet(s)DSLD:17515
- ShakleeVita-Lea without Iron FormulaZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 2 Tablet(s)DSLD:17500
- ShakleeVitalizerZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 1 Strip(s)DSLD:17332
- Simply RightVision Multi 50+9 mgper 1 Softgel(s)DSLD:206368
- Smart SenseCentury Adult11 mgper 1 Tablet(s)DSLD:175041
- Smart SenseCentury Mature11 mgper 1 Tablet(s)DSLD:175031
- SolgarMale MultipleZinc Chelate · Zinc (Form: as Zinc Glycinate Chelate)50 mgper 3 Tablet(s)DSLD:201405
- SomaLife InternationalSomaVit PlusZinc Hydrolyzed Vegetable Rice Protein Chelate25 mgper 2 Capsule(s)DSLD:16509
- Sonoran BloomWellavoh Daily Multi-Nutrient Complex For Women AM FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 3 Softgel(s)DSLD:11623
- Sonoran BloomWellavoh Daily Multi-Nutrient Complex For Women PM FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)11 mgper 3 Softgel(s)DSLD:11630
- Source NaturalsAdvanced One MultipleZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))15 mgper 1 Tablet(s)DSLD:181591
- Source NaturalsAdvanced One MultipleZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))15 mgper 1 Tablet(s)DSLD:181628
- Source NaturalsAdvanced One MultipleZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))15 mgper 1 Tablet(s)DSLD:181630
- Source NaturalsAdvanced One MultipleZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))15 mgper 1 Tablet(s)DSLD:181633
- Source NaturalsAdvanced One MultipleZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))15 mgper 1 Tablet(s)DSLD:181634
- Source NaturalsAdvanced One MultipleZinc Monomethionine · Zinc (Form: as Zinc Monomethionine (Alt. Name: OptiZinc))15 mgper 1 Tablet(s)DSLD:181635
- Source NaturalsAdvanced Triple Boron with CalciumZinc Citrate · Zinc (Form: as Zinc Citrate)7.5 Gram(s)per 2 Capsule(s)DSLD:181724
- Source NaturalsAller-ResponseZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)10 mgper 3 Tablet(s)DSLD:174098
- Source NaturalsAller-ResponseZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)10 mgper 2 Tablet(s)DSLD:173902
- Source NaturalsAller-ResponseZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)10 mgper 1 Tablet(s)DSLD:181754
- Source NaturalsAttentive ChildZinc Picolinate · Zinc (Form: as Zinc Picolinate)2 mgper 1 Tablet(s)DSLD:185302
- Source NaturalsCholestrexZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)1 mgper 2 Tablet(s)DSLD:185154
- Source NaturalsCholestrexZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)1 mgper 2 Tablet(s)DSLD:185161
- Source NaturalsCholestrexZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)1 mgper 2 Tablet(s)DSLD:185187
- Source NaturalsCholestrexZinc Ascorbate · Zinc (Form: as Zinc Ascorbate)1 mgper 2 Tablet(s)DSLD:185212
- Spray For LifeFast Acting Melatonin Spearmint & Lemon FlavorZinc Gluconate · Zinc (Form: as Zinc Gluconate)1 mgper 0.042 mLDSLD:176283
- Spray For LifeVitamin C + Zinc Apple & Pear FlavorZinc Gluconate · Zinc (Form: as Zinc Gluconate)11 mgper 0.042 mLDSLD:176310
- Spring ValleyChildren's Multivitamin GummiesZinc Sulfate · Zinc (Form: as Zinc Sulfate)amount not statedper 1 Gummy(ies)DSLD:178559
- Spring ValleyDiabetes Daily Pack11 mgper 1 Packet(s)DSLD:178643
- Spring ValleyMaca ExtractZinc Arginate · Zinc (Form: as Zinc Arginate)15 mgper 1 Capsule(s)DSLD:178319
- Spring ValleyMen's MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 2 Tablet(s)DSLD:178316
- Spring ValleyMen's MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 2 Tablet(s)DSLD:178383
- Spring ValleyOrganic Multivitamin Real Fruit GummiesZinc Sulfate · Zinc (Form: as Zinc Sulfate)5 mgper 2 Gummie(s)DSLD:178710
- Spring ValleyWomen's MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 2 Tablet(s)DSLD:178361
- Spring ValleyWomen's MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 2 Tablet(s)DSLD:178398
- Spring ValleyWomen's MultivitaminZinc Oxide · Zinc (Form: as Zinc Oxide)25 mgper 2 Tablet(s)DSLD:178791
- Sundown NaturalsIron Free Daily Multiple 50+Zinc Oxide · Zinc (Form: as Zinc Oxide)22.5 mgper 1 Caplet(s)DSLD:1094
- Sundown NaturalsMultivitamin GummiesZinc Citrate · Zinc (Form: as Zinc Citrate)5 mgper 2 Gummy(ies)DSLD:174988
- Sundown NaturalsProstate HealthZinc Oxide · Zinc (Form: as Zinc Oxide)5 mgper 2 Capsule(s)DSLD:1078
- Sunfood SuperfoodsNutrient-Rich Chlorella Tablets32 mcgper 6 Tablet(s)DSLD:16694
- Sunfood SuperfoodsNutrient-Rich Chlorella Tablets32 mcgper 6 Tablet(s)DSLD:16736
- SunmarkAnimal Shapes Complete With Choline6 mgper 0.5 Tablet(s)DSLD:10008
- SunmarkComplete Advanced Formula USP11 mgper 1 Tablet(s)DSLD:12168
- SunriderMetabalance 44Zinc Gluconate6.6 mgper 2 Capsule(s)DSLD:12150
- SwansonMulti and MineralZinc Sulfate · Zinc (Form: from Zinc Sulfate)15 mgper 1 Capsule(s)DSLD:202571
- SwansonMulti with Iron Century FormulaZinc Sulfate · Zinc (Form: from Zinc Sulfate)15 mgper 1 Tablet(s)DSLD:187463
- SwansonProstate EssentialsZinc Picolinate · Zinc (Form: from Zinc Picolinate)15 mgper 1 Veggie Capsule(s)DSLD:184601
- SwansonZinc CarnosinePepZinGI Zinc-Carnosine · Zinc (Form: from PepZinGI Zinc-Carnosine)8 mgper 1 Capsule(s)DSLD:188864
- Terry NaturallyAgeless Radianceamount not statedper 1 Capsule(s)DSLD:175054
- Terry NaturallyP-5-P/MagZinc Glycinate Chelate · Zinc (Form: from Zinc Glycinate Chelate)5 mgper 1 Capsule(s)DSLD:177142
- Terry NaturallyP-5-P/MagZinc Glycinate Chelate · Zinc (Form: from Zinc Glycinate Chelate)5 mgper 1 Capsule(s)DSLD:177143
- Terry NaturallyViraProZinc Gluconate · Zinc (Form: from Zinc Gluconate)15 mgper 1 Tablet(s)DSLD:176327
- The Isopure CompanyIsopoure Low Carb Dutch Chocolate4.2 mgper 33 Gram(s)DSLD:173793
- The Isopure CompanyIsopure Low Carb Dutch Chocolate4.2 mgper 33 Gram(s)DSLD:173825
- The Isopure CompanyIsopure Low Carb Dutch Chocolate4.2 mgper 33 Gram(s)DSLD:173873
- The Isopure CompanyIsopure Low Carb Dutch Chocolate4.2 mgper 33 Gram(s)DSLD:173881
- The Isopure CompanyIsopure Whey Protein Isolate Natural Chocolate Flavor2 mgper 35 Gram(s)DSLD:174075
- The Isopure CompanyIsopure Zero Carb Creamy Vanilla4.2 mgper 31 Gram(s)DSLD:173841
- The Isopure CompanyIsopure Zero Carb Creamy Vanilla4.2 mgper 31 Gram(s)DSLD:173797
- The Isopure CompanyIsopure Zero Carb Creamy Vanilla4.2 mgper 31 Gram(s)DSLD:173878
- The Isopure CompanyIsopure Zero Carb Creamy Vanilla4.2 mgper 31 Gram(s)DSLD:173886
- The Isopure CompanyIsopure Zero Carb Protein Powder Cookies & Cream4.2 mgper 31 Gram(s)DSLD:176458
- The Isopure CompanyIsopure Zero Carb Protein Powder Cookies & Cream4.2 mgper 31 Gram(s)DSLD:176466
- The Isopure CompanyIsopure Zero Carb Toasted Coconut4.2 mgper 32 Gram(s)DSLD:173831
- The Professional SeriesHyper Ten SupportZinc Krebs Cycle Chelates · Zinc (Form: from Zinc Krebs Note: Citrate, Fumarate, Glutarate, Malate, Succinate and Oxide Complex)2.5 mgper 1 Capsule(s)DSLD:10737
- The Vitamin ShoppeActive-C with Bioflavonoids 1000 mg4 mgper 1 Tablet(s)DSLD:183899
- The Vitamin ShoppeCalcium Magnesium ZincZinc Amino Acid Chelate · Zinc (Form: as Zinc Oxide, Zinc Amino Acid Chelate)25 mgper 2 Tablet(s)DSLD:184257
- The Vitamin ShoppeCalcium Magnesium ZincZinc Amino Acid Chelate · Zinc (Form: as Zinc Oxide, Zinc Amino Acid Chelate)25 mgper 2 Tablet(s)DSLD:184259
- The Vitamin ShoppeCoral Calcium Plus 1500 mgZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 3 Capsule(s)DSLD:184498
- The Vitamin ShoppeLiquid Multi Orange Vanilla FlavorZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 1 oz.DSLD:13175
- The Vitamin ShoppeMulti Minerals with Boron & Vitamin DZinc Oxide · Zinc (Form: as Zinc Oxide)22.5 mgper 3 Tablet(s)DSLD:180743
- The Vitamin ShoppeStress FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)7 mgper 3 Tablet(s)DSLD:180500
- The Vitamin ShoppeSuper AntioxidantZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 2 Capsule(s)DSLD:12989
- The Vitamin ShoppeSuper AntioxidantZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 2 Capsule(s)DSLD:184549
- The Vitamin ShoppeSuper AntioxidantZinc Picolinate · Zinc (Form: as Zinc Picolinate)15 mgper 2 Capsule(s)DSLD:184561
- The Vitamin ShoppeThyroid ComplexZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)3 mgper 1 Capsule(s)DSLD:183443
- Tokkyo NutritionProtein 100% Whey Chocolateamount not statedper 30 Gram(s)DSLD:180565
- Tokkyo NutritionTokkyo Anabolic Stackamount not statedper 3 Capsule(s)DSLD:16446
- Tokkyo NutritionTokkyo T3amount not statedper 2 Capsule(s)DSLD:16510
- Tokkyo NutritionTokkyo Test-FXamount not statedper 3 Capsule(s)DSLD:16437
- Top CareCentury Ultimate Men's11 mgper 1 Tablet(s)DSLD:12115
- Top CareOne Daily Men's Formula15 mgper 1 Tablet(s)DSLD:12113
- Trader Joe'sGummi VitesZinc Chelate · Zinc (Form: as Zinc Chelate)2.4 mgper 1 Gummy(ies)DSLD:174232
- Trader Joe'sHigh Potency Multiple Vitamin & MineralZinc Oxide5 mgper 2 Tablet(s)DSLD:174087
- Trader Joe'sWomen's High Potency Multiple Vitamin & MineralZinc Oxide8 mgper 2 Tablet(s)DSLD:174178
- Traditional NutritionalsProsta-Plex PlusZinc Gluconate · Zinc (Form: from Zinc Gluconate)15 mgper 4 Capsule(s)DSLD:11465
- TriVitaBone Growth FactorZinc Aspartate · Zinc (Form: as Zinc Aspartate)15 mgper 2 Capsule(s)DSLD:11504
- TriVitaGlucoManage FormulaZinc Oxide · Zinc (Form: as Zinc Oxide)12.5 mgper 1 Capsule(s)DSLD:16268
- TriVitaLeanologyZinc Gluconate · Zinc (Form: as Zinc Gluconate)960 mcgper 3 Capsule(s)DSLD:11516
- TriVitaNerve FormulaZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)10 mgper 1 Capsule(s)DSLD:11495
- TriVitaPM FormulaZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 2 Tablet(s)DSLD:11477
- TriVitaProstate Health FormulaZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 2 Capsule(s)DSLD:16271
- TriVitaVisionGuardZinc Citrate · Zinc (Form: as Zinc Citrate)5 mgper 2 Capsule(s)DSLD:16274
- TriVitaVitaCal-Mag DZinc Amino Acid Chelate · Zinc (Form: from (zinc) aspartate, (zinc) oxide, and (zinc) amino acid chelate)7.5 mgper 2 Tablet(s)DSLD:11473
- True AthleteBalanced Hydration Powder Lemon LimeZinc Gluconate · Zinc (Form: as Zinc Gluconate)3 mgper 4 Gram(s)DSLD:183467
- True HealthDr. Cutler's Mega-MineralsZinc Malate · Zinc (Form: as zinc malate)15 mgper 2 Capsule(s)DSLD:16687
- True HealthDr. Cutler's Ultimate Bone Gro FormulaZinc Glycinate Chelate · Zinc (Form: from {zinc} glycinate chelate)2.5 mgper 3 Tablet(s)DSLD:16735
- True HealthDr. Cutler's Ultimate Multi-CompleteZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)7.5 mgper 2 Capsule(s)DSLD:16779
- True HealthDr. Cutler's Ultimate Thyroid SupportZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)7.5 mgper 1 Capsule(s)DSLD:16829
- True HealthDr. Cutler's Ultimate Vision FormulaZinc Glycinate Chelate · Zinc (Form: as {Zinc} glycinate chelate)10 mgper 3 Capsule(s)DSLD:16834
- TwinlabBariatric Support Basic Essentials ChocolateZinc Gluconate · Zinc (Form: as Zinc Gluconate)5.25 mgper 28 Gram(s)DSLD:17036
- TwinlabBariatric Support Basic Essentials VanillaZinc Gluconate · Zinc (Form: as Zinc Gluconate)5.25 mgper 28 Gram(s)DSLD:17032
- TwinlabTri-Boron PlusZinc Histidinate · Zinc (Form: from zinc picolinate, zinc histidinate)7.5 mgper 2 Capsule(s)DSLD:12957
- U.S. Doctors' ClinicalLung Support FormulaZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)7 mgper 1 Capsule(s)DSLD:176388
- U.S. Doctors' ClinicalNeoGeneZinc Picolinate · Zinc (Form: as Zinc Picolinate)1.2 mgper 2 Tablet(s)DSLD:176509
- U.S. Doctors' ClinicalProstataZinc Arginate · Zinc (Form: as Zinc Arginate)5 mgper 1 Capsule(s)DSLD:176520
- UltimaUltima Replenisher Cherry PomegranateZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183049
- UltimaUltima Replenisher Cherry PomegranateZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183097
- UltimaUltima Replenisher Cherry PomegranateZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183155
- UltimaUltima Replenisher Cherry PomegranateZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183179
- UltimaUltima Replenisher Cherry PomegranateZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183190
- UltimaUltima Replenisher GrapeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183054
- UltimaUltima Replenisher GrapeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183100
- UltimaUltima Replenisher GrapeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183157
- UltimaUltima Replenisher GrapeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183174
- UltimaUltima Replenisher GrapeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183191
- UltimaUltima Replenisher LemonadeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.5 Gram(s)DSLD:183060
- UltimaUltima Replenisher LemonadeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.5 Gram(s)DSLD:183102
- UltimaUltima Replenisher LemonadeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.5 Gram(s)DSLD:183153
- UltimaUltima Replenisher LemonadeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.5 Gram(s)DSLD:183177
- UltimaUltima Replenisher LemonadeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.5 Gram(s)DSLD:183192
- UltimaUltima Replenisher OrangeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183064
- UltimaUltima Replenisher OrangeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183106
- UltimaUltima Replenisher OrangeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183159
- UltimaUltima Replenisher OrangeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183173
- UltimaUltima Replenisher OrangeZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.4 Gram(s)DSLD:183196
- UltimaUltima Replenisher RaspberryZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.2 Gram(s)DSLD:183205
- UltimaUltima Replenisher RaspberryZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.2 Gram(s)DSLD:183068
- UltimaUltima Replenisher RaspberryZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.2 Gram(s)DSLD:183079
- UltimaUltima Replenisher RaspberryZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.2 Gram(s)DSLD:183160
- UltimaUltima Replenisher RaspberryZinc Citrate · Zinc (Form: as Zinc Citrate)1 mgper 3.2 Gram(s)DSLD:183169
- UltimaUltima Toddler Formula Berry PunchZinc Citrate · Zinc (Form: as Zinc Citrate)0.5 mgper 2.4 Gram(s)DSLD:183045
- UltimaUltima Toddler Formula Berry PunchZinc Citrate · Zinc (Form: as Zinc Citrate)0.5 mgper 2.4 Gram(s)DSLD:183110
- UltimaUltima Toddler Formula Berry PunchZinc Citrate · Zinc (Form: as Zinc Citrate)0.5 mgper 2.4 Gram(s)DSLD:183187
- Ultra PlanUltimate-PlusZinc Sulfate · Zinc (Form: as Zinc Sulfate)30 mgper 3 Tablet(s)DSLD:12951
- up&upMultivitamin Women's 50+ Advanced22.5 mgper 1 Tablet(s)DSLD:12051
- up&upTeen for Her Advanced15 mgper 1 Tablet(s)DSLD:12081
- up&upWomen's Multivitamin/Multimineral15 mgper 1 Tablet(s)DSLD:12052
- VegaOne All-In-One Nutritional Shake BerryZinc Citrate Dihydrate · Zinc (Form: as Zinc Citrate Dihydrate)7.5 mgper 42.5 Gram(s)DSLD:14856
- VegaOne All-In-One Nutritional Shake BerryZinc Citrate Dihydrate · Zinc (Form: as Zinc Citrate Dihydrate)7.5 mgper 42.5 Gram(s)DSLD:14861
- VegaOne All-In-One Nutritional Shake ChocolateZinc Citrate Dihydrate · Zinc (Form: as Zinc Citrate Dihydrate)7.5 mgper 10.95 Gram(s)DSLD:18359
- VegaOne All-In-One Nutritional Shake NaturalZinc Citrate Dihydrate · Zinc (Form: as Zinc Citrate Dihydrate)7.5 mgper 8.975 Gram(s)DSLD:18362
- VegaOne All-In-One Nutritional Shake Vanilla ChaiZinc Citrate Dihydrate · Zinc (Form: as Zinc Citrate Dihydrate)7.5 mgper 9.925 Gram(s)DSLD:18364
- Vega SportElectrolyte Hydrator Lemon LimeZinc Citrate Dihydrate · Zinc (Form: as Zinc Citrate Dihydrate)1 mgper 0.16 Ounce(s)DSLD:18376
- Vega SportElectrolyte Hydrator Pom-BerryZinc Citrate Dihydrate · Zinc (Form: as Zinc Citrate Dihydrate)1 mgper 0.13 Ounce(s)DSLD:18380
- Vega SportElectrolyte Hydrator Pom-Berry Lemon LimeZinc Citrate Dihydrate · Zinc (Form: as Zinc Citrate Dihydrate)1 mgper 1 Pack(s)DSLD:18372
- ViandaAvlimil MultiZinc Citrate · Zinc (Form: as Zinc Citrate)15 mgper 2 Capsule(s)DSLD:176260
- ViandaPavaxinZinc Aspartate · Zinc (Form: as Zinc Aspartate)15 mgper 2 Tablet(s)DSLD:176361
- Vibrant HealthMetabolic Vibrance Orange MangoZinc Krebs Cycle Chelates · Zinc (Form: as Zinc Krebs Cycle)30 mgper 4 Gram(s)DSLD:183870
- Vibrant HealthSuper Kids Vibrance Awesome AppleZinc Note: from plants4 mgper 6.6 Gram(s)DSLD:183893
- Vibrant HealthTrilogy WomenZinc Note: from plants2.25 mgper 1 Packet(s)DSLD:184335
- Virtus PharmaceuticalsPNV Tabs 29-1Zinc Oxide15 mgper 1 Tablet(s)DSLD:180567
- Virtus PharmaceuticalsPrePLUS TabletZinc Oxide25 mgper 1 Tablet(s)DSLD:180495
- Virtus PharmaceuticalsPreTAB TabletZinc Oxide · Zinc (Form: as Zinc Oxide)15 mgper 1 Tablet(s)DSLD:180564
- Virtus PharmaceuticalsVirt-NateZinc Oxide25 mgper 1 Tablet(s)DSLD:180519
- Virtus PharmaceuticalsVirt-PNZinc Oxide15 mgper 1 Tablet(s)DSLD:180521
- vitafusionPlatinum 50+ Natural Peach FlavorZinc Chelate · Zinc (Form: as Zinc Chelate)1.2 mgper 2 Gummy Vitamin(s)DSLD:177046
- vitafusionVitamin C Plus Vitamin D & Zinc Natural Orange Pineapple FlavorZinc Gluconate · Zinc (Form: as Zinc Gluconate)6 mgper 2 Gummy Vitamin(s)DSLD:177089
- Vitamin WorldBone-Active Bone Reinforcer With HydroxyapatiteZinc Amino Acid Chelate · Zinc (Form: zinc amino acid chelate, and Zinc Gluconate)15 mgper 4 Caplet(s)DSLD:1823
- Vitamin WorldFantastic Kids Gummies MultiVitaminZinc Citrate · Zinc (Form: as Zinc Citrate)2 mgper 2 Gummy(ies)DSLD:1829
- Vitamin WorldUltra Man Hair FormulaZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)5 mgper 3 Caplet(s)DSLD:1854
- Vitamin WorldVitamins For The HairZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)5 mgper 3 Caplet(s)DSLD:1197
- VitolRussian BearZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate, Zinc Citrate)75 mgper 8 Tablet(s)DSLD:18005
- Viva VitaminsBe WellZinc Oxide · Zinc (Form: as Zinc Oxide)30 mgper 3 Tablet(s)DSLD:1782
- Viva VitaminsCal 500-Mag 250-Zinc 25Zinc Citrate · Zinc (Form: as {Zinc} Citrate)25 mgper 1 Tablet(s)DSLD:1798
- Viva VitaminsComplete Minerals Ultra StrengthZinc Amino Acid Chelate10 mgper 1 Tablet(s)DSLD:1767
- Viva VitaminsComplete Multi Extra Strength Iron & Copper FreeZinc Amino Acid Chelate20 mgper 1 Tablet(s)DSLD:1771
- Viva VitaminsJoints UltraZinc Monomethionine OptiZinc · Zinc (Form: as Zinc Monomethionine OptiZinc)10 mgper 2 Tablet(s)DSLD:1790
- Viva VitaminsProstate25 mgper 1 Tablet(s)DSLD:1785
- Viva VitaminsSuper Zinc 50 mgZinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)50 mgper 1 Tablet(s)DSLD:1810
- Viva VitaminsV.M.T. Extra StrengthZinc Aspartate30 mgper 3 Tablet(s)DSLD:1753
- Viva VitaminsV.M.T. Regular StrengthZinc Aspartate15 mgper 3 Tablet(s)DSLD:1752
- WalgreensA Thru Z Active Performance11 mgper 1 Tablet(s)DSLD:12931
- WalgreensAdvanced Formula A Thru Z11 mgper 1 Tablet(s)DSLD:12922
- WalgreensChildren's Gummies2.5 mgper 1 Gummy(ies)DSLD:12938
- Weider PrimeHealthy Testosterone Support For MenZinc Mono-L-Methionine Sulfate · Zinc (Form: as Zinc Mono-L-Methionine Sulfate (Alt. Name: L-OptiZinc))15 mgper 2 Capsule(s)DSLD:171962
- Wiley's FinestBold Vision Proactive11 mgper 2 Softgel(s)DSLD:178215
- WindmillZinc (Gluconate) 15 mgZinc Gluconate · Zinc (Form: as Zinc Gluconate)15 mgper 1 Tablet(s)DSLD:181036
- WindmillZinc Lozenges with Echinacea & Vitamin C Cherry FlavorZinc Citrate · Zinc (Form: as Zinc Citrate)10 mgper 1 Lozenge(s)DSLD:180635
- Windmill ComparablesVisivites with LuteinZinc Oxide · Zinc (Form: as Zinc Oxide)40 mgper 1 Tablet(s)DSLD:181080
- Women to WomenEssential Nutrients and Omega-3Zinc Amino Acid Chelate · Zinc (Form: as Zinc Amino Acid Chelate)7 mgper 1 Packet(s)DSLD:12915
- XtendlifeArthrit-EzeZinc Citrate · Zinc (Form: as Zinc Citrate)9 mgper 6 Tablet(s)DSLD:17012
- XtendlifeCardio-KlenzZinc Orotate · Zinc (Form: as Zinc Orotate)9 mgper 6 Tablet(s)DSLD:17014
- XtendlifeDiabet-EzeZinc Citrate · Zinc (Form: as Zinc Citrate)9 mgper 6 Tablet(s)DSLD:17016
- XtendlifeNeuro-Natural MemoryZinc Citrate · Zinc (Form: as Zinc Citrate)2.5 mgper 2 Tablet(s)DSLD:17031
- XtendlifeViral-ProtecZinc Citrate · Zinc (Form: as Zinc Citrate)9 mgper 3 Tablet(s)DSLD:17058
- Young LivingSuper CZinc Gluconate · Zinc (Form: as Zinc Gluconate)1 mgper 2 Tablet(s)DSLD:12911
- YuhanDabotamin Q Tab.15 mgper 1 Tablet(s)DSLD:12908
- Yum-V'sMulti Vitamin + Mineral Formula Yummy Grape Flavor1 mgper 2 Gummy(ies)DSLD:17775
Label record: NIH Office of Dietary Supplements · CC0
Where it reaches
10 systems, 21 regions, 77 tissues, 93 transporter routes — routes, not measurements: transporters known to carry Zn(2+) are expressed there, and no source reports it arriving.
Loading the model…
Papers screened
2,391 papers
- Compound
- Zn(2+)
- Screened
- 2,391
- Admitted
- 74
- Discarded
- 1,058
- Not read
- 1,259
- Showing
- 200 of 2,391
Produced a finding74 papers
- PMID:231378582026-10-25
- PMID:234408012026-10-25
- PMID:237646692026-10-25
- PMID:237757052026-10-25
- PMID:241486072026-10-25
- PMID:253655242026-10-25
- PMID:262652932026-10-25
- PMID:281890772026-10-25
- PMID:300124972026-10-25
- PMID:304422292026-10-25
- PMID:291033462026-10-25
- PMID:314088962026-10-25
and 62 more.
Read and discarded1,058 papers
- PMID:10801944cited by PMID:22856593; not about the subject it would be filed under2026-10-26
- PMID:11340099cited by PMID:22870238; not about the subject it would be filed under2026-10-26
- PMID:11892493cited by PMID:22856593; not about the subject it would be filed under2026-10-26
- PMID:15346718cited by PMID:22870238; not about the subject it would be filed under2026-10-26
- PMID:18026621cited by PMID:22870238; not about the subject it would be filed under2026-10-26
- PMID:18054190cited by PMID:22870238; not about the subject it would be filed under2026-10-26
- PMID:21666789cited by PMID:22870238; not about the subject it would be filed under2026-10-26
- PMID:9323478cited by PMID:22870238; not about the subject it would be filed under2026-10-26
- PMID:10079829no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-26
- PMID:15705693no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-26
- PMID:18272895no PMID parsed, abstract under 200 characters, or no record returned by efetch2026-10-26
- PMID:10225235cited by PMID:22713768; not about the subject it would be filed under2026-10-26
and 1,046 more.
Measured, not recorded
- Compound
- Zn(2+)
- Endpoints measured
- 12,678 endpoints
- Recorded as a finding
- No
Show what was measured
all cause mortality, deaths
no effect, p = 0.1
All cause mortality was non-significantly lower in children given zinc compared with those given placebo (5 v 12, P=0.1)
PMID:11431296 · one of two readings recorded this
incidence of falciparum malaria
no effect
(relative risk 0.98, 95% confidence interval 0.86 to 1.11)
PMID:11431296 · one of two readings recorded this
incidence of symptomatic falciparum malaria (temperature >=37.5 C with >=5000 parasites/microlitre), primary outcome; also prevalence of diarrhoea and all cause mortality
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Zinc supplementation was significantly associated with a reduced prevalence of diarrhoea (0.87, 0.79 to 0.95).
PMID:11431296 · one of two readings recorded this
prevalence of diarrhoea
decreases
Zinc supplementation was significantly associated with a reduced prevalence of diarrhoea (0.87, 0.79 to 0.95)
PMID:11431296 · one of two readings recorded this
change in serum hematocrit after 5 years of supplementation
no effect, no significant differences in changes in serum hematocrit, copper or lipids
Not recorded as a finding: the intervention held more than the compound
After 5 y, no significant differences in changes in serum hematocrit, copper or lipids were found between participants assigned to formulations containing zinc and copper, and those assigned to formulations without zinc and copper.
PMID:11925463 · one of two readings recorded this
serum copper change
no effect
After 5 y, no significant differences in changes in serum hematocrit, copper or lipids were found between participants assigned to formulations containing zinc and copper
PMID:11925463 · one of two readings recorded this
serum hematocrit change
no effect
After 5 y, no significant differences in changes in serum hematocrit, copper or lipids were found between participants assigned to formulations containing zinc and copper
PMID:11925463 · one of two readings recorded this
serum hematocrit, copper and lipids, and serum zinc, after 5-year supplementation in AREDS participants
no effect, no significant differences in changes in hematocrit, copper or lipids
Not recorded as a finding: the intervention held more than the compound
After 5 y, no significant differences in changes in serum hematocrit, copper or lipids were found between participants assigned to formulations containing zinc and copper, and those assigned to formulations without zinc and copper.
PMID:11925463 · one of two readings recorded this
serum lipids change
no effect
After 5 y, no significant differences in changes in serum hematocrit, copper or lipids were found between participants assigned to formulations containing zinc and copper
PMID:11925463 · one of two readings recorded this
serum zinc, median increase at 5-y exam
increases, p = 0.001
the median increase in serum zinc levels for participants assigned to zinc formulations was 17% compared with a 2% increase for participants not assigned to zinc (P < 0.001)
PMID:11925463 · one of two readings recorded this
acute lower respiratory tract infection, proportion of children
no effect
(absolute risk reduction -0.2%, 95% confidence interval -3.9% to 3.6%)
PMID:12052800 · one of two readings recorded this
incidence of pneumonia, absolute risk reduction
decreases
(absolute risk reduction 2.5%, 95% confidence interval 0.4% to 4.6%)
PMID:12052800 · one of two readings recorded this
incidence of pneumonia and of acute lower respiratory tract infection during four months of follow up; plasma zinc concentration
decreases, absolute risk reduction 2.5%, 95% CI 0.4% to 4.6%
Not recorded as a finding: this platform holds no node for the endpoint
Zinc supplementation resulted in a lower incidence of pneumonia than placebo (absolute risk reduction 2.5%, 95% confidence interval 0.4% to 4.6%).
PMID:12052800 · one of two readings recorded this
incidence of pneumonia and of acute lower respiratory tract infection in children, weekly household surveillance with WHO breathing-rate criteria
decreases, absolute risk reduction 2.5%, 95% CI 0.4% to 4.6%
Not recorded as a finding: this platform holds no node for the endpoint
Zinc supplementation resulted in a lower incidence of pneumonia than placebo (absolute risk reduction 2.5%, 95% confidence interval 0.4% to 4.6%).
PMID:12052800 · one of two readings recorded this
incidence of pneumonia, generalised estimating equations
decreases
the odds ratio was 0.74, 95% confidence interval 0.56 to 0.99
PMID:12052800 · one of two readings recorded this
mean plasma zinc concentration
increases, p = 0.001
At four months the mean plasma zinc concentration was higher in the zinc group (19.8 (SD 10.1) v 9.3 (2.1) micromol/l, P<0.001)
PMID:12052800 · one of two readings recorded this
admission for acute lower respiratory infection
no effect
Admission for acute lower respiratory infection was lower in the intervention group, but this was not statistically significant (0.81, 0.53 to 1.23)
PMID:12424162 · one of two readings recorded this
admission to hospital for diarrhoea
decreases
Admission to hospital of children with diarrhoea was lower in the intervention group than in the comparison group (0.76, 0.59 to 0.98)
PMID:12424162 · one of two readings recorded this
duration of diarrhoea episode
decreases
shorter duration (hazard ratio 0.76, 95% confidence interval 0.65 to 0.90)
PMID:12424162 · one of two readings recorded this
duration of episode of diarrhoea in children given zinc 20 mg/day for 14 days, cluster randomised; also incidence of diarrhoea and acute lower respiratory infections, hospital admission, child mortality
decreases, shorter duration, hazard ratio 0.76, 95% CI 0.65 to 0.90
Not recorded as a finding: the supporting sentence never names the compound
They had a shorter duration (hazard ratio 0.76, 95% confidence interval 0.65 to 0.90) and lower incidence of diarrhoea (rate ratio 0.85, 0.76 to 0.96) than children in the comparison group.
PMID:12424162 · one of two readings recorded this
incidence of diarrhoea
decreases
lower incidence of diarrhoea (rate ratio 0.85, 0.76 to 0.96)
PMID:12424162 · one of two readings recorded this
non-injury child mortality
decreases, rate ratio 0.49, 0.25 to 0.94
Not recorded as a finding: Non-injury deaths are not all-cause mortality; the all-cause mortality node requires death from any cause and a stated horizon.
The rate of non-injury deaths in the intervention clusters was considerably lower (0.49, 0.25 to 0.94).
PMID:12424162 · one of two readings recorded this
non-injury child mortality
decreases
The rate of non-injury deaths in the intervention clusters was considerably lower (0.49, 0.25 to 0.94)
PMID:12424162 · one of two readings recorded this
Fecal anti-CTB IgA response
increases, p = 0.084
while the median fecal anti-CTB IgA response after two doses was estimated to be fourfold higher (P = 0.084) in the zinc-supplemented vaccinees
PMID:12819076 · one of two readings recorded this
serum anti-CTB IgA and IgG responses, serum vibriocidal responses and fecal anti-CTB IgA response to oral cholera vaccine
decreases, 13-fold lower median serum anti-CTB IgA and IgG response
Not recorded as a finding: this platform holds no node for the endpoint
The median serum anti-CTB immunoglobulin A (IgA) and IgG responses from day 0 to day 30, i.e. after two vaccine doses, were 13-fold lower (P value for identical distribution, <0.005) in the zinc-supplemented compared to the nonsupplemented vaccinees.
PMID:12819076 · both readings recorded this
Serum anti-CTB IgA response
decreases, p = 0.005
The median serum anti-CTB immunoglobulin A (IgA) and IgG responses from day 0 to day 30, i.e. after two vaccine doses, were 13-fold lower (P value for identical distribution, <0.005) in the zinc-supplemented compared to the nonsupplemented vaccinees
PMID:12819076 · one of two readings recorded this
Serum anti-CTB IgG response
decreases, p = 0.005
The median serum anti-CTB immunoglobulin A (IgA) and IgG responses from day 0 to day 30, i.e. after two vaccine doses, were 13-fold lower (P value for identical distribution, <0.005) in the zinc-supplemented compared to the nonsupplemented vaccinees
PMID:12819076 · one of two readings recorded this
Serum vibriocidal response
increases, p = 0.033
The median serum vibriocidal responses from baseline to after one (day 0 to day 17) and two (day 0 to day 30) vaccine doses were at least sixfold (P = 0.033) and fourfold (P = 0.091) higher
PMID:12819076 · one of two readings recorded this
Serum vibriocidal response
increases, p = 0.091
The median serum vibriocidal responses from baseline to after one (day 0 to day 17) and two (day 0 to day 30) vaccine doses were at least sixfold (P = 0.033) and fourfold (P = 0.091) higher
PMID:12819076 · one of two readings recorded this
Parent ADHD Rating Scale, baseline between-group difference
no effect, p = 0.86
There were no significant differences between two groups at day 0 (baseline) on the Parent ADHD Rating Scale (P = 0.86)
PMID:15070418 · one of two readings recorded this
Parent ADHD Rating Scale, between-group difference at endpoint
decreases, p = 0.001
The differences between the two treatments were significant at the endpoint (P = 0.0009 & P = 0.001 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Parent ADHD Rating Scale, between-group difference at endpoint
decreases, p = 0.0009
The differences between the two treatments were significant at the endpoint (P = 0.0009 & P = 0.001 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Parent ADHD Rating Scale, group effect (between-subjects)
decreases, p = 0.045
The difference between the two treatments was significant as indicated by the effect of group, the between-subjects factor (F = 4.15, d.f. = 1, P = 0.048 & F = 4.27, d.f. = 1, P = 0.045 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Parent ADHD Rating Scale, group effect (between-subjects)
decreases, p = 0.048
The difference between the two treatments was significant as indicated by the effect of group, the between-subjects factor (F = 4.15, d.f. = 1, P = 0.048 & F = 4.27, d.f. = 1, P = 0.045 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Parent ADHD Rating Scale, groups-by-time interaction
modulates
The behavior of the two treatment groups was not homogeneous across the time (groups-by-time interaction, P < 0.000)
PMID:15070418 · one of two readings recorded this
Parent ADHD Rating Scale, reduction at week 6 versus baseline (both groups)
decreases, p = 0.0001
A significant difference was observed on the reduction of scores of the Parent ADHD Rating Scale at week 6 compared to baseline in the two groups (P = 0.0003 & P = 0.0001 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Parent ADHD Rating Scale, reduction at week 6 versus baseline (both groups)
decreases, p = 0.0003
A significant difference was observed on the reduction of scores of the Parent ADHD Rating Scale at week 6 compared to baseline in the two groups (P = 0.0003 & P = 0.0001 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Parent and Teacher ADHD Rating Scale scores over 6 weeks, methylphenidate plus zinc sulfate versus methylphenidate plus placebo
group effect F = 4.15, d.f. = 1, P = 0.048 (Parent scale, observed cases), p = 0.048
Not recorded as a finding: this platform holds no node for the endpoint
The difference between the two treatments was significant as indicated by the effect of group, the between-subjects factor (F = 4.15, d.f. = 1, P = 0.048 & F = 4.27, d.f. = 1, P = 0.045 for OC and LOCF analyses respectively).
PMID:15070418 · one of two readings recorded this
Parent and Teacher ADHD Rating Scale scores, zinc sulfate plus methylphenidate versus placebo plus methylphenidate over 6 weeks
p = 0.048
Not recorded as a finding: this platform holds no node for the endpoint
The difference between the two treatments was significant as indicated by the effect of group, the between-subjects factor (F = 4.15, d.f. = 1, P = 0.048 & F = 4.27, d.f. = 1, P = 0.045 for OC and LOCF analyses respectively).
PMID:15070418 · one of two readings recorded this
Side effect: abdominal pain, between-group comparison
no effect, p = 0.31
Abdominal Pain | 8 | 4 | 0.31
PMID:15070418 · one of two readings recorded this
Side effect: metallic taste, between-group comparison
increases, p = 0.0001
Metallic taste | 13 | 0 | 0.0001
PMID:15070418 · one of two readings recorded this
Side effect: nausea, between-group comparison
no effect, p = 0.08
Nausea | 9 | 3 | 0.08
PMID:15070418 · one of two readings recorded this
Teacher ADHD Rating Scale, baseline between-group difference
no effect, p = 0.85
No significant differences were observed at baseline on the Teacher ADHD Rating Scale (P = 0.85)
PMID:15070418 · one of two readings recorded this
Teacher ADHD Rating Scale, between-group difference at endpoint
decreases, p = 0.001
The differences between the two treatments were significant at the endpoint (P = 0.0009 & P = 0.001 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Teacher ADHD Rating Scale, between-group difference at endpoint
decreases, p = 0.0009
The differences between the two treatments were significant at the endpoint (P = 0.0009 & P = 0.001 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Teacher ADHD Rating Scale, group effect (between-subjects)
decreases, p = 0.038
The difference between the two treatments was significant as indicated by the effect of the group, the between-subjects factor (F = 4.50, d.f. = 1, P = 0.04 & F = 4.58, d.f. = 1, P = 0.038 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Teacher ADHD Rating Scale, group effect (between-subjects)
decreases, p = 0.04
The difference between the two treatments was significant as indicated by the effect of the group, the between-subjects factor (F = 4.50, d.f. = 1, P = 0.04 & F = 4.58, d.f. = 1, P = 0.038 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Teacher ADHD Rating Scale, groups-by-time interaction
modulates
The behavior of the two treatment groups was not homogeneous across the time (groups-by-time interaction; P < 0.000)
PMID:15070418 · one of two readings recorded this
Teacher ADHD Rating Scale, reduction at week 6 versus baseline (both groups)
decreases, p = 0.0005
A significant difference was observed on the reduction of scores of the Teacher ADHD Rating Scale at week 6 compared to baseline in the two groups (P= 0.0004 & P = 0.0005 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Teacher ADHD Rating Scale, reduction at week 6 versus baseline (both groups)
decreases, p = 0.0004
A significant difference was observed on the reduction of scores of the Teacher ADHD Rating Scale at week 6 compared to baseline in the two groups (P= 0.0004 & P = 0.0005 for OC and LOCF analyses respectively)
PMID:15070418 · one of two readings recorded this
Development and behavior scores by birth weight
increases
Heavier birth weight infants had better scores on all measures of development and behavior at 6 months
PMID:15121945 · one of two readings recorded this
infant development and behavior at 6 and 10 months, Bayley Scales of Infant Development II
no effect, no direct effects of zinc supplementation
Not recorded as a finding: this platform holds no node for the endpoint
There were no direct effects of zinc supplementation on the infants' development or behavior at either 6 or 10 months.
PMID:15121945 · one of two readings recorded this
Infant development and behavior (Bayley Scales of Infant Development II)
no effect
There were no direct effects of zinc supplementation on the infants' development or behavior at either 6 or 10 months
PMID:15121945 · one of two readings recorded this
Infant development and behavior (Bayley Scales of Infant Development II)
no effect
There were no direct effects of zinc supplementation on the infants' development or behavior at either 6 or 10 months
PMID:15121945 · one of two readings recorded this
infant mental and motor development and behavior at 6 and 10 months, Bayley Scales of Infant Development II
no effect, no direct effects of zinc supplementation on development or behavior
Not recorded as a finding: this platform holds no node for the endpoint
There were no direct effects of zinc supplementation on the infants' development or behavior at either 6 or 10 months.
PMID:15121945 · one of two readings recorded this
Infant temperament by birth weight
no effect
in the control group, birth weight was not associated with temperament
PMID:15121945 · one of two readings recorded this
Infant temperament difficulty by birth weight
increases
In a subgroup analysis among the zinc-supplemented infants, lower birth weight infants were perceived to be more temperamentally difficult than higher weight infants
PMID:15121945 · one of two readings recorded this
Mental development and orientation/engagement by socioeconomic status
increases
Infants who were from families of higher socioeconomic status (indexed by parental education, house size, and home ownership) had higher scores on mental development
PMID:15121945 · one of two readings recorded this
Mental development, emotional regulation and weight gain by sex
increases
Boys had better weight gain and higher scores on mental development and emotional regulation than girls
PMID:15121945 · one of two readings recorded this
All-cause mortality, advanced AMD vs few or no drusen
increases
participants with advanced age-related macular degeneration (AMD) compared with participants with few, if any, drusen had increased mortality (relative risk [RR], 1.41; 95% confidence interval [CI], 1.08-1.86)
PMID:15136320 · one of two readings recorded this
All-cause mortality, cataract surgery
increases
cataract surgery (RR, 1.55; 95% CI, 1.18-2.05)
PMID:15136320 · one of two readings recorded this
All-cause mortality, nuclear opacity
increases
Nuclear opacity (RR, 1.40; 95% CI, 1.12-1.75)
PMID:15136320 · one of two readings recorded this
All-cause mortality, overall
n = 4753
During median follow-up of 6.5 years, 534 (11%) of 4753 AREDS participants died
PMID:15136320 · one of two readings recorded this
All-cause mortality, randomization to zinc vs no zinc
decreases
Participants randomly assigned to receive zinc had lower mortality than those not taking zinc (RR, 0.73; 95% CI, 0.61-0.89)
PMID:15136320 · one of two readings recorded this
All-cause mortality, visual acuity worse than 20/40 in 1 eye
increases
visual acuity worse than 20/40 in 1 eye had increased mortality (RR, 1.36; 95% CI, 1.12-1.65)
PMID:15136320 · one of two readings recorded this
correlation of total daily dose of positively charged zinc species with reduction in mean duration of common cold
decreases, p = 0.02
Statistically significant correlation was shown between total daily dosages of positively charged zinc species and reductions in median (p = 0.005) and mean duration (p < 0.02) of common colds in these trials
PMID:15499830 · one of two readings recorded this
correlation of total daily dose of positively charged zinc species with reduction in median duration of common cold
decreases, p = 0.005
Statistically significant correlation was shown between total daily dosages of positively charged zinc species and reductions in median (p = 0.005) and mean duration (p < 0.02) of common colds in these trials
PMID:15499830 · one of two readings recorded this
duration of common cold in 1984 trial
decreases
Common colds were shortened by 7 days in a 1984 clinical trial using zinc gluconate throat lozenges each 2 h
PMID:15499830 · one of two readings recorded this
duration of common colds (median and mean), correlated across 11 placebo-controlled zinc lozenge trials with total daily dose of positively charged zinc species
decreases, correlation between daily dose of positively charged zinc species and reduction in median cold duration, p = 0.005
Not recorded as a finding: this platform holds no node for the endpoint
Statistically significant correlation was shown between total daily dosages of positively charged zinc species and reductions in median (p = 0.005) and mean duration (p < 0.02) of common colds in these trials.
PMID:15499830 · one of two readings recorded this
duration of common colds (median and mean), correlated with total daily dosage of positively charged zinc species in lozenge trials
decreases, correlation between daily positively charged zinc dose and reduction in median (p = 0.005) and mean duration (p < 0.02) of colds, p = 0.005
Not recorded as a finding: this platform holds no node for the endpoint
Statistically significant correlation was shown between total daily dosages of positively charged zinc species and reductions in median (p = 0.005) and mean duration (p < 0.02) of common colds in these trials.
PMID:15499830 · one of two readings recorded this
Birth weight of newborns
no effect, p = 0.57
No significant difference was found in the birth weights between the cases supplemented with 20 mg elemental zinc and controls receiving oral placebos (p=0.57)
PMID:15724045 · one of two readings recorded this
expression of zinc transporters SLC30A1, SLC30A4, SLC30A5, SLC39A1, SLC39A4 and metallothionein in ileal biopsies, RT-PCR and immunoblotting
decreases, SLC30A1 mRNA 1.4-fold lower
Not recorded as a finding: this platform holds no node for the endpoint
The zinc supplement reduced SLC30A1 mRNA (1.4-fold) together with SLC30A1, SLC30A5, and SLC39A4 protein (1.8-fold, 3.7-fold, and to undetectable levels, respectively) in ileal mucosa and increased metallothionein mRNA (1.7-fold).
PMID:15753530 · one of two readings recorded this
Metallothionein mRNA expression in ileal biopsies
increases
increased metallothionein mRNA (1.7-fold)
PMID:15753530 · one of two readings recorded this
SLC30A1 mRNA and protein in Caco-2 cells
decreases
SLC30A1, SLC30A5, and SLC39A4 mRNA and protein were reduced in Caco-2 cells cultured at 200 muM compared with 100 muM zinc
PMID:15753530 · one of two readings recorded this
SLC30A1 mRNA expression in ileal biopsies
decreases
The zinc supplement reduced SLC30A1 mRNA (1.4-fold)
PMID:15753530 · one of two readings recorded this
SLC30A1 protein expression in ileal mucosa
decreases
SLC30A1, SLC30A5, and SLC39A4 protein (1.8-fold, 3.7-fold, and to undetectable levels, respectively)
PMID:15753530 · one of two readings recorded this
SLC30A4 and SLC39A1 mRNA expression in ileal biopsies
no effect
The supplement had no effect on expression of SLC30A4 or SLC39A1 mRNA
PMID:15753530 · one of two readings recorded this
SLC30A5 mRNA and protein in Caco-2 cells
decreases
SLC30A1, SLC30A5, and SLC39A4 mRNA and protein were reduced in Caco-2 cells cultured at 200 muM compared with 100 muM zinc
PMID:15753530 · one of two readings recorded this
SLC30A5 protein expression in ileal mucosa
decreases
SLC30A1, SLC30A5, and SLC39A4 protein (1.8-fold, 3.7-fold, and to undetectable levels, respectively)
PMID:15753530 · one of two readings recorded this
SLC39A4 mRNA and protein in Caco-2 cells
decreases
SLC30A1, SLC30A5, and SLC39A4 mRNA and protein were reduced in Caco-2 cells cultured at 200 muM compared with 100 muM zinc
PMID:15753530 · one of two readings recorded this
SLC39A4 protein expression in ileal mucosa
decreases
SLC30A1, SLC30A5, and SLC39A4 protein (1.8-fold, 3.7-fold, and to undetectable levels, respectively)
PMID:15753530 · one of two readings recorded this
diarrhoea severity
no effect, p = 0.05, n = 280
There was no significant difference in diarrhoea severity by treatment group (p>0.05)
PMID:16354711 · one of two readings recorded this
duration of diarrhoea after starting supplementation, zinc sulfate 15-30 mg elemental zinc daily for 14 days versus open-label control, children aged 6-60 months with acute diarrhoea
no effect, no significant difference in diarrhoea duration by treatment group
Not recorded as a finding: the supporting sentence never names the compound
There was no significant difference in diarrhoea duration by treatment group (p>0.05).
PMID:16354711 · one of two readings recorded this
duration of diarrhoea after starting supplementation, zinc sulfate 15-30 mg elemental zinc daily for 14 days versus open-label untreated control
no effect
Not recorded as a finding: the supporting sentence never names the compound
There was no significant difference in diarrhoea duration by treatment group (p>0.05).
PMID:16354711 · one of two readings recorded this
duration of diarrhoea after starting supplementation
no effect, n = 280
The mean duration of diarrhoea after starting supplementation was 3.02+/-2 days in the zinc group and 3.67+/-3.2 days in the control group
PMID:16354711 · one of two readings recorded this
incidence and prevalence of diarrhoea
no effect, n = 280
No significant effect was found on the incidence and prevalence of diarrhoea in the zinc compared with the control group
PMID:16354711 · one of two readings recorded this
number of stools
no effect, n = 280
The number of stools after starting supplementation was 5.8+/-3.7 and 5.1+/-3.9 on day 1, 2.9+/-1.6 and 3.0+/-2.2 on day 2, and 1.8+/-1.1 and 1.6+/-0.9 on day 3 in the zinc and control groups, respectively
PMID:16354711 · one of two readings recorded this
number of stools
no effect, n = 280
The number of stools after starting supplementation was 5.8+/-3.7 and 5.1+/-3.9 on day 1, 2.9+/-1.6 and 3.0+/-2.2 on day 2, and 1.8+/-1.1 and 1.6+/-0.9 on day 3 in the zinc and control groups, respectively
PMID:16354711 · one of two readings recorded this
number of stools
no effect, n = 280
The number of stools after starting supplementation was 5.8+/-3.7 and 5.1+/-3.9 on day 1, 2.9+/-1.6 and 3.0+/-2.2 on day 2, and 1.8+/-1.1 and 1.6+/-0.9 on day 3 in the zinc and control groups, respectively
PMID:16354711 · one of two readings recorded this
plasma zinc level at day 14
increases
Supplemented children had significantly improved plasma zinc levels by day 14 of therapy
PMID:16354711 · one of two readings recorded this
zinc deficiency prevalence
no effect
Zinc deficiency was observed in 2.6% of the treatment and 3.3% of the control group
PMID:16354711 · one of two readings recorded this
sustained biochemical response (normal aminotransferase 6 mo after treatment)
no effect
Sustained biochemical response, defined as a normal aminotransferase level at the end of the 6-mo post-treatment observation, was 68% and 69%
PMID:16521225 · one of two readings recorded this
sustained virological response (undetectable HCV-RNA 6 mo after treatment)
no effect
sustained virological response, defined as undetectable HCV-RNA at the end of the 6-mo post-treatment observation, was 54% and 67% for regimens A and B, respectively
PMID:16521225 · one of two readings recorded this
sustained virological response, undetectable HCV-RNA 6 months after treatment, consensus interferon with or without polaprezinc
did not enhance the effect of CIFN
Not recorded as a finding: subject_absent
CIFN treatment combined with zinc did not enhance the effect of CIFN as shown by biochemical, virological criteria.
PMID:16521225 · one of two readings recorded this
gastrointestinal side effects
decreases, p = 0.019, n = 102
gastrointestinal symptoms, which were less in the triple therapy group (P=0.019)
PMID:16534882 · one of two readings recorded this
sustained virological response (negative HCV-RNA 6 mo after treatment)
no effect, n = 102
SVR was observed in 33.3% of the triple therapy group and 33.3% of the dual therapy group
PMID:16534882 · one of two readings recorded this
sustained virological response, negative serum HCV-RNA 6 months after 24 weeks of peginterferon plus ribavirin with or without polaprezinc (zinc-carnosine) 150 mg/d; interferon and ribavirin in both arms
33.3% vs 33.3%
Not recorded as a finding: this platform holds no node for the endpoint
SVR was observed in 33.3% of the triple therapy group and 33.3% of the dual therapy group.
PMID:16534882 · one of two readings recorded this
sustained virological response, negative serum HCV-RNA 6 months after treatment, interferon plus ribavirin with or without polaprezinc
no effect, SVR 33.3% in both triple and dual therapy groups
Not recorded as a finding: subject_absent
SVR was observed in 33.3% of the triple therapy group and 33.3% of the dual therapy group.
PMID:16534882 · one of two readings recorded this
longitudinal prevalence of diarrhoea, percentage of days a child had diarrhoea out of days observed
decreases, 15% (SD 10%) child-days versus 26% (SD 20%) in placebo
Not recorded as a finding: the intervention held more than the compound
Mean longitudinal prevalence of diarrhoea in the micronutrient-zinc group was 15% (SD = 10%) child-days compared to 26% (SD = 20%) child-days in the placebo group and 26% (SD = 19%) child-days in the micronutrient-zinc-LAB group.
PMID:16556612 · one of two readings recorded this
longitudinal prevalence of diarrhoea, percentage of observed child-days with diarrhoea over two months
decreases
Not recorded as a finding: the intervention held more than the compound
The daily provision of micronutrients (including zinc) reduces the longitudinal prevalence of diarrhoea and thus may also reduce diarrhoea related mortality in young children; heat inactivated LAB has negative effects in these children.
PMID:16556612 · one of two readings recorded this
longitudinal prevalence of diarrhoea
no effect, n = 75
26% (SD = 19%) child-days in the micronutrient-zinc-LAB group
PMID:16556612 · one of two readings recorded this
longitudinal prevalence of diarrhoea
decreases, n = 75
Mean longitudinal prevalence of diarrhoea in the micronutrient-zinc group was 15% (SD = 10%) child-days compared to 26% (SD = 20%) child-days in the placebo group
PMID:16556612 · one of two readings recorded this
cell migration
increases, p = 0.01
causing an approximate threefold increase in migration and proliferation (both p<0.01)
PMID:16777920 · one of two readings recorded this
cell proliferation
increases, p = 0.01
causing an approximate threefold increase in migration and proliferation (both p<0.01)
PMID:16777920 · one of two readings recorded this
gastric injury
decreases, p = 0.01
Oral ZnC decreased gastric (75% reduction at 5 mg/ml) and small-intestinal injury (50% reduction in villus shortening at 40 mg/ml; both p<0.01)
PMID:16777920 · one of two readings recorded this
gut permeability (lactulose:rhamnose ratio), before vs after indomethacin
increases, p = 0.01
lactulose:rhamnose ratios were (mean (standard error of mean)) 0.35 (0.035) before indomethacin treatment and 0.88 (0.11) after 5 days of indomethacin treatment (p<0.01)
PMID:16777920 · one of two readings recorded this
gut permeability with ZnC coadministration
no effect
whereas no significant increase in permeability was seen when ZnC was coadministered
PMID:16777920 · one of two readings recorded this
small-intestinal injury (villus shortening)
decreases, p = 0.01
Oral ZnC decreased gastric (75% reduction at 5 mg/ml) and small-intestinal injury (50% reduction in villus shortening at 40 mg/ml; both p<0.01)
PMID:16777920 · one of two readings recorded this
days of antibiotherapy
decreases, p = 0.021
The number of days of antibiotherapy was significantly lower in the supplemented group (p = 0.021)
PMID:17081282 · one of two readings recorded this
length of ICU stay per percentage of burned body surface area, and nosocomial pneumonia episodes per patient, in severely burned patients
decreases, median 0.63 versus 0.99 days per percentage of burned BSA, p = 0.002
Not recorded as a finding: the intervention held more than the compound
The length of stay was significantly reduced in the supplemented patients, with a median of 0.63 days versus 0.99 days per percentage of burned BSA (p = 0.002).
PMID:17081282 · one of two readings recorded this
length of ICU stay per percentage of burned BSA
decreases, p = 0.002
The length of stay was significantly reduced in the supplemented patients, with a median of 0.63 days versus 0.99 days per percentage of burned BSA (p = 0.002)
PMID:17081282 · one of two readings recorded this
mortality
no effect
Among clinical endpoints (Table 3), mortality and requirement for mechanical ventilation did not differ significantly
PMID:17081282 · one of two readings recorded this
nosocomial pneumonia episodes per patient
decreases, p = 0.001
a mean of 0.33 episodes per patient in the supplemented group versus 1.55 episodes per patient in the placebo group, p < 0.001
PMID:17081282 · one of two readings recorded this
number of nosocomial pneumonia episodes per patient within 30 days (SIRS plus new infiltrate, hypoxaemia, purulent secretions, culture-confirmed)
decreases, 0.33 vs 1.55 episodes per patient
Not recorded as a finding: the intervention held more than the compound
However, the number of infectious complications was lower in the supplemented group, this decrease being due to a lower number of nosocomial pneumonias (a mean of 0.33 episodes per patient in the supplemented group versus 1.55 episodes per patient in the placebo group, p < 0.001; Table 4).
PMID:17081282 · one of two readings recorded this
plasma zinc concentration
increases, p = 0.02
Plasma selenium and GSHPx concentrations were normalised and significantly higher in the supplemented patients after day five, and plasma zinc was higher from day ten, as were the skin selenium and zinc concentrations on day 20 (p < 0.02)
PMID:17081282 · one of two readings recorded this
recurrent pneumonia
decreases
Finally, in the supplemented group, significantly fewer patients experienced recurrent pneumonia
PMID:17081282 · one of two readings recorded this
requirement for mechanical ventilation
no effect
Among clinical endpoints (Table 3), mortality and requirement for mechanical ventilation did not differ significantly
PMID:17081282 · one of two readings recorded this
skin zinc concentration
increases, p = 0.02
Plasma selenium and GSHPx concentrations were normalised and significantly higher in the supplemented patients after day five, and plasma zinc was higher from day ten, as were the skin selenium and zinc concentrations on day 20 (p < 0.02)
PMID:17081282 · one of two readings recorded this
ventilator-associated pneumonia frequency
decreases, p = 0.001
VAP was also significantly less frequent (p = 0.001)
PMID:17081282 · one of two readings recorded this
wound, bloodstream and urinary infections
no effect
Wound, bloodstream, and urinary infections did not differ between the groups
PMID:17081282 · one of two readings recorded this
liver zinc pool (Qb)
unclear, p = 0.12
the liver zinc pool (Qb; from 10.2 (0.6) to 11.4 (0.8) mg; p = 0.12)
PMID:17138634 · one of two readings recorded this
plasma zinc concentration and short-term kinetics (Qa rapidly exchangeable plasma pool, Qb liver pool) after 70Zn infusion, maximal exercise versus rest
decreases, mean nadir 13.9% (SD 4.1%) at 70 min after exercise
Not recorded as a finding: the compound is what was measured, not what was given
Plasma zinc concentrations decreased (p<0.05) after exercise, with a mean (SD) nadir of 13.9% (4.1%) observed at 70 min after exercise.
PMID:17138634 · one of two readings recorded this
plasma zinc concentration and the sizes of the rapidly exchangeable plasma zinc pool and liver zinc pool after 70Zn tracer infusion, exhaustive exercise versus rest
decreases, nadir 13.9% (4.1%) at 70 min
Not recorded as a finding: the compound is what was measured, not what was given
Plasma zinc concentrations decreased (p<0.05) after exercise, with a mean (SD) nadir of 13.9% (4.1%) observed at 70 min after exercise.
PMID:17138634 · one of two readings recorded this
plasma zinc concentration nadir
decreases, p = 0.05
Plasma zinc concentrations decreased (p<0.05) after exercise, with a mean (SD) nadir of 13.9% (4.1%) observed at 70 min after exercise
PMID:17138634 · one of two readings recorded this
rapidly exchangeable plasma zinc pool (Qa)
increases, p = 0.05
There were increases in the size of the rapidly exchangeable plasma zinc pool (Qa; from 3.1 (0.2) to 3.6 (0.2) mg; p<0.05)
PMID:17138634 · one of two readings recorded this
plasma cystine (CySS) and plasma thiol/disulfide redox status (GSH, GSSG, Cys, CySS) at 20 and 80 months, zinc 80 mg as zinc oxide with 2 mg cupric oxide versus no zinc
decreases, CySS 54.9 vs 64.1 microM at the second blood draw, p = 0.01
Not recorded as a finding: this platform holds no node for the endpoint
Although zinc supplementation had no apparent effect on plasma thiol/disulfide redox status at the first blood draw, the group of patients receiving zinc supplementation at the second blood draw had significantly less CySS compared with those not receiving zinc (54.9 vs 64.1 microM; P = .01).
PMID:17157802 · one of two readings recorded this
plasma cystine (CySS) at second blood draw
decreases, p = 0.01
the group of patients receiving zinc supplementation at the second blood draw had significantly less CySS compared with those not receiving zinc (54.9 vs 64.1 microM; P = .01)
PMID:17157802 · one of two readings recorded this
plasma cystine (CySS), cysteine, glutathione (GSH) and oxidized glutathione (GSSG) and their thiol/disulfide redox potentials at 20 and 80 months, zinc oxide 80 mg with cupric oxide 2 mg versus no zinc (factorial AREDS ancillary)
decreases, 54.9 vs 64.1 microM, p = 0.01
Not recorded as a finding: this platform holds no node for the endpoint
Although zinc supplementation had no apparent effect on plasma thiol/disulfide redox status at the first blood draw, the group of patients receiving zinc supplementation at the second blood draw had significantly less CySS compared with those not receiving zinc (54.9 vs 64.1 microM; P = .01).
PMID:17157802 · one of two readings recorded this
plasma thiol/disulfide redox status (GSH, GSSG, Cys, CySS) at first blood draw
no effect
Although zinc supplementation had no apparent effect on plasma thiol/disulfide redox status at the first blood draw
PMID:17157802 · one of two readings recorded this
admitted to hospital for any reason during study
no effect, p = 0.141, n = 335
Admitted to hospital for any reason during study | 4 (3.5) | 10 (8.8) | 11 (10.1) | 0.141
PMID:17593956 · one of two readings recorded this
children ever admitted to hospital with diarrhea
no effect, p = 0.195, n = 335
Children ever admitted to hospital with diarrhea: n (%) | 2 (1.8) | 4 (3.5) | 7 (6.4) | 0.195
PMID:17593956 · one of two readings recorded this
children who ever had blood in stools
no effect, p = 0.939, n = 335
Children who ever had blood in stools, n (%) | 26 (23.0) | 26 (23.0) | 27 (24.8) | 0.939
PMID:17593956 · one of two readings recorded this
children who ever had diarrhea episodes of 14 days or more
no effect, p = 0.168, n = 335
Children who ever had diarrhea episodes ≥14 days, n (%) | 5 (4.4) | 11 (9.7) | 12 (11.0) | 0.168
PMID:17593956 · one of two readings recorded this
children who ever had diarrhea
no effect, p = 0.484, n = 335
Children who ever had diarrhea, n (%) | 98 (86.7) | 92 (81.4) | 89 (81.7) | 0.484
PMID:17593956 · one of two readings recorded this
children who ever had pneumonia by maternal report
no effect, p = 0.366, n = 335
Children who ever had pneumonia by maternal report, n (%) | 23 (20.4) | 30 (26.5) | 21 (19.3) | 0.366
PMID:17593956 · one of two readings recorded this
children who ever had pneumonia confirmed by respiratory rate
no effect, p = 0.261, n = 335
Children who ever had pneumonia confirmed by respiratory rate, n (%) | 17 (15.0) | 20 (17.7) | 11 (10.1) | 0.261
PMID:17593956 · one of two readings recorded this
children who ever visited clinic for diarrhea
no effect, p = 0.223, n = 335
Children who ever visited clinic for diarrhea, n (%) | 61 (54.0) | 48 (42.5) | 52 (47.7) | 0.223
PMID:17593956 · one of two readings recorded this
children with >5 stools/day on worst day of diarrhea episode
no effect, p = 0.55, n = 335
Children with >5 stools/day on worst day of diarrhea episode * | 40/98 (40.8) | 43/92 (46.7) | 43/89 (48.3) | 0.550
PMID:17593956 · one of two readings recorded this
diarrhea episodes per child
no effect, p = 0.917, n = 335
Diarrhea episodes per child | 2 (1–5) | 3 (1–4) | 2 (1–5) | 0.917
PMID:17593956 · one of two readings recorded this
died during study
no effect, p = 0.478, n = 335
Died during study, n (%) | 3 (2.7) | 6 (5.3) | 3 (2.8) | 0.478
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, three cohorts combined, vitamin A plus zinc versus multiple micronutrients
no effect, n = 335
0 days (−0.8, 0.6) | 0 days (−0.5, 0.8) | 0 days (−0.8, 0.7)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, three cohorts combined, vitamin A versus multiple micronutrients
no effect, n = 335
0 days (−0.8, 0.6) | 0 days (−0.5, 0.8) | 0 days (−0.8, 0.7)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, three cohorts combined, vitamin A versus vitamin A plus zinc
no effect, n = 335
0 days (−0.8, 0.6) | 0 days (−0.5, 0.8) | 0 days (−0.8, 0.7)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, vitamin A plus zinc versus multiple micronutrients
no effect, n = 20
Vitamin A plus zinc versus multiple micronutrients | 0.1 days (−8.3, 7.1) | 0 days (−0.9, 1.2) | 0 days (−1.1, 0.8)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, vitamin A plus zinc versus multiple micronutrients
no effect, n = 93
Vitamin A plus zinc versus multiple micronutrients | 0.1 days (−8.3, 7.1) | 0 days (−0.9, 1.2) | 0 days (−1.1, 0.8)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, vitamin A plus zinc versus multiple micronutrients
no effect, n = 109
Vitamin A plus zinc versus multiple micronutrients | 0.1 days (−8.3, 7.1) | 0 days (−0.9, 1.2) | 0 days (−1.1, 0.8)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, vitamin A versus multiple micronutrients
no effect, n = 19
Vitamin A versus multiple micronutrients | −1.9 days (−13.9, 2.8) | −0.2 days (−1.2, 0.7) | 0 days (−0.8, 1.1)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, vitamin A versus multiple micronutrients
no effect, n = 95
Vitamin A versus multiple micronutrients | −1.9 days (−13.9, 2.8) | −0.2 days (−1.2, 0.7) | 0 days (−0.8, 1.1)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, vitamin A versus multiple micronutrients
no effect, n = 108
Vitamin A versus multiple micronutrients | −1.9 days (−13.9, 2.8) | −0.2 days (−1.2, 0.7) | 0 days (−0.8, 1.1)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, vitamin A versus vitamin A+zinc
no effect, n = 28
Vitamin A versus vitamin A plus zinc | −2.6 days (−8.8, 2.5) | −0.2 days (−1.3, 0.7) | 0.2 days (−0.6, 1.2)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, vitamin A versus vitamin A+zinc
no effect, n = 142
Vitamin A versus vitamin A plus zinc | −2.6 days (−8.8, 2.5) | −0.2 days (−1.3, 0.7) | 0.2 days (−0.6, 1.2)
PMID:17593956 · one of two readings recorded this
difference in median percentage of days of diarrhea, vitamin A versus vitamin A+zinc
no effect, n = 165
Vitamin A versus vitamin A plus zinc | −2.6 days (−8.8, 2.5) | −0.2 days (−1.3, 0.7) | 0.2 days (−0.6, 1.2)
PMID:17593956 · one of two readings recorded this
duration of diarrhea episodes
no effect, p = 0.067, n = 335
Duration of diarrhea episodes, days | 3.0 (2.5–4.6) | 4.0 (2.7–5.0) | 4.0 (2.6–5.7) | 0.067
PMID:17593956 · one of two readings recorded this
percentage of days with diarrhea per child, caregiver-report home visit questionnaire, vitamin A plus zinc 10 mg versus vitamin A alone
no effect, no significant difference between treatment groups in any of the three cohorts
Not recorded as a finding: this platform holds no node for the endpoint
There was no significant difference between treatment groups in the primary outcome-percentage of days with diarrhea–in any of the three cohorts (Tables 2 and 3).
PMID:17593956 · one of two readings recorded this
percentage of days with diarrhea per child, caregiver-reported at weekly home visits, vitamin A plus zinc versus vitamin A alone
no effect
Not recorded as a finding: this platform holds no node for the endpoint
There was no significant difference between treatment groups in the primary outcome-percentage of days with diarrhea–in any of the three cohorts (Tables 2 and 3).
PMID:17593956 · one of two readings recorded this
percentage of days with diarrhea per child (primary), median (25th-75th range)
no effect, n = 335
Percentage of days with diarrhea per child | 3.4 (0.8–9.4) | 7.1 (2.4–12.3) | 5.9 (1.5–16.1) | 0.668 | 2.3 (0.7–4.0) | 2.5 (0.8–4.4) | 2.2 (0.8–5.5) | 0.852 | 2.4 (0.9–5.0) | 1.8 (0.5–5.1) | 2.7 (0.5–4.6) | 0.857
PMID:17593956 · one of two readings recorded this
percentage of days with diarrhea per child, three cohorts combined
no effect, p = 0.935, n = 335
Percentage of days with diarrhea per child | 2.3 (0.8–4.5) | 2.4 (0.7–5.5) | 2.5 (0.8–5.4) | 0.935
PMID:17593956 · one of two readings recorded this
percentage of weeks with upper respiratory illness signs per child
no effect, p = 0.695, n = 335
Percentage of weeks with upper respiratory illness signs per child | 15.4 (8.4–24.4) | 15.8 (8.0–26.1) | 15.7 (8.4–25.0) | 0.695
PMID:17593956 · one of two readings recorded this
children with at least one diarrhoea episode
decreases, n = 154
26 of the 78 children (33%) in the zinc group experienced at least one episode of diarrhoea compared to 33 of the placebo group (33/76; 43%)
PMID:17615905 · one of two readings recorded this
cumulative gain in body weight over 12 weeks, whole cohort and subgroups
no effect
Not recorded as a finding: body-weight-gain node is defined for animal feeding periods and this is a human child cohort; sentence is agentless about the compound
There was no significant difference in cumulative gain in body-weight between the zinc and the control group as a whole or in the subgroups.
PMID:17615905 · one of two readings recorded this
cumulative gain in body weight
no effect, n = 154
There was no significant difference in cumulative gain in body-weight between the zinc and the control group as a whole or in the subgroups
PMID:17615905 · one of two readings recorded this
cumulative gain in length, all children
no effect, p = 0.6, n = 154
cumulative gain in length was comparable between the zinc-supplemented and the control children when data from all patients were compared (35.7±12.9 mm vs 31.2±12.6, p=0.6
PMID:17615905 · one of two readings recorded this
cumulative gain in length over 12 weeks, underweight subgroup (weight-for-age <=70%)
increases, 30.2±10.0 vs 24.4±10.8 mm, 24% greater gain in underweight children, n = 68
Not recorded as a finding: no outcome node for linear growth; result is a subgroup only (whole-population gain comparable, p=0.6)
Hence, when the gain in length was compared among underweight children (weight-for-age, ≤70% of NCHS, n=68), a greater cumulative gain in length (24%) was observed in the zinc-supplemented group (30.2±10.0 vs 24.4±10.8, p<0.03) compared to the control group.
PMID:17615905 · one of two readings recorded this
cumulative gain in length, underweight children
increases, p = 0.03, n = 68
a greater cumulative gain in length (24%) was observed in the zinc-supplemented group (30.2±10.0 vs 24.4±10.8, p<0.03)
PMID:17615905 · one of two readings recorded this
diarrhoea episodes during 12-week follow-up
decreases, p = 0.05, n = 68
Diarrhoea (no. of episodes) | 0.53±0.10 | 0.86±0.14 | 0.05
PMID:17615905 · one of two readings recorded this
duration of diarrhoea during 12-week follow-up
decreases, p = 0.05, n = 68
Duration (days) of diarrhoea | 1.9±0.40 | 3.4±0.62 | 0.05
PMID:17615905 · one of two readings recorded this
duration of RTI during 12-week follow-up
no effect, p = 0.92, n = 68
Duration (days) of RTI Student's t-test | 12.4±1.64 | 12.0±1.72 | 0.92
PMID:17615905 · one of two readings recorded this
incidence and duration of respiratory tract infection during 12-week follow-up
no effect, not associated with incidence or duration of respiratory infections
Not recorded as a finding: no outcome node for respiratory tract infection incidence or duration
Zinc supplementation was not associated with the incidence or duration of respiratory infections during the follow-up period.
PMID:17615905 · one of two readings recorded this
incidence and duration of respiratory tract infections, caregiver recall
no effect
Not recorded as a finding: no outcome node for respiratory infection incidence or duration
Zinc supplementation was not associated with the incidence or duration of respiratory infections during the follow-up period.
PMID:17615905 · one of two readings recorded this
length velocity, underweight children, second to 10th week
increases, p = 0.03, n = 68
The accelerated length velocity of underweight subjects continued from the second week to 10th week of follow-up (p=0.03)
PMID:17615905 · one of two readings recorded this
mean diarrhoeal episodes, all children
decreases, p = 0.05, n = 154
The mean diarrhoeal episodes were significantly less in the zinc-supplemented children compared to the control children (0.53±0.10, vs 0.86±0.14, p<0.05)
PMID:17615905 · one of two readings recorded this
mean duration of subsequent diarrhoea episodes, all children
decreases, p = 0.05, n = 154
The mean duration of subsequent diarrhoea episodes in the zinc group was 44% shorter compared to that of the control group (1.9±0.40 vs 3.4±0.62 days, p<0.05)
PMID:17615905 · one of two readings recorded this
number of diarrhoea episodes per child over 12 weeks of follow-up, caregiver recall
decreases, 0.53±0.10 vs 0.86±0.14
Not recorded as a finding: no outcome node for diarrhoea episode count or incidence
The mean diarrhoeal episodes were significantly less in the zinc-supplemented children compared to the control children (0.53±0.10, vs 0.86±0.14, p<0.05) (Table 3).
PMID:17615905 · one of two readings recorded this
respiratory tract infection episodes during 12-week follow-up
no effect, p = 0.55, n = 68
RTI (no. of episodes) | 1.42±0.14 | 1.54±0.86 | 0.55
PMID:17615905 · one of two readings recorded this
all-cause child mortality
no effect
Overall, there was no significant difference in mortality between the zinc and placebo groups (table 3)
PMID:17920918 · one of two readings recorded this
cause-specific mortality
no effect
Mortality rates did not differ by treatment group for any cause
PMID:17920918 · one of two readings recorded this
incidence rates of diarrhoea, persistent diarrhoea, dysentery and acute lower respiratory illness, morbidity substudy
no effect, did not differ between zinc and placebo groups
Not recorded as a finding: incidence rate, not diarrhoea duration; no outcome node for diarrhoea incidence or respiratory illness incidence
The rates of diarrhoea, persistent diarrhoea, dysentery, and acute lower respiratory illness did not differ between the zinc and placebo groups (tables 5 and 6).
PMID:17920918 · one of two readings recorded this
mortality, effect modification by age
unclear, p = 0.12
There was evidence of effect modification by age (test for interaction, p=0·12)
PMID:17920918 · one of two readings recorded this
mortality, effect modification by birthweight
decreases, p = 0.06
infants born weighing under 2000 g showing a non-significant 44% reduction in mortality versus no effect for those over 2000 g (table 3; test for interaction, p=0·06)
PMID:17920918 · one of two readings recorded this
mortality in children 12 months or older
decreases
there was non-significant 20% lower mortality among children 12 months or older in the zinc group
PMID:17920918 · one of two readings recorded this
proportion of assigned days supplement taken
Supplements were taken on 76·8% of assigned days in the placebo group versus 72·9% of days for the zinc group
PMID:17920918 · one of two readings recorded this
proportion of children with serum zinc below 9·2 μmol/L after 12 months
decreases
the proportion of children with concentrations below 9·2 μmol/L was 32% lower (95% CI −62 % to 22%) in the zinc group than in the placebo group
PMID:17920918 · one of two readings recorded this
rates of diarrhoea, persistent diarrhoea, dysentery and acute lower respiratory illness, caregiver-reported weekly morbidity substudy
no effect
Not recorded as a finding: no outcome node for diarrhoea incidence/rates or respiratory illness incidence; diarrhoea-duration node is episode duration, not rate
The rates of diarrhoea, persistent diarrhoea, dysentery, and acute lower respiratory illness did not differ between the zinc and placebo groups (tables 5 and 6).
PMID:17920918 · one of two readings recorded this
rates of diarrhoea, persistent diarrhoea, dysentery and acute lower respiratory illness
no effect
The rates of diarrhoea, persistent diarrhoea, dysentery, and acute lower respiratory illness did not differ between the zinc and placebo groups (tables 5 and 6)
PMID:17920918 · one of two readings recorded this
refusal to continue participation
increases
refusal to continue participation was more common in the zinc group than in the placebo group (1598 [8%] vs 907 [5%]; exact difference 3·15%, 95% CI 2·69−3·61)
PMID:17920918 · one of two readings recorded this
serum copper concentration
no effect
There was no difference in serum copper concentrations, which suggests that zinc supplementation did not interfere with copper absorption (table 2)
PMID:17920918 · one of two readings recorded this
all-cause mortality
decreases, p = 0.049
Normal baseline serum zinc concentrations were associated with a reduction in all-cause mortality (P = 0.049)
PMID:17921398 · one of two readings recorded this
days of antibiotic use
decreases, p = 0.004
fewer (by almost 50%) new antibiotic prescriptions, a shorter duration of pneumonia, and fewer days of antibiotic use (3.9 d compared with 2.6 d) (P <or= 0.004 for all)
PMID:17921398 · one of two readings recorded this
incidence and duration of pneumonia, new antibiotic prescriptions, days of antibiotic use, pneumonia-associated and all-cause mortality, by baseline or final serum zinc concentration (low <70 microg/dL vs normal >=70 microg/dL)
decreases, p = 0.049
Not recorded as a finding: another reason, stated per paper
Normal baseline serum zinc concentrations were associated with a reduction in all-cause mortality (P = 0.049).
PMID:17921398 · one of two readings recorded this
pneumonia incidence and duration, new antibiotic prescriptions, days of antibiotic use in nursing home elderly
decreases, days of antibiotic use 3.9 d compared with 2.6 d
Not recorded as a finding: no outcome node for pneumonia incidence or antibiotic use; observational serum zinc gradient
Compared with subjects with low zinc concentrations, subjects with normal final serum zinc concentrations had a lower incidence of pneumonia, fewer (by almost 50%) new antibiotic prescriptions, a shorter duration of pneumonia, and fewer days of antibiotic use (3.9 d compared with 2.6 d) (P <or= 0.004 for all).
PMID:17921398 · one of two readings recorded this
duration of diarrhoea
decreases, p = 0.028
Zinc supplemented patients had 12% shorter duration of diarrhoea than control patients (64.1 v 72.8 h, P=0.028) and 11% less stool output (1.6 v 1.8 kg/day, P=0.039)
PMID:18184631 · one of two readings recorded this
proportion recovered by two days and by three days
increases, 49% v 32% by two days; 81% v 68% by three days, p = 0.032
Not recorded as a finding: no outcome node for proportion recovered by a fixed day
More patients in the zinc group than in the control group recovered by two days (49% v 32%, P=0.032) and by three days (81% v 68%, P=0.03).
PMID:18184631 · one of two readings recorded this
proportion recovered
increases, p = 0.032
More patients in the zinc group than in the control group recovered by two days (49% v 32%, P=0.032) and by three days (81% v 68%, P=0.03)
PMID:18184631 · one of two readings recorded this
proportion recovered
increases, p = 0.03
More patients in the zinc group than in the control group recovered by two days (49% v 32%, P=0.032) and by three days (81% v 68%, P=0.03)
PMID:18184631 · one of two readings recorded this
stool output, kg/day
decreases, 11% less stool output (1.6 v 1.8 kg/day), p = 0.039
Not recorded as a finding: no outcome node for stool output
Zinc supplemented patients had 12% shorter duration of diarrhoea than control patients (64.1 v 72.8 h, P=0.028) and 11% less stool output (1.6 v 1.8 kg/day, P=0.039).
PMID:18184631 · both readings recorded this
stool output
decreases, p = 0.039
Zinc supplemented patients had 12% shorter duration of diarrhoea than control patients (64.1 v 72.8 h, P=0.028) and 11% less stool output (1.6 v 1.8 kg/day, P=0.039)
PMID:18184631 · one of two readings recorded this
association of zinc-mediated TB and Candida skin-test augmentation
increases, p = 0.05, n = 50
Zinc-mediated TB and Candida skin-test augmentation were associated (R = 0.3, p = 0.05)
PMID:18214192 · one of two readings recorded this
Candida skin-test induration size
increases, p = 0.001, n = 50
the Candida skin-test reactions with zinc cream were an average of 23% larger than the contralateral skin-test reactions associated with placebo cream applied in a double-blind manner (p<0.001)
PMID:18214192 · one of two readings recorded this
control TB skin-test reaction diameter (placebo cream), lowest vs highest plasma zinc quartile
increases, p = 0.03
the quarter of the population with the lowest concentrations had, on average, control TB skin-test reactions that were 14 mm in diameter compared with 27 mm for the quarter of the population with the highest plasma zinc concentrations (p = 0.03)
PMID:18214192 · one of two readings recorded this
control TB skin-test reaction vs plasma zinc, univariate and multiple regression
increases, p = 0.03, n = 49
Plasma zinc (mg/L; n = 49) | 0.66 (0.17) 31% deficient (<0.6) | 0.3 | 0.04 | 0.3 | 0.03
PMID:18214192 · one of two readings recorded this
Sources cited
66 papers
- Subject
- Zn(2+)
- Findings
- 108
- Papers
- 66
Effects of zinc and probiotic co-supplementation on inflammation, gastrointestinal symptoms, quality of life, and mood in irritable bowel syndrome patients.record2026PMID:421620211 finding
Effects of Zinc Supplementation on Anthropometric Indices and Adipokines in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.record2026PMID:416179505 findings
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.record2026PMID:425943419 findings
Serum Manganese, Cobalt, Copper, Zinc, Selenium, and Iodine Levels, and the Incidence of Type 2 Diabetes: A Nested Case-control Study.record2026PMID:420009641 finding
Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver Cirrhosis.record2026PMID:421240801 finding
Zinc as a potential prophylactic adjuvant therapy for prolonged hospitalization: A systematic review and meta-analysis of an umbrella of randomized controlled trials.record2025PMID:394358771 finding
Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial.record2025PMID:410085751 finding
Effect of zinc supplementation in the management of type 2 diabetes: A grading of recommendations assessment, development, and evaluation-assessed, dose-response meta-analysis of randomized controlled trials.record2024PMID:371836972 findings
Effect of Zinc Supplementation on Lipid Profile and Body Composition in Patients with Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Dose-Response Meta-analysis.record2024PMID:382244026 findings
Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.record2024PMID:396835101 finding
Zinc supplementation for acute and persistent watery diarrhoea in children: A systematic review and meta-analysis.record2024PMID:396413381 finding
Effects of Zinc Supplementation on Inflammatory and Cognitive Parameters in Middle-Aged Women with Overweight or Obesity.record2023PMID:378924711 finding
Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate Cancer.record2023PMID:364532651 finding
The Effect of Zinc Supplementation on Lipid Profiles in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials.record2023PMID:376043072 findings
Association of selenium, zinc and copper concentrations during pregnancy with birth weight: A systematic review and meta-analysis.record2022PMID:348231021 finding
Effect of zinc supplementation on mortality in under 5-year children: a systematic review and meta-analysis of randomized clinical trials.record2022PMID:341202461 finding
Enteral Zinc Supplementation in Preterm or Low Birth Weight Infants: A Systematic Review and Meta-analysis.record2022PMID:359216751 finding
Zinc in depression: From development to treatment: A comparative/ dose response meta-analysis of observational studies and randomized controlled trials.record2022PMID:328299281 finding
Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study.record2022PMID:363269791 finding
Zinc supplementation and immune factors in adults: a systematic review and meta-analysis of randomized clinical trials.record2022PMID:333564672 findings
Clinical efficacy of zinc supplementation in improving antioxidant defense system: A comprehensive systematic review and time-response meta-analysis of controlled clinical trials.record2021PMID:341021852 findings
Effects of Dose and Duration of Zinc Interventions on Risk Factors for Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis.record2021PMID:327227901 finding
Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.record2021PMID:337106262 findings
Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study.record2021PMID:346634111 finding
Profiling inflammatory cytokines following zinc supplementation: a systematic review and meta-analysis of controlled trials.record2021PMID:334682792 findings
Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study.record2021PMID:342240551 finding
Serum Zinc Levels and Incidence of Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.record2021PMID:344125131 finding
Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation.record2021PMID:335972691 finding
Zinc supplementation for improving pregnancy and infant outcome.record2021PMID:337244461 finding
Zinc supplementation is associated with a reduction in serum markers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials.record2021PMID:333333943 findings
Clinical effectiveness of zinc supplementation on the biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.record2020PMID:328289103 findings
Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial.record2020PMID:323837481 finding
Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials.record2020PMID:314948084 findings
Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.record2020PMID:324512772 findings
Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis.record2020PMID:316110641 finding
Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients.record2020PMID:333754771 finding
The effect of zinc supplementation on blood pressure: a systematic review and dose-response meta-analysis of randomized-controlled trials.record2020PMID:320902942 findings
Efficacy of zinc supplementation for neonatal sepsis: a systematic review and meta-analysis.record2019PMID:291033462 findings
The Effect of Zinc Supplementation on Serum Leptin Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.record2019PMID:314088961 finding
Zinc Intake and Status and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.record2019PMID:310719301 finding
Effect of Zinc Supplementation on Growth Outcomes in Children under 5 Years of Age.record2018PMID:295583831 finding
Increased total iron and zinc intake and lower heme iron intake reduce the risk of esophageal cancer: A dose-response meta-analysis.record2018PMID:304422291 finding
The effect of zinc supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials.record2018PMID:300124971 finding
Dietary zinc and iron intake and risk of depression: A meta-analysis.record2017PMID:281890771 finding
Effect of Zinc Supplementation on Maintenance Hemodialysis Patients: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials.record2017PMID:294570232 findings
Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer.record2017PMID:284440842 findings
Effect of Zinc Intake on Growth in Infants: A Meta-analysis.record2016PMID:253655241 finding
Oral zinc for treating diarrhoea in children.record2016PMID:279960881 finding
The Effect of Low Dose Iron and Zinc Intake on Child Micronutrient Status and Development during the First 1000 Days of Life: A Systematic Review and Meta-Analysis.record2016PMID:279168732 findings
Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis.record2016PMID:269326831 finding
Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.record2015PMID:262652931 finding
Zinc supplementation for improving pregnancy and infant outcome.record2015PMID:259271011 finding
Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis.record2014PMID:241486073 findings
Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation.record2013PMID:236892631 finding
Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients.record2013PMID:232890095 findings
Oral zinc for treating diarrhoea in children.record2013PMID:234408011 finding
Oral zinc supplementation for the treatment of acute diarrhea in children: a systematic review and meta-analysis.record2013PMID:242846151 finding
Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans.record2013PMID:231378581 finding
Zinc for the common cold.record2013PMID:237757051 finding
Zinc supplementation for treating diarrhea in children: a systematic review and meta-analysis.record2013PMID:237646691 finding
Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis.record2011PMID:218105991 finding
Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age.record2011PMID:219757681 finding
Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial.record2008PMID:181846311 finding
Effect of daily zinc supplementation on child mortality in southern Nepal: a community-based, cluster randomised, placebo-controlled trial.record2007PMID:179209181 finding
Oral zinc supplementation in pregnant women and its effect on birth weight: a randomised controlled trial.record2005PMID:157240451 finding
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13.record2004PMID:151363201 finding
Other names
9 names
Resolves to: Zn(2+)
- Also called
- dietary zinczinc cationZINC IONzinc, ion (Zn2+)Zn(II)Zn2+
- Systematic name
- zinc(2+)zinc(2+) ionzinc(II) cation